primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
121895522,12189552,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,2,F,,20180306.0,20160318,20180314,EXP,,GB-ASTRAZENECA-2016SE28084,ASTRAZENECA,,59.0,YR,,F,Y,,,20180314.0,,OT,GB,GB,2018,Q1,Adult
126404464,12640446,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5110.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Cardiac failure,,2018,Q1,4,F,20160804.0,20180129.0,20160810,20180201,EXP,,IN-ASTRAZENECA-2016SE85612,ASTRAZENECA,,23365.0,DY,,M,Y,,,20180201.0,,MD,IN,IN,2018,Q1,Elderly
126404464,12640446,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5110.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Coronary artery disease,,2018,Q1,4,F,20160804.0,20180129.0,20160810,20180201,EXP,,IN-ASTRAZENECA-2016SE85612,ASTRAZENECA,,23365.0,DY,,M,Y,,,20180201.0,,MD,IN,IN,2018,Q1,Elderly
126404464,12640446,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5110.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Cardiac failure,,2018,Q1,4,F,20160804.0,20180129.0,20160810,20180201,EXP,,IN-ASTRAZENECA-2016SE85612,ASTRAZENECA,,23365.0,DY,,M,Y,,,20180201.0,,MD,IN,IN,2018,Q1,Elderly
126404464,12640446,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5110.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Coronary artery disease,,2018,Q1,4,F,20160804.0,20180129.0,20160810,20180201,EXP,,IN-ASTRAZENECA-2016SE85612,ASTRAZENECA,,23365.0,DY,,M,Y,,,20180201.0,,MD,IN,IN,2018,Q1,Elderly
126825388,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Blood bicarbonate decreased,,2018,Q1,8,F,,20180219.0,20160825,20180305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180305.0,,CN,IT,IT,2018,Q1,Adult
126825388,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Blood lactic acid increased,,2018,Q1,8,F,,20180219.0,20160825,20180305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180305.0,,CN,IT,IT,2018,Q1,Adult
126825388,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,8,F,,20180219.0,20160825,20180305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180305.0,,CN,IT,IT,2018,Q1,Adult
126825388,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Ketonuria,,2018,Q1,8,F,,20180219.0,20160825,20180305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180305.0,,CN,IT,IT,2018,Q1,Adult
126825388,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Metabolic acidosis,,2018,Q1,8,F,,20180219.0,20160825,20180305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180305.0,,CN,IT,IT,2018,Q1,Adult
134266615,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Blood bicarbonate decreased,,2018,Q1,5,F,,20180308.0,20170411,20180322,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180322.0,,OT,GB,IT,2018,Q1,Adult
134266615,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Blood lactic acid increased,,2018,Q1,5,F,,20180308.0,20170411,20180322,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180322.0,,OT,GB,IT,2018,Q1,Adult
134266615,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,5,F,,20180308.0,20170411,20180322,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180322.0,,OT,GB,IT,2018,Q1,Adult
134266615,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Ketonuria,,2018,Q1,5,F,,20180308.0,20170411,20180322,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180322.0,,OT,GB,IT,2018,Q1,Adult
134266615,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Metabolic acidosis,,2018,Q1,5,F,,20180308.0,20170411,20180322,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180322.0,,OT,GB,IT,2018,Q1,Adult
139113813,13911381,18,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q1,Blood pressure increased,,2018,Q1,3,F,2016.0,20180118.0,20170828,20180124,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180124.0,,OT,CA,CA,2018,Q1,Elderly
139113813,13911381,18,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q1,Crohn's disease,,2018,Q1,3,F,2016.0,20180118.0,20170828,20180124,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180124.0,,OT,CA,CA,2018,Q1,Elderly
139113813,13911381,18,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q1,Fatigue,,2018,Q1,3,F,2016.0,20180118.0,20170828,20180124,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180124.0,,OT,CA,CA,2018,Q1,Elderly
139113813,13911381,18,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q1,Laceration,,2018,Q1,3,F,2016.0,20180118.0,20170828,20180124,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180124.0,,OT,CA,CA,2018,Q1,Elderly
139113813,13911381,18,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q1,Type 1 diabetes mellitus,,2018,Q1,3,F,2016.0,20180118.0,20170828,20180124,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180124.0,,OT,CA,CA,2018,Q1,Elderly
140803025,14080302,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11210.0,MG,N,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,5,F,20170912.0,20180312.0,20171012,20180315,EXP,,AU-ASTRAZENECA-2017SE94134,ASTRAZENECA,,28397.0,DY,,M,Y,,,20180315.0,,MD,AU,AU,2018,Q1,Elderly
140803025,14080302,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11210.0,MG,N,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Urosepsis,,2018,Q1,5,F,20170912.0,20180312.0,20171012,20180315,EXP,,AU-ASTRAZENECA-2017SE94134,ASTRAZENECA,,28397.0,DY,,M,Y,,,20180315.0,,MD,AU,AU,2018,Q1,Elderly
141378262,14137826,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q1,Blood calcium decreased,,2018,Q1,2,F,,20171019.0,20171027,20180119,EXP,,PL-ASTRAZENECA-2017SF08503,ASTRAZENECA,,17.0,YR,,F,Y,,,20180118.0,,,PL,PL,2018,Q1,Youth
141378262,14137826,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q1,Cough,,2018,Q1,2,F,,20171019.0,20171027,20180119,EXP,,PL-ASTRAZENECA-2017SF08503,ASTRAZENECA,,17.0,YR,,F,Y,,,20180118.0,,,PL,PL,2018,Q1,Youth
141378262,14137826,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q1,Dysphonia,,2018,Q1,2,F,,20171019.0,20171027,20180119,EXP,,PL-ASTRAZENECA-2017SF08503,ASTRAZENECA,,17.0,YR,,F,Y,,,20180118.0,,,PL,PL,2018,Q1,Youth
141378262,14137826,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q1,Tetanus,,2018,Q1,2,F,,20171019.0,20171027,20180119,EXP,,PL-ASTRAZENECA-2017SF08503,ASTRAZENECA,,17.0,YR,,F,Y,,,20180118.0,,,PL,PL,2018,Q1,Youth
141604404,14160440,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,4,F,20170101.0,20171219.0,20171104,20180103,EXP,,IT-AUROBINDO-AUR-APL-2017-42848,AUROBINDO,BELVISO A.. DAPAGLIFLOZIN: OLTRE IL CONTROLLO GLICEMICO IN UN PAZIENTE DIABETICO SCOMPENSATO.. MEDIA. 2017;17:162-3,63.0,YR,,F,Y,,,20180102.0,,OT,IT,IT,2018,Q1,Adult
141655163,14165516,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Condition aggravated,,2018,Q1,3,F,20140201.0,20171220.0,20171107,20180105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100338,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,129.0,KG,20180105.0,,OT,IT,IT,2018,Q1,Adult
141655163,14165516,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,3,F,20140201.0,20171220.0,20171107,20180105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100338,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,129.0,KG,20180105.0,,OT,IT,IT,2018,Q1,Adult
141655163,14165516,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Drug ineffective,,2018,Q1,3,F,20140201.0,20171220.0,20171107,20180105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100338,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,129.0,KG,20180105.0,,OT,IT,IT,2018,Q1,Adult
141655163,14165516,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Glycosylated haemoglobin increased,,2018,Q1,3,F,20140201.0,20171220.0,20171107,20180105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100338,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,129.0,KG,20180105.0,,OT,IT,IT,2018,Q1,Adult
141655163,14165516,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Hyperglycaemia,,2018,Q1,3,F,20140201.0,20171220.0,20171107,20180105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100338,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,129.0,KG,20180105.0,,OT,IT,IT,2018,Q1,Adult
141655163,14165516,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Overdose,,2018,Q1,3,F,20140201.0,20171220.0,20171107,20180105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100338,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,129.0,KG,20180105.0,,OT,IT,IT,2018,Q1,Adult
141655163,14165516,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Weight increased,,2018,Q1,3,F,20140201.0,20171220.0,20171107,20180105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100338,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,129.0,KG,20180105.0,,OT,IT,IT,2018,Q1,Adult
141687315,14168731,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,5,F,2014.0,20171225.0,20171107,20180109,EXP,IT-MINISAL02-433704,IT-MYLANLABS-2017M1068934,MYLAN,,63.0,YR,,F,Y,,,20180109.0,,CN,IT,IT,2018,Q1,Adult
141687315,14168731,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,5,F,2014.0,20171225.0,20171107,20180109,EXP,IT-MINISAL02-433704,IT-MYLANLABS-2017M1068934,MYLAN,,63.0,YR,,F,Y,,,20180109.0,,CN,IT,IT,2018,Q1,Adult
142443713,14244371,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"UNK, 2X/DAY (BID)",,,,U,,,,,,,BID,2018,Q1,Latent tuberculosis,,2018,Q1,3,F,20171017.0,20171227.0,20171201,20180109,EXP,,DE-UCBSA-2017047950,UCB,,58.0,YR,,M,Y,95.0,KG,20180109.0,,MD,DE,DE,2018,Q1,Adult
142734622,14273462,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,,,,,202293.0,,,TABLET,,2018,Q1,Blood glucose increased,,2018,Q1,2,F,,20171206.0,20171211,20180115,EXP,,BR-ASTRAZENECA-2017SF25138,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20180115.0,,CN,BR,BR,2018,Q1,Adult
142734622,14273462,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,,,,,202293.0,,,TABLET,,2018,Q1,Cataract,,2018,Q1,2,F,,20171206.0,20171211,20180115,EXP,,BR-ASTRAZENECA-2017SF25138,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20180115.0,,CN,BR,BR,2018,Q1,Adult
142734622,14273462,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,,,,,202293.0,,,TABLET,,2018,Q1,Coronary artery disease,,2018,Q1,2,F,,20171206.0,20171211,20180115,EXP,,BR-ASTRAZENECA-2017SF25138,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20180115.0,,CN,BR,BR,2018,Q1,Adult
142734622,14273462,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,,,,,202293.0,,,TABLET,,2018,Q1,Intermittent claudication,,2018,Q1,2,F,,20171206.0,20171211,20180115,EXP,,BR-ASTRAZENECA-2017SF25138,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20180115.0,,CN,BR,BR,2018,Q1,Adult
142734622,14273462,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,,,,,202293.0,,,TABLET,,2018,Q1,Umbilical hernia,,2018,Q1,2,F,,20171206.0,20171211,20180115,EXP,,BR-ASTRAZENECA-2017SF25138,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20180115.0,,CN,BR,BR,2018,Q1,Adult
142734622,14273462,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,,,,,202293.0,,,TABLET,,2018,Q1,Weight decreased,,2018,Q1,2,F,,20171206.0,20171211,20180115,EXP,,BR-ASTRAZENECA-2017SF25138,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20180115.0,,CN,BR,BR,2018,Q1,Adult
142827412,14282741,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,2,F,2014.0,20171226.0,20171213,20180109,EXP,IT-MINISAL02-435560,IT-BAUSCH-BL-2017-033187,BAUSCH AND LOMB,BELVISO A. DAPAGLIFLOZIN: OLTRE IL CONTROLLO GLICEMICO IN UN PAZIENTE DIABETICO SCOMPENSATO. MEDIA. 2017;17:162-163.,63.0,YR,,F,Y,,,20180109.0,,OT,IT,IT,2018,Q1,Adult
143189222,14318922,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,2,F,2014.0,20171227.0,20171222,20180108,EXP,,IT-TAKEDA-2017EPA006450AA,TAKEDA,,63.0,YR,,F,Y,,,20180108.0,,OT,IT,IT,2018,Q1,Adult
143225852,14322585,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,2,F,20140101.0,20180130.0,20171225,20180207,EXP,IT-MINISAL02-435827,PHHY2017IT192924,SANDOZ,,63.0,YR,,F,Y,,,20180208.0,,OT,IT,IT,2018,Q1,Adult
143252082,14325208,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13180.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Ankle fracture,,2018,Q1,2,F,20171129.0,20171227.0,20171226,20180101,EXP,,PL-ASTRAZENECA-2017SF31991,ASTRAZENECA,,24162.0,DY,,F,Y,,,20180101.0,,MD,PL,PL,2018,Q1,Elderly
143294412,14329441,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q1,Diabetes mellitus,,2018,Q1,2,F,201701.0,20180124.0,20171227,20180207,EXP,,CZ-TEVA-2017-CZ-836300,TEVA,RADOVA B. AN EXPERIENCE WITH AN EARLY INITIATION OF A COMBINED FIXED THERAPY DEGLUDEC/LIRAGLUTIDE IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15(3):17-18.,50.0,YR,,M,Y,160.0,KG,20180207.0,,MD,CZ,CZ,2018,Q1,Adult
143294412,14329441,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q1,Glycosylated haemoglobin increased,,2018,Q1,2,F,201701.0,20180124.0,20171227,20180207,EXP,,CZ-TEVA-2017-CZ-836300,TEVA,RADOVA B. AN EXPERIENCE WITH AN EARLY INITIATION OF A COMBINED FIXED THERAPY DEGLUDEC/LIRAGLUTIDE IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15(3):17-18.,50.0,YR,,M,Y,160.0,KG,20180207.0,,MD,CZ,CZ,2018,Q1,Adult
143294412,14329441,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q1,Hyperglycaemia,,2018,Q1,2,F,201701.0,20180124.0,20171227,20180207,EXP,,CZ-TEVA-2017-CZ-836300,TEVA,RADOVA B. AN EXPERIENCE WITH AN EARLY INITIATION OF A COMBINED FIXED THERAPY DEGLUDEC/LIRAGLUTIDE IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2017;15(3):17-18.,50.0,YR,,M,Y,160.0,KG,20180207.0,,MD,CZ,CZ,2018,Q1,Adult
143354413,14335441,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetes mellitus,,2018,Q1,3,F,201604.0,20180109.0,20171229,20180116,EXP,,CZ-ASTRAZENECA-2017SF30703,ASTRAZENECA,,50.0,YR,,M,Y,160.0,KG,20180116.0,,MD,CZ,CZ,2018,Q1,Adult
143354413,14335441,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2018,Q1,Drug ineffective,,2018,Q1,3,F,201604.0,20180109.0,20171229,20180116,EXP,,CZ-ASTRAZENECA-2017SF30703,ASTRAZENECA,,50.0,YR,,M,Y,160.0,KG,20180116.0,,MD,CZ,CZ,2018,Q1,Adult
143416321,14341632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,110.0,MG,,,,,202293.0,5.0,MG,TABLET,QD,2018,Q1,International normalised ratio decreased,,2018,Q1,1,I,20171025.0,20171226.0,20180102,20180102,EXP,,GB-ASTRAZENECA-2017SF32153,ASTRAZENECA,,59.0,YR,,F,Y,75.0,KG,20180102.0,,,GB,GB,2018,Q1,Adult
143458251,14345825,2,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,D,U, UNKNOWN,,,,,,,2018,Q1,Ketoacidosis,,2018,Q1,1,I,,20171220.0,20180103,20180103,EXP,DE-BOEHRINGERINGELHEIM-2017-BI-063895,DE-TORRENT-00007497,TORRENT,,65.0,YR,,F,Y,,,20180103.0,,MD,DE,DE,2018,Q1,Elderly
143466721,14346672,21,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, UNK",,,,,,,,10.0,MG,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,1,I,2014.0,20171011.0,20180103,20180103,EXP,,IT-BAYER-2017-198370,BAYER,ANTONIO BELVISO. DAPAGLIFLOZIN: OLTRE IL CONTROLLO GLICEMICO IN UN PAZIENTE DIABETICO SCOMPENSATO. TUTTO DIABETE. 2017;17:162-163,63.0,YR,A,F,Y,,,20180103.0,,OT,GB,IT,2018,Q1,Adult
143518891,14351889,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Diabetes mellitus,,2018,Q1,1,I,201701.0,20171221.0,20180104,20180104,EXP,,CZ-MYLANLABS-2017M1083920,MYLAN,RADOVA B.. AN EXPERIENCE WITH AN EARLY INITIATION OF A COMBINED FIXED THERAPY DEGLUDEC/LIRAGLUTIDE IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII.. 2017;15(3):17-8,50.0,YR,,M,Y,160.0,KG,20180104.0,,MD,CZ,CZ,2018,Q1,Adult
143518891,14351889,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Glycosylated haemoglobin increased,,2018,Q1,1,I,201701.0,20171221.0,20180104,20180104,EXP,,CZ-MYLANLABS-2017M1083920,MYLAN,RADOVA B.. AN EXPERIENCE WITH AN EARLY INITIATION OF A COMBINED FIXED THERAPY DEGLUDEC/LIRAGLUTIDE IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII.. 2017;15(3):17-8,50.0,YR,,M,Y,160.0,KG,20180104.0,,MD,CZ,CZ,2018,Q1,Adult
143518891,14351889,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q1,Hyperglycaemia,,2018,Q1,1,I,201701.0,20171221.0,20180104,20180104,EXP,,CZ-MYLANLABS-2017M1083920,MYLAN,RADOVA B.. AN EXPERIENCE WITH AN EARLY INITIATION OF A COMBINED FIXED THERAPY DEGLUDEC/LIRAGLUTIDE IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII.. 2017;15(3):17-8,50.0,YR,,M,Y,160.0,KG,20180104.0,,MD,CZ,CZ,2018,Q1,Adult
143544962,14354496,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14800.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20171213.0,20180119.0,20180105,20180125,EXP,,CA-ASTRAZENECA-2017SF28798,ASTRAZENECA,,80.0,YR,,M,Y,,,20180125.0,,MD,CA,CA,2018,Q1,Elderly
143544962,14354496,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14800.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Hyperglycaemic hyperosmolar nonketotic syndrome,,2018,Q1,2,F,20171213.0,20180119.0,20180105,20180125,EXP,,CA-ASTRAZENECA-2017SF28798,ASTRAZENECA,,80.0,YR,,M,Y,,,20180125.0,,MD,CA,CA,2018,Q1,Elderly
143544962,14354496,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14800.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Loss of consciousness,,2018,Q1,2,F,20171213.0,20180119.0,20180105,20180125,EXP,,CA-ASTRAZENECA-2017SF28798,ASTRAZENECA,,80.0,YR,,M,Y,,,20180125.0,,MD,CA,CA,2018,Q1,Elderly
143544962,14354496,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14800.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20171213.0,20180119.0,20180105,20180125,EXP,,CA-ASTRAZENECA-2017SF28798,ASTRAZENECA,,80.0,YR,,M,Y,,,20180125.0,,MD,CA,CA,2018,Q1,Elderly
143544962,14354496,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14800.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Hyperglycaemic hyperosmolar nonketotic syndrome,,2018,Q1,2,F,20171213.0,20180119.0,20180105,20180125,EXP,,CA-ASTRAZENECA-2017SF28798,ASTRAZENECA,,80.0,YR,,M,Y,,,20180125.0,,MD,CA,CA,2018,Q1,Elderly
143544962,14354496,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14800.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Loss of consciousness,,2018,Q1,2,F,20171213.0,20180119.0,20180105,20180125,EXP,,CA-ASTRAZENECA-2017SF28798,ASTRAZENECA,,80.0,YR,,M,Y,,,20180125.0,,MD,CA,CA,2018,Q1,Elderly
143674901,14367490,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Micturition disorder,,2018,Q1,1,I,20170731.0,20180101.0,20180109,20180109,EXP,,GB-ASTRAZENECA-2018SE00611,ASTRAZENECA,,66.0,YR,,F,Y,55.0,KG,20180109.0,,,GB,GB,2018,Q1,Elderly
143674901,14367490,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Palpitations,,2018,Q1,1,I,20170731.0,20180101.0,20180109,20180109,EXP,,GB-ASTRAZENECA-2018SE00611,ASTRAZENECA,,66.0,YR,,F,Y,55.0,KG,20180109.0,,,GB,GB,2018,Q1,Elderly
143685702,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Blood bicarbonate decreased,,2018,Q1,2,F,,20180313.0,20180109,20180327,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180327.0,,OT,IT,IT,2018,Q1,Adult
143685702,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Blood lactic acid increased,,2018,Q1,2,F,,20180313.0,20180109,20180327,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180327.0,,OT,IT,IT,2018,Q1,Adult
143685702,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,2,F,,20180313.0,20180109,20180327,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180327.0,,OT,IT,IT,2018,Q1,Adult
143685702,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Ketonuria,,2018,Q1,2,F,,20180313.0,20180109,20180327,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180327.0,,OT,IT,IT,2018,Q1,Adult
143685702,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q1,Metabolic acidosis,,2018,Q1,2,F,,20180313.0,20180109,20180327,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180327.0,,OT,IT,IT,2018,Q1,Adult
143715121,14371512,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Liver function test abnormal,,2018,Q1,1,I,20171103.0,20180102.0,20180110,20180110,EXP,,CN-ASTRAZENECA-2018SE02446,ASTRAZENECA,,19630.0,DY,,M,Y,60.0,KG,20180110.0,,MD,CN,CN,2018,Q1,Elderly
143751041,14375104,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2018,Q1,Chest pain,,2018,Q1,1,I,201704.0,20180102.0,20180111,20180111,EXP,DE-BFARM-17414404,DE-009507513-1801DEU000567,MERCK,,70.0,YR,,F,Y,,,20180111.0,,MD,DE,DE,2018,Q1,Elderly
143751041,14375104,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2018,Q1,Gastrointestinal carcinoma,,2018,Q1,1,I,201704.0,20180102.0,20180111,20180111,EXP,DE-BFARM-17414404,DE-009507513-1801DEU000567,MERCK,,70.0,YR,,F,Y,,,20180111.0,,MD,DE,DE,2018,Q1,Elderly
143751041,14375104,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2018,Q1,Lymphadenopathy,,2018,Q1,1,I,201704.0,20180102.0,20180111,20180111,EXP,DE-BFARM-17414404,DE-009507513-1801DEU000567,MERCK,,70.0,YR,,F,Y,,,20180111.0,,MD,DE,DE,2018,Q1,Elderly
143751041,14375104,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2018,Q1,Neoplasm malignant,,2018,Q1,1,I,201704.0,20180102.0,20180111,20180111,EXP,DE-BFARM-17414404,DE-009507513-1801DEU000567,MERCK,,70.0,YR,,F,Y,,,20180111.0,,MD,DE,DE,2018,Q1,Elderly
143751041,14375104,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2018,Q1,Pancreatic disorder,,2018,Q1,1,I,201704.0,20180102.0,20180111,20180111,EXP,DE-BFARM-17414404,DE-009507513-1801DEU000567,MERCK,,70.0,YR,,F,Y,,,20180111.0,,MD,DE,DE,2018,Q1,Elderly
143837781,14383778,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,15170.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q1,Bone neoplasm,,2018,Q1,1,I,20171215.0,20180110.0,20180115,20180115,EXP,,US-ASTRAZENECA-2018SE04575,ASTRAZENECA,,26060.0,DY,,M,Y,,,20180115.0,,MD,US,US,2018,Q1,Elderly
143924331,14392433,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Lip swelling,,2018,Q1,1,I,20170922.0,20171215.0,20180116,20180116,EXP,,GB-ASTRAZENECA-2018SE06193,ASTRAZENECA,,26308.0,DY,,F,Y,104.0,KG,20180116.0,,MD,GB,GB,2018,Q1,Elderly
143924331,14392433,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Skin ulcer,,2018,Q1,1,I,20170922.0,20171215.0,20180116,20180116,EXP,,GB-ASTRAZENECA-2018SE06193,ASTRAZENECA,,26308.0,DY,,F,Y,104.0,KG,20180116.0,,MD,GB,GB,2018,Q1,Elderly
144057192,14405719,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,200.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20180109.0,20180202.0,20180118,20180208,EXP,,CA-ASTRAZENECA-2018SE05620,ASTRAZENECA,,27094.0,DY,,F,Y,,,20180208.0,,MD,CA,CA,2018,Q1,Elderly
144057192,14405719,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,200.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Dysarthria,,2018,Q1,2,F,20180109.0,20180202.0,20180118,20180208,EXP,,CA-ASTRAZENECA-2018SE05620,ASTRAZENECA,,27094.0,DY,,F,Y,,,20180208.0,,MD,CA,CA,2018,Q1,Elderly
144058621,14405862,1,PS,DAPAGLIFLOZINA + METFORMINA,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,56.0,DF,Y,U,,,205649.0,1.0,DF,TABLET,QD,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,20171225.0,20180112.0,20180118,20180118,EXP,,ES-ASTRAZENECA-2018SE04671,ASTRAZENECA,,72.0,YR,,M,Y,,,20180118.0,,MD,ES,ES,2018,Q1,Elderly
144086401,14408640,2,SS,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"UNK UNK, UNKNOWN",,,D,,,,,,,,,2018,Q1,Medication error,,2018,Q1,1,I,,20180102.0,20180118,20180118,EXP,,US-ENDO PHARMACEUTICALS INC-2018-013351,ENDO,"GUMMIN D D, MOWRY J B, SPYKER D A, BROOKS D E, FRASER M O, BANNER W.. 2016 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 34TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2017;55 (10):1072-1254",61.0,YR,,M,Y,,,20180119.0,,MD,US,US,2018,Q1,Adult
144113591,14411359,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Euglycaemic diabetic ketoacidosis,,2018,Q1,1,I,,20180112.0,20180119,20180119,EXP,,KW-ASTRAZENECA-2018SE06059,ASTRAZENECA,,28.0,YR,,F,Y,50.0,KG,20180119.0,,OT,KW,KW,2018,Q1,Young Adult
144113591,14411359,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Vulvovaginal discomfort,,2018,Q1,1,I,,20180112.0,20180119,20180119,EXP,,KW-ASTRAZENECA-2018SE06059,ASTRAZENECA,,28.0,YR,,F,Y,50.0,KG,20180119.0,,OT,KW,KW,2018,Q1,Young Adult
144113591,14411359,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Vulvovaginal pruritus,,2018,Q1,1,I,,20180112.0,20180119,20180119,EXP,,KW-ASTRAZENECA-2018SE06059,ASTRAZENECA,,28.0,YR,,F,Y,50.0,KG,20180119.0,,OT,KW,KW,2018,Q1,Young Adult
144258444,14425844,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, QD",,,,,,,,5.0,MG,TABLET,QD,2018,Q1,Diplopia,,2018,Q1,4,F,20170317.0,20180216.0,20180123,20180227,EXP,,GB-TAKEDA-2018TUS001692,TAKEDA,,59.0,YR,,M,Y,88.0,KG,20180227.0,,MD,GB,GB,2018,Q1,Adult
144258444,14425844,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, QD",,,,,,,,5.0,MG,TABLET,QD,2018,Q1,Nausea,,2018,Q1,4,F,20170317.0,20180216.0,20180123,20180227,EXP,,GB-TAKEDA-2018TUS001692,TAKEDA,,59.0,YR,,M,Y,88.0,KG,20180227.0,,MD,GB,GB,2018,Q1,Adult
144258444,14425844,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, QD",,,,,,,,5.0,MG,TABLET,QD,2018,Q1,Paraesthesia,,2018,Q1,4,F,20170317.0,20180216.0,20180123,20180227,EXP,,GB-TAKEDA-2018TUS001692,TAKEDA,,59.0,YR,,M,Y,88.0,KG,20180227.0,,MD,GB,GB,2018,Q1,Adult
144258444,14425844,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, QD",,,,,,,,5.0,MG,TABLET,QD,2018,Q1,Suicidal ideation,,2018,Q1,4,F,20170317.0,20180216.0,20180123,20180227,EXP,,GB-TAKEDA-2018TUS001692,TAKEDA,,59.0,YR,,M,Y,88.0,KG,20180227.0,,MD,GB,GB,2018,Q1,Adult
144311491,14431149,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13420.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q1,Renal cell carcinoma,,2018,Q1,1,I,20180109.0,20180120.0,20180124,20180124,EXP,,CA-ASTRAZENECA-2018SE09121,ASTRAZENECA,,89.0,YR,,M,Y,,,20180124.0,,MD,CA,CA,2018,Q1,Elderly
144327781,14432778,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Diabetic metabolic decompensation,,2018,Q1,1,I,2014.0,20171016.0,20180124,20180124,EXP,,PHHY2017IT155500,SANDOZ,,63.0,YR,,F,Y,,,20180124.0,,OT,IT,IT,2018,Q1,Adult
144381973,14438197,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,240.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,3,F,20171001.0,20180202.0,20180125,20180205,EXP,,CA-ASTRAZENECA-2018SE01524,ASTRAZENECA,,28824.0,DY,,F,Y,,,20180205.0,,MD,CA,CA,2018,Q1,Elderly
144381973,14438197,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,240.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Skin ulcer,,2018,Q1,3,F,20171001.0,20180202.0,20180125,20180205,EXP,,CA-ASTRAZENECA-2018SE01524,ASTRAZENECA,,28824.0,DY,,F,Y,,,20180205.0,,MD,CA,CA,2018,Q1,Elderly
144488071,14448807,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2018,Q1,Dehydration,,2018,Q1,1,I,20171104.0,20180117.0,20180126,20180126,EXP,,SG-009507513-1801SGP006789,MERCK,,56.0,YR,,F,Y,57.8,KG,20180126.0,,OT,SG,SG,2018,Q1,Adult
144488071,14448807,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2018,Q1,Drug eruption,,2018,Q1,1,I,20171104.0,20180117.0,20180126,20180126,EXP,,SG-009507513-1801SGP006789,MERCK,,56.0,YR,,F,Y,57.8,KG,20180126.0,,OT,SG,SG,2018,Q1,Adult
144488071,14448807,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2018,Q1,Euglycaemic diabetic ketoacidosis,,2018,Q1,1,I,20171104.0,20180117.0,20180126,20180126,EXP,,SG-009507513-1801SGP006789,MERCK,,56.0,YR,,F,Y,57.8,KG,20180126.0,,OT,SG,SG,2018,Q1,Adult
144488071,14448807,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2018,Q1,Hyperkalaemia,,2018,Q1,1,I,20171104.0,20180117.0,20180126,20180126,EXP,,SG-009507513-1801SGP006789,MERCK,,56.0,YR,,F,Y,57.8,KG,20180126.0,,OT,SG,SG,2018,Q1,Adult
144488071,14448807,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2018,Q1,Metabolic acidosis,,2018,Q1,1,I,20171104.0,20180117.0,20180126,20180126,EXP,,SG-009507513-1801SGP006789,MERCK,,56.0,YR,,F,Y,57.8,KG,20180126.0,,OT,SG,SG,2018,Q1,Adult
144595191,14459519,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,,,TABLET,,2018,Q1,Acute kidney injury,,2018,Q1,1,I,20171127.0,20180125.0,20180130,20180130,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180130.0,,MD,US,US,2018,Q1,Elderly
144595191,14459519,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,,,TABLET,,2018,Q1,Colitis,,2018,Q1,1,I,20171127.0,20180125.0,20180130,20180130,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180130.0,,MD,US,US,2018,Q1,Elderly
144595191,14459519,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,,,TABLET,,2018,Q1,Hernia,,2018,Q1,1,I,20171127.0,20180125.0,20180130,20180130,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180130.0,,MD,US,US,2018,Q1,Elderly
144595191,14459519,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,,,TABLET,,2018,Q1,Sepsis,,2018,Q1,1,I,20171127.0,20180125.0,20180130,20180130,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180130.0,,MD,US,US,2018,Q1,Elderly
144595191,14459519,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,,,TABLET,,2018,Q1,Small intestinal obstruction,,2018,Q1,1,I,20171127.0,20180125.0,20180130,20180130,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180130.0,,MD,US,US,2018,Q1,Elderly
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Alcohol abuse,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Amnesia,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Anxiety,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Asthenia,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Cerebrovascular accident,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Diabetes mellitus,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Diplopia,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Disturbance in attention,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Feeling of despair,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Hypertension,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Nausea,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Negative thoughts,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Panic disorder,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Panic reaction,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Paraesthesia,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Psychiatric symptom,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Suicidal ideation,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Tearfulness,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144717303,14471730,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, DAILY",,,U,,,,,5.0,MG,,QD,2018,Q1,Thinking abnormal,,2018,Q1,3,F,2009.0,20180226.0,20180131,20180307,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201801009982,ELI LILLY AND CO,,57.0,YR,,M,Y,88.0,KG,20180307.0,,CN,GB,GB,2018,Q1,Adult
144754201,14475420,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q1,Cardiac failure congestive,,2018,Q1,1,I,20170906.0,20170920.0,20180201,20180201,EXP,,BR-ASTRAZENECA-2017SE96260,ASTRAZENECA,,25028.0,DY,,M,Y,,,20180201.0,,MD,BR,BR,2018,Q1,Elderly
144754201,14475420,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q1,Urinary tract infection,,2018,Q1,1,I,20170906.0,20170920.0,20180201,20180201,EXP,,BR-ASTRAZENECA-2017SE96260,ASTRAZENECA,,25028.0,DY,,M,Y,,,20180201.0,,MD,BR,BR,2018,Q1,Elderly
144766791,14476679,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,,,2018,Q1,Diarrhoea,,2018,Q1,1,I,20170503.0,20180129.0,20180201,20180201,EXP,GB-MHRA-EYC 00172681,GB-BAUSCH-BL-2018-002943,BAUSCH AND LOMB,,65.0,YR,,M,Y,103.0,KG,20180201.0,,OT,GB,GB,2018,Q1,Elderly
144766791,14476679,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,,,2018,Q1,Hypokalaemia,,2018,Q1,1,I,20170503.0,20180129.0,20180201,20180201,EXP,GB-MHRA-EYC 00172681,GB-BAUSCH-BL-2018-002943,BAUSCH AND LOMB,,65.0,YR,,M,Y,103.0,KG,20180201.0,,OT,GB,GB,2018,Q1,Elderly
144820151,14482015,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2018,Q1,Toe amputation,,2018,Q1,1,I,20170810.0,,20180202,20180202,DIR,,,FDA-CTU,,58.0,YR,,M,N,101.8,KG,20180202.0,N,MD,US,US,2018,Q1,Adult
144820151,14482015,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,D,,,,10.0,MG,,QD,2018,Q1,Ulcer,,2018,Q1,1,I,20170810.0,,20180202,20180202,DIR,,,FDA-CTU,,58.0,YR,,M,N,101.8,KG,20180202.0,N,MD,US,US,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Alcohol abuse,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Amnesia,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Anxiety,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Asthenia,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Cerebrovascular accident,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Diabetes mellitus,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Diplopia,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Disturbance in attention,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Drug ineffective,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Feeling of despair,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Hypertension,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Job dissatisfaction,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Nausea,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Negative thoughts,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Panic disorder,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Panic reaction,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Paraesthesia,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Psychiatric symptom,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Suicidal ideation,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Tearfulness,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Thinking abnormal,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144829394,14482939,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MILLIGRAM, ONCE A DAY",,,,,,,,5.0,MG,,QD,2018,Q1,Treatment noncompliance,,2018,Q1,4,F,20170317.0,20180223.0,20180203,20180309,EXP,,GB-AUROBINDO-AUR-APL-2018-004374,AUROBINDO,,57.0,YR,,M,Y,88.0,KG,20180309.0,,MD,GB,GB,2018,Q1,Adult
144854341,14485434,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180125.0,20180205,20180205,EXP,,GB-ASTRAZENECA-2018SE10638,ASTRAZENECA,,73.0,YR,,F,Y,,,20180205.0,,,GB,GB,2018,Q1,Elderly
144882221,14488222,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,,,,,10.0,MG,,,2018,Q1,Euglycaemic diabetic ketoacidosis,,2018,Q1,1,I,,20180124.0,20180205,20180205,EXP,,"IE-IMPAX LABORATORIES, INC-2018-IPXL-00298",IMPAX,"DURKAN MC, O^SULLIVAN EP, O^BOYLE C. EUGLYCEMIC DKA POST-GASTRIC BYPASS IN A DM2 PATIENT ON A SGLT2 INHIBITOR: LESSONS LEARNED, NEW RECOMMENDATIONS. DIABETES. 2016;65(SUPPL 1):A314",51.0,YR,,F,Y,,,20180205.0,,OT,IE,IE,2018,Q1,Adult
144882221,14488222,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,,,,,10.0,MG,,,2018,Q1,Pneumonia,,2018,Q1,1,I,,20180124.0,20180205,20180205,EXP,,"IE-IMPAX LABORATORIES, INC-2018-IPXL-00298",IMPAX,"DURKAN MC, O^SULLIVAN EP, O^BOYLE C. EUGLYCEMIC DKA POST-GASTRIC BYPASS IN A DM2 PATIENT ON A SGLT2 INHIBITOR: LESSONS LEARNED, NEW RECOMMENDATIONS. DIABETES. 2016;65(SUPPL 1):A314",51.0,YR,,F,Y,,,20180205.0,,OT,IE,IE,2018,Q1,Adult
144983751,14498375,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,1.0,DF,UNSPECIFIED,,2018,Q1,Peripheral coldness,,2018,Q1,1,I,,20180130.0,20180207,20180207,EXP,,GB-JNJFOC-20180137433,JANSSEN,,48.0,YR,A,F,Y,67.0,KG,20180207.0,,PH,GB,GB,2018,Q1,Adult
144984652,14498465,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,440.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20170829.0,20180323.0,20180207,20180328,EXP,,BR-ASTRAZENECA-2018SE11986,ASTRAZENECA,,29432.0,DY,,M,Y,,,20180329.0,,MD,BR,BR,2018,Q1,Elderly
144984652,14498465,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,440.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q1,Cardiac failure,,2018,Q1,2,F,20170829.0,20180323.0,20180207,20180328,EXP,,BR-ASTRAZENECA-2018SE11986,ASTRAZENECA,,29432.0,DY,,M,Y,,,20180329.0,,MD,BR,BR,2018,Q1,Elderly
144985261,14498526,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,Y,,,,202293.0,5.0,MG,TABLET,,2018,Q1,Diarrhoea,,2018,Q1,1,I,20170503.0,20180130.0,20180207,20180207,EXP,,GB-ASTRAZENECA-2018SE12907,ASTRAZENECA,,65.0,YR,,M,Y,103.0,KG,20180207.0,,,GB,GB,2018,Q1,Elderly
144985261,14498526,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,Y,,,,202293.0,5.0,MG,TABLET,,2018,Q1,Hypokalaemia,,2018,Q1,1,I,20170503.0,20180130.0,20180207,20180207,EXP,,GB-ASTRAZENECA-2018SE12907,ASTRAZENECA,,65.0,YR,,M,Y,103.0,KG,20180207.0,,,GB,GB,2018,Q1,Elderly
145105101,14510510,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,TABLET,QD,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180202.0,20180209,20180209,EXP,,TW-ASTRAZENECA-2018SE14796,ASTRAZENECA,,64.0,YR,,F,Y,,,20180209.0,,OT,TW,TW,2018,Q1,Adult
145193491,14519349,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,440.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q1,Myocardial infarction,,2018,Q1,1,I,20180208.0,20180209.0,20180212,20180212,EXP,,PL-ASTRAZENECA-2018SE17897,ASTRAZENECA,,25602.0,DY,,M,Y,,,20180212.0,,MD,PL,PL,2018,Q1,Elderly
145197571,14519757,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,20180101.0,20180207.0,20180212,20180212,EXP,GB-MHRA-EYC 00173278,GB-BAUSCH-BL-2018-003919,BAUSCH AND LOMB,,54.0,YR,,F,Y,85.6,KG,20180212.0,,PH,GB,GB,2018,Q1,Adult
145197571,14519757,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Cough,,2018,Q1,1,I,20180101.0,20180207.0,20180212,20180212,EXP,GB-MHRA-EYC 00173278,GB-BAUSCH-BL-2018-003919,BAUSCH AND LOMB,,54.0,YR,,F,Y,85.6,KG,20180212.0,,PH,GB,GB,2018,Q1,Adult
145197571,14519757,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,1,I,20180101.0,20180207.0,20180212,20180212,EXP,GB-MHRA-EYC 00173278,GB-BAUSCH-BL-2018-003919,BAUSCH AND LOMB,,54.0,YR,,F,Y,85.6,KG,20180212.0,,PH,GB,GB,2018,Q1,Adult
145197571,14519757,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Pancreatitis acute,,2018,Q1,1,I,20180101.0,20180207.0,20180212,20180212,EXP,GB-MHRA-EYC 00173278,GB-BAUSCH-BL-2018-003919,BAUSCH AND LOMB,,54.0,YR,,F,Y,85.6,KG,20180212.0,,PH,GB,GB,2018,Q1,Adult
145245951,14524595,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,Y,U,,,,5.0,MG,,,2018,Q1,Diarrhoea,,2018,Q1,1,I,20170503.0,20180129.0,20180213,20180213,EXP,,GB-AUROBINDO-AUR-APL-2018-005819,AUROBINDO,,65.0,YR,,M,Y,103.0,KG,20180213.0,,OT,GB,GB,2018,Q1,Elderly
145245951,14524595,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,Y,U,,,,5.0,MG,,,2018,Q1,Hypokalaemia,,2018,Q1,1,I,20170503.0,20180129.0,20180213,20180213,EXP,,GB-AUROBINDO-AUR-APL-2018-005819,AUROBINDO,,65.0,YR,,M,Y,103.0,KG,20180213.0,,OT,GB,GB,2018,Q1,Elderly
145257731,14525773,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q1,Hyperglycaemia,,2018,Q1,1,I,,20180206.0,20180213,20180213,EXP,,SK-BAUSCH-BL-2018-003842,BAUSCH AND LOMB,,53.0,YR,,M,Y,140.0,KG,20180213.0,,MD,SK,SK,2018,Q1,Adult
145259861,14525986,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",55.0,MG,Y,,,,,5.0,MG,,QD,2018,Q1,Diarrhoea,,2018,Q1,1,I,20170503.0,20180129.0,20180213,20180213,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-013593,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,103.0,KG,20180213.0,,OT,GB,GB,2018,Q1,Elderly
145259861,14525986,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",55.0,MG,Y,,,,,5.0,MG,,QD,2018,Q1,Hypokalaemia,,2018,Q1,1,I,20170503.0,20180129.0,20180213,20180213,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-013593,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,103.0,KG,20180213.0,,OT,GB,GB,2018,Q1,Elderly
145264641,14526464,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14510.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q1,Transitional cell carcinoma,,2018,Q1,1,I,20180126.0,20180206.0,20180213,20180213,EXP,,CA-ASTRAZENECA-2018SE17103,ASTRAZENECA,,68.0,YR,,M,Y,,,20180213.0,,MD,CA,CA,2018,Q1,Elderly
145266062,14526606,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13690.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Pneumonia,,2018,Q1,2,F,20180121.0,20180210.0,20180213,20180216,EXP,,TH-ASTRAZENECA-2018SE16533,ASTRAZENECA,,29525.0,DY,,F,Y,,,20180216.0,,MD,TH,TH,2018,Q1,Elderly
145301201,14530120,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,TABLET,,2018,Q1,Confusional state,,2018,Q1,1,I,,20180206.0,20180214,20180214,EXP,,US-ASTRAZENECA-2018SE15885,ASTRAZENECA,,49.0,YR,,,Y,,,20180214.0,,OT,US,US,2018,Q1,Adult
145301201,14530120,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,TABLET,,2018,Q1,Intentional product misuse,,2018,Q1,1,I,,20180206.0,20180214,20180214,EXP,,US-ASTRAZENECA-2018SE15885,ASTRAZENECA,,49.0,YR,,,Y,,,20180214.0,,OT,US,US,2018,Q1,Adult
145301201,14530120,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,TABLET,,2018,Q1,Suicide attempt,,2018,Q1,1,I,,20180206.0,20180214,20180214,EXP,,US-ASTRAZENECA-2018SE15885,ASTRAZENECA,,49.0,YR,,,Y,,,20180214.0,,OT,US,US,2018,Q1,Adult
145302021,14530202,1,PS,DAPAGLIFLOZIN+METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,,,,205649.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180204.0,20180214,20180214,EXP,,US-ASTRAZENECA-2018SE15466,ASTRAZENECA,,28.0,YR,,F,Y,,,20180214.0,,MD,US,US,2018,Q1,Young Adult
145302021,14530202,1,PS,DAPAGLIFLOZIN+METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,,,,205649.0,,,TABLET,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180204.0,20180214,20180214,EXP,,US-ASTRAZENECA-2018SE15466,ASTRAZENECA,,28.0,YR,,F,Y,,,20180214.0,,MD,US,US,2018,Q1,Young Adult
145401251,14540125,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,,QD,2018,Q1,Diabetes mellitus inadequate control,,2018,Q1,1,I,,20180206.0,20180216,20180216,EXP,,TW-009507513-1802TWN003394,MERCK,"CHAN MJ, WENG CH, HSU CW, HUANG WH AND YEN TH. DAPAGLIFLOZIN ASSOCIATED KETOACIDOSIS: A MUST KNOW FACT FOR NEPHROLOGISTS. NEPHROLOGY. 2018;23(2):192",64.0,YR,,F,Y,,,20180216.0,,OT,TW,TW,2018,Q1,Adult
145454071,14545407,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Acute coronary syndrome,,2018,Q1,1,I,,20180205.0,20180219,20180219,EXP,,PHHY2018HU022399,SANDOZ,,66.0,YR,,M,Y,,,20180219.0,,OT,HU,HU,2018,Q1,Elderly
145454071,14545407,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Carbohydrate metabolism disorder,,2018,Q1,1,I,,20180205.0,20180219,20180219,EXP,,PHHY2018HU022399,SANDOZ,,66.0,YR,,M,Y,,,20180219.0,,OT,HU,HU,2018,Q1,Elderly
145454071,14545407,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Drug ineffective,,2018,Q1,1,I,,20180205.0,20180219,20180219,EXP,,PHHY2018HU022399,SANDOZ,,66.0,YR,,M,Y,,,20180219.0,,OT,HU,HU,2018,Q1,Elderly
145454071,14545407,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180205.0,20180219,20180219,EXP,,PHHY2018HU022399,SANDOZ,,66.0,YR,,M,Y,,,20180219.0,,OT,HU,HU,2018,Q1,Elderly
145493132,14549313,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,U,,,,,10.0,MG,,QD,2018,Q1,Supraventricular tachycardia,,2018,Q1,2,F,,20180315.0,20180219,20180320,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201802004592,ELI LILLY AND CO,,62.0,YR,,M,Y,75.2,KG,20180320.0,,MD,GB,GB,2018,Q1,Adult
145514911,14551491,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,20180101.0,20180207.0,20180220,20180220,EXP,GB-MHRA-EYC 00173278,GB-CONCORDIA PHARMACEUTICALS INC.-E2B_00009965,CONCORDIA,,54.0,YR,,F,Y,85.6,KG,20180220.0,,OT,GB,GB,2018,Q1,Adult
145514911,14551491,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Cough,,2018,Q1,1,I,20180101.0,20180207.0,20180220,20180220,EXP,GB-MHRA-EYC 00173278,GB-CONCORDIA PHARMACEUTICALS INC.-E2B_00009965,CONCORDIA,,54.0,YR,,F,Y,85.6,KG,20180220.0,,OT,GB,GB,2018,Q1,Adult
145514911,14551491,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,1,I,20180101.0,20180207.0,20180220,20180220,EXP,GB-MHRA-EYC 00173278,GB-CONCORDIA PHARMACEUTICALS INC.-E2B_00009965,CONCORDIA,,54.0,YR,,F,Y,85.6,KG,20180220.0,,OT,GB,GB,2018,Q1,Adult
145514911,14551491,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Pancreatitis acute,,2018,Q1,1,I,20180101.0,20180207.0,20180220,20180220,EXP,GB-MHRA-EYC 00173278,GB-CONCORDIA PHARMACEUTICALS INC.-E2B_00009965,CONCORDIA,,54.0,YR,,F,Y,85.6,KG,20180220.0,,OT,GB,GB,2018,Q1,Adult
145549191,14554919,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",10.0,MG,D,, JH2196,,,10.0,MG,,QD,2018,Q1,Blood potassium increased,,2018,Q1,1,I,20171201.0,20180209.0,20180220,20180220,EXP,,CN-NOVOPROD-585782,NOVO NORDISK,,48.0,YR,A,M,Y,91.0,KG,20180220.0,,OT,CN,CN,2018,Q1,Adult
145549191,14554919,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",10.0,MG,D,, JH2196,,,10.0,MG,,QD,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,20171201.0,20180209.0,20180220,20180220,EXP,,CN-NOVOPROD-585782,NOVO NORDISK,,48.0,YR,A,M,Y,91.0,KG,20180220.0,,OT,CN,CN,2018,Q1,Adult
145549191,14554919,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",10.0,MG,D,, JH2196,,,10.0,MG,,QD,2018,Q1,Nausea,,2018,Q1,1,I,20171201.0,20180209.0,20180220,20180220,EXP,,CN-NOVOPROD-585782,NOVO NORDISK,,48.0,YR,A,M,Y,91.0,KG,20180220.0,,OT,CN,CN,2018,Q1,Adult
145549191,14554919,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",10.0,MG,D,, JH2196,,,10.0,MG,,QD,2018,Q1,Renal impairment,,2018,Q1,1,I,20171201.0,20180209.0,20180220,20180220,EXP,,CN-NOVOPROD-585782,NOVO NORDISK,,48.0,YR,A,M,Y,91.0,KG,20180220.0,,OT,CN,CN,2018,Q1,Adult
145549191,14554919,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",10.0,MG,D,, JH2196,,,10.0,MG,,QD,2018,Q1,Vomiting,,2018,Q1,1,I,20171201.0,20180209.0,20180220,20180220,EXP,,CN-NOVOPROD-585782,NOVO NORDISK,,48.0,YR,A,M,Y,91.0,KG,20180220.0,,OT,CN,CN,2018,Q1,Adult
145608851,14560885,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Alice in wonderland syndrome,,2018,Q1,1,I,,20180214.0,20180222,20180222,EXP,,NL-ASTRAZENECA-2018SE20330,ASTRAZENECA,,45.0,YR,,M,Y,,,20180222.0,,OT,NL,NL,2018,Q1,Adult
145608851,14560885,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,,20180214.0,20180222,20180222,EXP,,NL-ASTRAZENECA-2018SE20330,ASTRAZENECA,,45.0,YR,,M,Y,,,20180222.0,,OT,NL,NL,2018,Q1,Adult
145693321,14569332,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,QD,2018,Q1,Toe amputation,,2018,Q1,1,I,,20180216.0,20180223,20180223,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-009951",BOEHRINGER INGELHEIM,"KHOURI C, CRACOWSKI J, ROUSTIT M. SGLT-2 INHIBITORS AND THE RISK OF LOWER-LIMB AMPUTATION: IS THIS A CLASS EFFECT. DIABETES OBESITY AND METABOLISM. 2018;.",56.0,YR,,F,Y,,,20180224.0,,MD,FR,US,2018,Q1,Adult
145783822,14578382,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4850.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Leg amputation,,2018,Q1,2,F,20170809.0,20180226.0,20180227,20180306,EXP,,GB-ASTRAZENECA-2018SE24566,ASTRAZENECA,,62.0,YR,,M,Y,77.0,KG,20180306.0,,,GB,GB,2018,Q1,Adult
145783822,14578382,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4850.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Peripheral ischaemia,,2018,Q1,2,F,20170809.0,20180226.0,20180227,20180306,EXP,,GB-ASTRAZENECA-2018SE24566,ASTRAZENECA,,62.0,YR,,M,Y,77.0,KG,20180306.0,,,GB,GB,2018,Q1,Adult
145875091,14587509,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,90.0,DF,,,,,,1.0,DF,,QD,2018,Q1,Pancreatic carcinoma,,2018,Q1,1,I,20180207.0,20180224.0,20180301,20180301,EXP,,GB-ASTRAZENECA-2018SE24452,ASTRAZENECA,,72.0,YR,,M,Y,100.0,KG,20180301.0,,,GB,GB,2018,Q1,Elderly
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Arthralgia,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Bone pain,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Cervical vertebral fracture,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Lip discolouration,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Musculoskeletal chest pain,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Oral mucosal discolouration,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Pain,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Pain in extremity,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Respiratory disorder,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Upper limb fracture,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145920351,14592035,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,U,,,,,,,,,2018,Q1,Weight decreased,,2018,Q1,1,I,,20180226.0,20180302,20180302,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK033524,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20180302.0,,MD,CA,CA,2018,Q1,Adult
145973011,14597301,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Brain oedema,,2018,Q1,1,I,20171117.0,20180224.0,20180305,20180305,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-018651,BRISTOL MYERS SQUIBB,,49.0,YR,,M,Y,,,20180305.0,,PH,GB,GB,2018,Q1,Adult
145973011,14597301,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Haemorrhage intracranial,,2018,Q1,1,I,20171117.0,20180224.0,20180305,20180305,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-018651,BRISTOL MYERS SQUIBB,,49.0,YR,,M,Y,,,20180305.0,,PH,GB,GB,2018,Q1,Adult
145973011,14597301,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Metastases to central nervous system,,2018,Q1,1,I,20171117.0,20180224.0,20180305,20180305,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-018651,BRISTOL MYERS SQUIBB,,49.0,YR,,M,Y,,,20180305.0,,PH,GB,GB,2018,Q1,Adult
145983361,14598336,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,20180206.0,20180226.0,20180305,20180305,EXP,,GB-ASTRAZENECA-2018SE25469,ASTRAZENECA,,51.0,YR,,M,Y,,,20180305.0,,,GB,GB,2018,Q1,Adult
146094161,14609416,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,20171105.0,20180226.0,20180307,20180307,EXP,,GB-ASTRAZENECA-2018SE24589,ASTRAZENECA,,54.0,YR,,M,Y,,,20180307.0,,OT,GB,GB,2018,Q1,Adult
146128311,14612831,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Pruritus,,2018,Q1,1,I,20180106.0,20180228.0,20180308,20180308,EXP,,CN-ASTRAZENECA-2018SE28452,ASTRAZENECA,,16793.0,DY,,M,Y,95.0,KG,20180308.0,,MD,CN,CN,2018,Q1,Elderly
146134571,14613457,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180306.0,20180308,20180308,EXP,,AU-009507513-1803AUS003210,MERCK,,59.0,YR,,M,Y,,,20180308.0,,OT,AU,AU,2018,Q1,Adult
146161932,14616193,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,,BID,2018,Q1,General physical health deterioration,,2018,Q1,2,F,20180213.0,20180308.0,20180309,20180313,EXP,,ES-ROCHE-2082970,ROCHE,,65.0,YR,,M,Y,93.0,KG,20180313.0,,MD,ES,ES,2018,Q1,Elderly
146172611,14617261,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,D,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180309,20180309,EXP,,AU-ASTRAZENECA-2018SE27382,ASTRAZENECA,,75.0,YR,,F,Y,,,20180309.0,,OT,AU,AU,2018,Q1,Elderly
146173981,14617398,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG UNKNOWN,,,U,,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180309,20180309,EXP,,AU-ASTRAZENECA-2018SE27331,ASTRAZENECA,,53.0,YR,,M,Y,,,20180309.0,,OT,AU,AU,2018,Q1,Adult
146175061,14617506,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG UNKNOWN,,,U,,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180309,20180309,EXP,,AU-ASTRAZENECA-2018SE27338,ASTRAZENECA,,67.0,YR,,F,Y,,,20180309.0,,OT,AU,AU,2018,Q1,Elderly
146176071,14617607,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q1,Constipation,,2018,Q1,1,I,20180214.0,20180301.0,20180309,20180309,EXP,,GB-ASTRAZENECA-2018SE26906,ASTRAZENECA,,51.0,YR,,F,Y,81.0,KG,20180309.0,,,GB,GB,2018,Q1,Adult
146176071,14617607,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q1,Lethargy,,2018,Q1,1,I,20180214.0,20180301.0,20180309,20180309,EXP,,GB-ASTRAZENECA-2018SE26906,ASTRAZENECA,,51.0,YR,,F,Y,81.0,KG,20180309.0,,,GB,GB,2018,Q1,Adult
146176071,14617607,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q1,Malaise,,2018,Q1,1,I,20180214.0,20180301.0,20180309,20180309,EXP,,GB-ASTRAZENECA-2018SE26906,ASTRAZENECA,,51.0,YR,,F,Y,81.0,KG,20180309.0,,,GB,GB,2018,Q1,Adult
146218371,14621837,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,20171128.0,20180228.0,20180310,20180310,EXP,,GB-ASTRAZENECA-2018SE26074,ASTRAZENECA,,46.0,YR,,F,Y,,,20180310.0,,OT,GB,GB,2018,Q1,Adult
146218381,14621838,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG UNKNOWN,,,U,,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180310,20180310,EXP,,AU-ASTRAZENECA-2018SE27343,ASTRAZENECA,,67.0,YR,,F,Y,,,20180310.0,,OT,AU,AU,2018,Q1,Elderly
146218981,14621898,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180310,20180310,EXP,,AU-ASTRAZENECA-2018SE27353,ASTRAZENECA,,38.0,YR,,F,Y,,,20180310.0,,OT,AU,AU,2018,Q1,Adult
146218991,14621899,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180310,20180310,EXP,,AU-ASTRAZENECA-2018SE27358,ASTRAZENECA,,82.0,YR,,M,Y,,,20180310.0,,OT,AU,AU,2018,Q1,Elderly
146219001,14621900,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180310,20180310,EXP,,AU-ASTRAZENECA-2018SE27363,ASTRAZENECA,,64.0,YR,,F,Y,,,20180310.0,,OT,AU,AU,2018,Q1,Adult
146219341,14621934,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180310,20180310,EXP,,AU-ASTRAZENECA-2018SE27369,ASTRAZENECA,,70.0,YR,,M,Y,,,20180310.0,,OT,AU,AU,2018,Q1,Elderly
146219351,14621935,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20180301.0,20180310,20180310,EXP,,AU-ASTRAZENECA-2018SE27378,ASTRAZENECA,,45.0,YR,,F,Y,,,20180310.0,,OT,AU,AU,2018,Q1,Adult
146251761,14625176,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Hyperkalaemia,,2018,Q1,1,I,20180228.0,20180302.0,20180312,20180312,EXP,,KR-ASTRAZENECA-2018SE28119,ASTRAZENECA,,25553.0,DY,,F,Y,,,20180312.0,,MD,KR,KR,2018,Q1,Elderly
146251761,14625176,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Pelvic fracture,,2018,Q1,1,I,20180228.0,20180302.0,20180312,20180312,EXP,,KR-ASTRAZENECA-2018SE28119,ASTRAZENECA,,25553.0,DY,,F,Y,,,20180312.0,,MD,KR,KR,2018,Q1,Elderly
146251761,14625176,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q1,Scapula fracture,,2018,Q1,1,I,20180228.0,20180302.0,20180312,20180312,EXP,,KR-ASTRAZENECA-2018SE28119,ASTRAZENECA,,25553.0,DY,,F,Y,,,20180312.0,,MD,KR,KR,2018,Q1,Elderly
146363291,14636329,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,Y,, UNKNOWN,,,5.0,MG,,,2018,Q1,Diarrhoea,,2018,Q1,1,I,20170503.0,20180306.0,20180314,20180314,EXP,GB-MHRA-EYC 00172681,PHHY2018GB042892,SANDOZ,,65.0,YR,,M,Y,103.0,KG,20180314.0,,OT,GB,GB,2018,Q1,Elderly
146363291,14636329,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,Y,, UNKNOWN,,,5.0,MG,,,2018,Q1,Hypokalaemia,,2018,Q1,1,I,20170503.0,20180306.0,20180314,20180314,EXP,GB-MHRA-EYC 00172681,PHHY2018GB042892,SANDOZ,,65.0,YR,,M,Y,103.0,KG,20180314.0,,OT,GB,GB,2018,Q1,Elderly
146363462,14636346,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,2,F,20171011.0,20180312.0,20180314,20180316,EXP,,GB-ASTRAZENECA-2018SE29984,ASTRAZENECA,,72.0,YR,,M,Y,,,20180316.0,,,GB,GB,2018,Q1,Elderly
146363462,14636346,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Arrhythmia,,2018,Q1,2,F,20171011.0,20180312.0,20180314,20180316,EXP,,GB-ASTRAZENECA-2018SE29984,ASTRAZENECA,,72.0,YR,,M,Y,,,20180316.0,,,GB,GB,2018,Q1,Elderly
146363462,14636346,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Dehydration,,2018,Q1,2,F,20171011.0,20180312.0,20180314,20180316,EXP,,GB-ASTRAZENECA-2018SE29984,ASTRAZENECA,,72.0,YR,,M,Y,,,20180316.0,,,GB,GB,2018,Q1,Elderly
146363462,14636346,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Metabolic acidosis,,2018,Q1,2,F,20171011.0,20180312.0,20180314,20180316,EXP,,GB-ASTRAZENECA-2018SE29984,ASTRAZENECA,,72.0,YR,,M,Y,,,20180316.0,,,GB,GB,2018,Q1,Elderly
146372161,14637216,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11680.0,MG,N,, NA,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Dry gangrene,,2018,Q1,1,I,20180221.0,20180308.0,20180314,20180314,EXP,,GB-ASTRAZENECA-2018SE29987,ASTRAZENECA,,59.0,YR,,F,Y,62.6,KG,20180314.0,,,GB,GB,2018,Q1,Adult
146387091,14638709,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2018,Q1,Diarrhoea,,2018,Q1,1,I,,20180305.0,20180315,20180315,EXP,GB-MHRA-EYC 00172681,GB-TEVA-2018-GB-869437,TEVA,,65.0,YR,,M,Y,103.0,KG,20180315.0,,OT,GB,GB,2018,Q1,Elderly
146387091,14638709,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2018,Q1,Hypokalaemia,,2018,Q1,1,I,,20180305.0,20180315,20180315,EXP,GB-MHRA-EYC 00172681,GB-TEVA-2018-GB-869437,TEVA,,65.0,YR,,M,Y,103.0,KG,20180315.0,,OT,GB,GB,2018,Q1,Elderly
146407511,14640751,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20161023.0,20180315,20180315,EXP,,GB-ASTRAZENECA-2016SF11967,ASTRAZENECA,,52.0,YR,,M,Y,,,20180315.0,,OT,GB,GB,2018,Q1,Adult
146408001,14640800,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20161023.0,20180315,20180315,EXP,,GB-ASTRAZENECA-2016SF11955,ASTRAZENECA,,59.0,YR,,,Y,,,20180315.0,,OT,GB,GB,2018,Q1,Adult
146408011,14640801,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,,20161023.0,20180315,20180315,EXP,,GB-ASTRAZENECA-2016SF11968,ASTRAZENECA,,37.0,YR,,F,Y,,,20180315.0,,OT,GB,GB,2018,Q1,Adult
146543552,14654355,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q1,Diabetic ketoacidosis,,2018,Q1,2,F,,20180306.0,20180319,20180319,EXP,,GB-ASTRAZENECA-2016SF11966,ASTRAZENECA,,51.0,YR,,F,Y,,,20180319.0,,OT,GB,GB,2018,Q1,Adult
146564531,14656453,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Haemoglobin decreased,,2018,Q1,1,I,20170724.0,,20180319,20180319,DIR,,,FDA-CTU,,52.0,YR,,M,N,142.88,KG,20180311.0,N,CN,US,US,2018,Q1,Adult
146564531,14656453,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Hepatic fibrosis,,2018,Q1,1,I,20170724.0,,20180319,20180319,DIR,,,FDA-CTU,,52.0,YR,,M,N,142.88,KG,20180311.0,N,CN,US,US,2018,Q1,Adult
146564531,14656453,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Platelet count decreased,,2018,Q1,1,I,20170724.0,,20180319,20180319,DIR,,,FDA-CTU,,52.0,YR,,M,N,142.88,KG,20180311.0,N,CN,US,US,2018,Q1,Adult
146564531,14656453,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,Red blood cell count decreased,,2018,Q1,1,I,20170724.0,,20180319,20180319,DIR,,,FDA-CTU,,52.0,YR,,M,N,142.88,KG,20180311.0,N,CN,US,US,2018,Q1,Adult
146564531,14656453,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q1,White blood cell count decreased,,2018,Q1,1,I,20170724.0,,20180319,20180319,DIR,,,FDA-CTU,,52.0,YR,,M,N,142.88,KG,20180311.0,N,CN,US,US,2018,Q1,Adult
146578281,14657828,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q1,Acute kidney injury,,2018,Q1,1,I,20171011.0,20180306.0,20180320,20180320,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-023483,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20180320.0,,PH,GB,GB,2018,Q1,Elderly
146578281,14657828,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q1,Arrhythmia,,2018,Q1,1,I,20171011.0,20180306.0,20180320,20180320,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-023483,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20180320.0,,PH,GB,GB,2018,Q1,Elderly
146578281,14657828,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q1,Dehydration,,2018,Q1,1,I,20171011.0,20180306.0,20180320,20180320,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-023483,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20180320.0,,PH,GB,GB,2018,Q1,Elderly
146578281,14657828,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q1,Metabolic acidosis,,2018,Q1,1,I,20171011.0,20180306.0,20180320,20180320,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-023483,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20180320.0,,PH,GB,GB,2018,Q1,Elderly
146581081,14658108,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10880.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Pyrexia,,2018,Q1,1,I,20171130.0,20180204.0,20180320,20180320,EXP,,AU-ASTRAZENECA-2018SE16203,ASTRAZENECA,,23644.0,DY,,M,Y,,,20180320.0,,MD,AU,AU,2018,Q1,Elderly
146581081,14658108,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10880.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Pyrexia,,2018,Q1,1,I,20171130.0,20180204.0,20180320,20180320,EXP,,AU-ASTRAZENECA-2018SE16203,ASTRAZENECA,,23644.0,DY,,M,Y,,,20180320.0,,MD,AU,AU,2018,Q1,Elderly
146581081,14658108,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10880.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Pyrexia,,2018,Q1,1,I,20171130.0,20180204.0,20180320,20180320,EXP,,AU-ASTRAZENECA-2018SE16203,ASTRAZENECA,,23644.0,DY,,M,Y,,,20180320.0,,MD,AU,AU,2018,Q1,Elderly
146590521,14659052,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Abdominal pain,,2018,Q1,1,I,20180223.0,20180312.0,20180320,20180320,EXP,,GB-ASTRAZENECA-2018SE31920,ASTRAZENECA,,58.0,YR,,F,Y,168.0,KG,20180320.0,,PH,GB,GB,2018,Q1,Adult
146590521,14659052,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Hyperhidrosis,,2018,Q1,1,I,20180223.0,20180312.0,20180320,20180320,EXP,,GB-ASTRAZENECA-2018SE31920,ASTRAZENECA,,58.0,YR,,F,Y,168.0,KG,20180320.0,,PH,GB,GB,2018,Q1,Adult
146590521,14659052,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Vomiting,,2018,Q1,1,I,20180223.0,20180312.0,20180320,20180320,EXP,,GB-ASTRAZENECA-2018SE31920,ASTRAZENECA,,58.0,YR,,F,Y,168.0,KG,20180320.0,,PH,GB,GB,2018,Q1,Adult
146593601,14659360,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,,20180312.0,20180320,20180320,EXP,GB-MHRA-EYC 00173278,GB-TEVA-2018-GB-871839,TEVA,,54.0,YR,,F,Y,85.6,KG,20180320.0,,PH,GB,GB,2018,Q1,Adult
146593601,14659360,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Cough,,2018,Q1,1,I,,20180312.0,20180320,20180320,EXP,GB-MHRA-EYC 00173278,GB-TEVA-2018-GB-871839,TEVA,,54.0,YR,,F,Y,85.6,KG,20180320.0,,PH,GB,GB,2018,Q1,Adult
146593601,14659360,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Dyspnoea,,2018,Q1,1,I,,20180312.0,20180320,20180320,EXP,GB-MHRA-EYC 00173278,GB-TEVA-2018-GB-871839,TEVA,,54.0,YR,,F,Y,85.6,KG,20180320.0,,PH,GB,GB,2018,Q1,Adult
146593601,14659360,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Pancreatitis acute,,2018,Q1,1,I,,20180312.0,20180320,20180320,EXP,GB-MHRA-EYC 00173278,GB-TEVA-2018-GB-871839,TEVA,,54.0,YR,,F,Y,85.6,KG,20180320.0,,PH,GB,GB,2018,Q1,Adult
146645351,14664535,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U,,,,10.0,MG,TABLET,QD,2018,Q1,Acute kidney injury,,2018,Q1,1,I,20171011.0,20180306.0,20180321,20180321,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-AUROBINDO-AUR-APL-2018-015004,AUROBINDO,,72.0,YR,,M,Y,,,20180321.0,,PH,GB,GB,2018,Q1,Elderly
146645351,14664535,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U,,,,10.0,MG,TABLET,QD,2018,Q1,Dehydration,,2018,Q1,1,I,20171011.0,20180306.0,20180321,20180321,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-AUROBINDO-AUR-APL-2018-015004,AUROBINDO,,72.0,YR,,M,Y,,,20180321.0,,PH,GB,GB,2018,Q1,Elderly
146645351,14664535,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U,,,,10.0,MG,TABLET,QD,2018,Q1,Metabolic acidosis,,2018,Q1,1,I,20171011.0,20180306.0,20180321,20180321,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-AUROBINDO-AUR-APL-2018-015004,AUROBINDO,,72.0,YR,,M,Y,,,20180321.0,,PH,GB,GB,2018,Q1,Elderly
146645351,14664535,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM,,,Y,U,,,,10.0,MG,TABLET,,2018,Q1,Acute kidney injury,,2018,Q1,1,I,20171011.0,20180306.0,20180321,20180321,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-AUROBINDO-AUR-APL-2018-015004,AUROBINDO,,72.0,YR,,M,Y,,,20180321.0,,PH,GB,GB,2018,Q1,Elderly
146645351,14664535,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM,,,Y,U,,,,10.0,MG,TABLET,,2018,Q1,Dehydration,,2018,Q1,1,I,20171011.0,20180306.0,20180321,20180321,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-AUROBINDO-AUR-APL-2018-015004,AUROBINDO,,72.0,YR,,M,Y,,,20180321.0,,PH,GB,GB,2018,Q1,Elderly
146645351,14664535,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM,,,Y,U,,,,10.0,MG,TABLET,,2018,Q1,Metabolic acidosis,,2018,Q1,1,I,20171011.0,20180306.0,20180321,20180321,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-AUROBINDO-AUR-APL-2018-015004,AUROBINDO,,72.0,YR,,M,Y,,,20180321.0,,PH,GB,GB,2018,Q1,Elderly
146649671,14664967,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2018,Q1,Diabetic ketoacidosis,,2018,Q1,1,I,20171013.0,,20180320,20180320,DIR,,,FDA-CTU,,41.0,YR,,M,N,101.0,KG,20180320.0,N,PH,US,US,2018,Q1,Adult
146649671,14664967,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2018,Q1,Duodenitis,,2018,Q1,1,I,20171013.0,,20180320,20180320,DIR,,,FDA-CTU,,41.0,YR,,M,N,101.0,KG,20180320.0,N,PH,US,US,2018,Q1,Adult
146649671,14664967,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2018,Q1,Hypertriglyceridaemia,,2018,Q1,1,I,20171013.0,,20180320,20180320,DIR,,,FDA-CTU,,41.0,YR,,M,N,101.0,KG,20180320.0,N,PH,US,US,2018,Q1,Adult
146649671,14664967,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2018,Q1,Metabolic acidosis,,2018,Q1,1,I,20171013.0,,20180320,20180320,DIR,,,FDA-CTU,,41.0,YR,,M,N,101.0,KG,20180320.0,N,PH,US,US,2018,Q1,Adult
146649671,14664967,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2018,Q1,Pancreatitis acute,,2018,Q1,1,I,20171013.0,,20180320,20180320,DIR,,,FDA-CTU,,41.0,YR,,M,N,101.0,KG,20180320.0,N,PH,US,US,2018,Q1,Adult
146649671,14664967,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2018,Q1,Sepsis,,2018,Q1,1,I,20171013.0,,20180320,20180320,DIR,,,FDA-CTU,,41.0,YR,,M,N,101.0,KG,20180320.0,N,PH,US,US,2018,Q1,Adult
146674231,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,,,2018,Q1,Acute kidney injury,,2018,Q1,1,I,20171011.0,20180308.0,20180322,20180322,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180322.0,,PH,GB,GB,2018,Q1,Elderly
146674231,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,,,2018,Q1,Arrhythmia,,2018,Q1,1,I,20171011.0,20180308.0,20180322,20180322,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180322.0,,PH,GB,GB,2018,Q1,Elderly
146674231,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,,,2018,Q1,Dehydration,,2018,Q1,1,I,20171011.0,20180308.0,20180322,20180322,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180322.0,,PH,GB,GB,2018,Q1,Elderly
146674231,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,,,2018,Q1,Metabolic acidosis,,2018,Q1,1,I,20171011.0,20180308.0,20180322,20180322,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180322.0,,PH,GB,GB,2018,Q1,Elderly
146721021,14672102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Anaemia,,2018,Q1,1,I,20180117.0,20180314.0,20180323,20180323,EXP,,AE-ASTRAZENECA-2018SE32809,ASTRAZENECA,,20316.0,DY,,M,Y,78.0,KG,20180323.0,,MD,AE,AE,2018,Q1,Elderly
146721021,14672102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q1,Haematuria,,2018,Q1,1,I,20180117.0,20180314.0,20180323,20180323,EXP,,AE-ASTRAZENECA-2018SE32809,ASTRAZENECA,,20316.0,DY,,M,Y,78.0,KG,20180323.0,,MD,AE,AE,2018,Q1,Elderly
146728381,14672838,2,SS,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,D,, UNKNOWN,,,,,,,2018,Q1,Medication error,,2018,Q1,1,I,,20180309.0,20180323,20180323,EXP,,US-LUPIN PHARMACEUTICALS INC.-2018-02465,LUPIN,,61.0,YR,,M,Y,,,20180323.0,,MD,US,US,2018,Q1,Adult
146750811,14675081,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,,,,,2018,Q1,Abdominal pain,,2018,Q1,1,I,201802.0,20180309.0,20180323,20180323,EXP,,"GR-OREXIGEN THERAPEUTICS, INC.-2044418",OREXIGEN THERAPEUTICS,,46.0,YR,,M,Y,,,20180323.0,,CN,GR,GR,2018,Q1,Adult
146750811,14675081,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,,,,,2018,Q1,Discomfort,,2018,Q1,1,I,201802.0,20180309.0,20180323,20180323,EXP,,"GR-OREXIGEN THERAPEUTICS, INC.-2044418",OREXIGEN THERAPEUTICS,,46.0,YR,,M,Y,,,20180323.0,,CN,GR,GR,2018,Q1,Adult
146750811,14675081,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,,,,,2018,Q1,Flatulence,,2018,Q1,1,I,201802.0,20180309.0,20180323,20180323,EXP,,"GR-OREXIGEN THERAPEUTICS, INC.-2044418",OREXIGEN THERAPEUTICS,,46.0,YR,,M,Y,,,20180323.0,,CN,GR,GR,2018,Q1,Adult
146750811,14675081,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,,,,,2018,Q1,Hyperhidrosis,,2018,Q1,1,I,201802.0,20180309.0,20180323,20180323,EXP,,"GR-OREXIGEN THERAPEUTICS, INC.-2044418",OREXIGEN THERAPEUTICS,,46.0,YR,,M,Y,,,20180323.0,,CN,GR,GR,2018,Q1,Adult
146750811,14675081,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,,,,,2018,Q1,Nausea,,2018,Q1,1,I,201802.0,20180309.0,20180323,20180323,EXP,,"GR-OREXIGEN THERAPEUTICS, INC.-2044418",OREXIGEN THERAPEUTICS,,46.0,YR,,M,Y,,,20180323.0,,CN,GR,GR,2018,Q1,Adult
146769551,14676955,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Condition aggravated,,2018,Q1,1,I,,20180316.0,20180324,20180324,EXP,GB-MHRA-EYC 00169353,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-025247,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,69.0,KG,20180324.0,,MD,GB,GB,2018,Q1,Elderly
146769551,14676955,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q1,Haemangioma of skin,,2018,Q1,1,I,,20180316.0,20180324,20180324,EXP,GB-MHRA-EYC 00169353,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-025247,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,69.0,KG,20180324.0,,MD,GB,GB,2018,Q1,Elderly
146905471,14690547,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2018,Q1,Blood bilirubin increased,,2018,Q1,1,I,201609.0,20180207.0,20180328,20180328,EXP,,SK-BAUSCH-BL-2018-003935,BAUSCH AND LOMB,,53.0,YR,,F,Y,102.0,KG,20180328.0,,MD,SK,SK,2018,Q1,Adult
146905471,14690547,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2018,Q1,Glycosylated haemoglobin increased,,2018,Q1,1,I,201609.0,20180207.0,20180328,20180328,EXP,,SK-BAUSCH-BL-2018-003935,BAUSCH AND LOMB,,53.0,YR,,F,Y,102.0,KG,20180328.0,,MD,SK,SK,2018,Q1,Adult
146905471,14690547,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2018,Q1,Weight increased,,2018,Q1,1,I,201609.0,20180207.0,20180328,20180328,EXP,,SK-BAUSCH-BL-2018-003935,BAUSCH AND LOMB,,53.0,YR,,F,Y,102.0,KG,20180328.0,,MD,SK,SK,2018,Q1,Adult
146943291,14694329,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2018,Q1,Hypoglycaemia,,2018,Q1,1,I,20180207.0,20180320.0,20180329,20180329,EXP,,GB-PFIZER INC-2018128359,PFIZER,,51.0,YR,,F,Y,,,20180329.0,,MD,GB,GB,2018,Q1,Adult
146982581,14698258,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Hypotension,,2018,Q1,1,I,20171116.0,20180131.0,20180330,20180330,EXP,,BR-ASTRAZENECA-2018SE13580,ASTRAZENECA,,18996.0,DY,,M,Y,,,20180330.0,,MD,BR,BR,2018,Q1,Elderly
146982581,14698258,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q1,Nephropathy,,2018,Q1,1,I,20171116.0,20180131.0,20180330,20180330,EXP,,BR-ASTRAZENECA-2018SE13580,ASTRAZENECA,,18996.0,DY,,M,Y,,,20180330.0,,MD,BR,BR,2018,Q1,Elderly
113288213,11328821,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,3880.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,3,F,20150708.0,20180627.0,20150731,20180628,EXP,,US-ASTRAZENECA-2015SE73836,ASTRAZENECA,,29491.0,DY,,F,Y,,,20180629.0,,MD,US,US,2018,Q2,Elderly
115195336,11519533,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4860.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acquired phimosis,,2018,Q2,6,F,20150806.0,20180418.0,20150918,20180531,EXP,,CZ-ASTRAZENECA-2015SE88947,ASTRAZENECA,,20671.0,DY,,M,Y,,,20180531.0,,MD,CZ,CZ,2018,Q2,Elderly
116162615,11616261,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2660.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Coronary artery disease,,2018,Q2,5,F,20150707.0,20180529.0,20151009,20180601,EXP,,TR-ASTRAZENECA-2015SE96851,ASTRAZENECA,,21460.0,DY,,M,Y,,,20180601.0,,MD,TR,TR,2018,Q2,Elderly
117387132,11738713,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acquired phimosis,,2018,Q2,2,F,20140301.0,20180323.0,20151113,20180420,EXP,,US-ASTRAZENECA-2014SE40498,ASTRAZENECA,,26632.0,DY,,M,Y,,,20180420.0,,CN,US,CZ,2018,Q2,Elderly
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Alanine aminotransferase increased,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Anaemia,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Aspartate aminotransferase increased,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Candidiasis of trachea,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Immune reconstitution inflammatory syndrome,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Pneumonia aspiration,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Progressive multifocal leukoencephalopathy,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Sepsis,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Staphylococcal infection,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
121389019,12138901,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2018,Q2,Toxoplasmosis,,2018,Q2,9,F,201601.0,20180405.0,20160302,20180416,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20180416.0,,MD,DE,DE,2018,Q2,Adult
126825389,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Blood bicarbonate decreased,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Blood lactic acid increased,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Ketonuria,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Metabolic acidosis,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Blood bicarbonate decreased,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Blood lactic acid increased,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Ketonuria,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
126825389,12682538,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Metabolic acidosis,,2018,Q2,9,F,,20180528.0,20160825,20180608,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20180608.0,,CN,IT,IT,2018,Q2,Adult
1278732910,12787329,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2018,Q2,Bronchitis,,2018,Q2,10,F,20160831.0,20180618.0,20160927,20180628,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20180628.0,,CN,US,US,2018,Q2,Adult
1278732910,12787329,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2018,Q2,Fatigue,,2018,Q2,10,F,20160831.0,20180618.0,20160927,20180628,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20180628.0,,CN,US,US,2018,Q2,Adult
1278732910,12787329,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2018,Q2,Malaise,,2018,Q2,10,F,20160831.0,20180618.0,20160927,20180628,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20180628.0,,CN,US,US,2018,Q2,Adult
1278732910,12787329,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2018,Q2,Pain,,2018,Q2,10,F,20160831.0,20180618.0,20160927,20180628,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20180628.0,,CN,US,US,2018,Q2,Adult
1278732910,12787329,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2018,Q2,Psoriatic arthropathy,,2018,Q2,10,F,20160831.0,20180618.0,20160927,20180628,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20180628.0,,CN,US,US,2018,Q2,Adult
1278732910,12787329,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2018,Q2,Rash,,2018,Q2,10,F,20160831.0,20180618.0,20160927,20180628,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20180628.0,,CN,US,US,2018,Q2,Adult
128890102,12889010,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,2,F,,20180412.0,20161027,20180419,EXP,,AU-ASTRAZENECA-2016SF08854,ASTRAZENECA,"COORAY SD, WORSLEY RN, SZTAL-MAZER S, BACH LA. SILENT DIABETIC KETOACIDOSIS: SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR-INDUCED EUGLYCAEMIC DIABETIC KETOACIDOSIS. 2016 JOINT ANNUAL SCIENTIFIC MEETING OF THE AUSTRALIAN DIABETES EDUCATORS ASSOCIATION (ADEA) AND AUSTRALIAN DIABETES SOCIETY (ADS) 2016;269..",51.0,YR,,M,Y,,,20180419.0,,MD,AU,AU,2018,Q2,Adult
133613472,13361347,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Abnormal loss of weight,,2018,Q2,2,F,20170308.0,20180427.0,20170323,20180503,EXP,,GB-ASTRAZENECA-2017SE28924,ASTRAZENECA,,45.0,YR,,F,Y,,,20180503.0,,OT,GB,GB,2018,Q2,Adult
133613472,13361347,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,2,F,20170308.0,20180427.0,20170323,20180503,EXP,,GB-ASTRAZENECA-2017SE28924,ASTRAZENECA,,45.0,YR,,F,Y,,,20180503.0,,OT,GB,GB,2018,Q2,Adult
133613472,13361347,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Malaise,,2018,Q2,2,F,20170308.0,20180427.0,20170323,20180503,EXP,,GB-ASTRAZENECA-2017SE28924,ASTRAZENECA,,45.0,YR,,F,Y,,,20180503.0,,OT,GB,GB,2018,Q2,Adult
133613472,13361347,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Polydipsia,,2018,Q2,2,F,20170308.0,20180427.0,20170323,20180503,EXP,,GB-ASTRAZENECA-2017SE28924,ASTRAZENECA,,45.0,YR,,F,Y,,,20180503.0,,OT,GB,GB,2018,Q2,Adult
133613472,13361347,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Polyuria,,2018,Q2,2,F,20170308.0,20180427.0,20170323,20180503,EXP,,GB-ASTRAZENECA-2017SE28924,ASTRAZENECA,,45.0,YR,,F,Y,,,20180503.0,,OT,GB,GB,2018,Q2,Adult
134141242,13414124,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,2,F,,20180601.0,20170407,20180605,EXP,,IT-BAUSCH-BL-2017-008643,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C. DIABETIC KETOACIDOSIS AND SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016;10(2):22.",61.0,YR,,M,Y,,,20180605.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Blood bicarbonate decreased,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Blood lactic acid increased,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Fatigue,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Ketonuria,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Metabolic acidosis,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Nausea,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134187494,13418749,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q2,Somnolence,,2018,Q2,4,F,,20180117.0,20170406,20180411,EXP,,PHHY2017IT046409,SANDOZ,,61.0,YR,,M,Y,,,20180411.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Blood bicarbonate decreased,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Blood lactic acid increased,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Fatigue,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Ketonuria,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Lactic acidosis,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Metabolic acidosis,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Nausea,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
134839264,13483926,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2018,Q2,Somnolence,,2018,Q2,4,F,,20180412.0,20170425,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-32887,AUROBINDO,,61.0,YR,,M,Y,,,20180426.0,,OT,IT,IT,2018,Q2,Adult
136920732,13692073,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,2,F,,20180412.0,20170627,20180420,EXP,,AU-ASTRAZENECA-2017SE63157,ASTRAZENECA,,59.0,YR,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Adult
136920732,13692073,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,2,F,,20180412.0,20170627,20180420,EXP,,AU-ASTRAZENECA-2017SE63157,ASTRAZENECA,,59.0,YR,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Adult
136920813,13692081,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,3,F,,20180412.0,20170627,20180423,EXP,,AU-ASTRAZENECA-2017SE63166,ASTRAZENECA,,64.0,YR,,F,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Adult
137181012,13718101,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,7919.583,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Necrotising fasciitis,,2018,Q2,2,F,20170425.0,20180509.0,20170705,20180517,EXP,,GB-ASTRAZENECA-2017SE67952,ASTRAZENECA,,60.0,YR,,M,Y,,,20180517.0,,OT,AE,GB,2018,Q2,Adult
137181012,13718101,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,7919.583,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Scrotal gangrene,,2018,Q2,2,F,20170425.0,20180509.0,20170705,20180517,EXP,,GB-ASTRAZENECA-2017SE67952,ASTRAZENECA,,60.0,YR,,M,Y,,,20180517.0,,OT,AE,GB,2018,Q2,Adult
137181012,13718101,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,7919.583,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Sepsis,,2018,Q2,2,F,20170425.0,20180509.0,20170705,20180517,EXP,,GB-ASTRAZENECA-2017SE67952,ASTRAZENECA,,60.0,YR,,M,Y,,,20180517.0,,OT,AE,GB,2018,Q2,Adult
137598944,13759894,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,UNSPECIFIED,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,4,F,20151023.0,20180508.0,20170717,20180511,EXP,,US-JNJFOC-20170709139,JANSSEN,,55.0,YR,A,F,Y,,,20180511.0,,CN,US,US,2018,Q2,Adult
137598944,13759894,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,UNSPECIFIED,,2018,Q2,Sepsis,,2018,Q2,4,F,20151023.0,20180508.0,20170717,20180511,EXP,,US-JNJFOC-20170709139,JANSSEN,,55.0,YR,A,F,Y,,,20180511.0,,CN,US,US,2018,Q2,Adult
138557952,13855795,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Angina unstable,,2018,Q2,2,F,20160313.0,20180404.0,20170810,20180404,EXP,,US-EISAI MEDICAL RESEARCH-EC-2016-015280,EISAI,,67.0,YR,,M,Y,95.8,KG,20180404.0,,MD,US,US,2018,Q2,Elderly
138557952,13855795,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Coronary artery disease,,2018,Q2,2,F,20160313.0,20180404.0,20170810,20180404,EXP,,US-EISAI MEDICAL RESEARCH-EC-2016-015280,EISAI,,67.0,YR,,M,Y,95.8,KG,20180404.0,,MD,US,US,2018,Q2,Elderly
139211214,13921121,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1690.0,MG,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Cardiac failure,,2018,Q2,4,F,20170823.0,20180404.0,20170830,20180412,EXP,,KR-ASTRAZENECA-2017SE86785,ASTRAZENECA,,20030.0,DY,,M,Y,,,20180413.0,,MD,KR,KR,2018,Q2,Elderly
139410036,13941003,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,9270.0,MG,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Angina pectoris,,2018,Q2,6,F,20170817.0,20180411.0,20170906,20180418,EXP,,US-ASTRAZENECA-2017SE88827,ASTRAZENECA,,25268.0,DY,,M,Y,,,20180419.0,,MD,US,US,2018,Q2,Elderly
139410036,13941003,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,9270.0,MG,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Coronary artery disease,,2018,Q2,6,F,20170817.0,20180411.0,20170906,20180418,EXP,,US-ASTRAZENECA-2017SE88827,ASTRAZENECA,,25268.0,DY,,M,Y,,,20180419.0,,MD,US,US,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Blood glucose increased,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Decreased appetite,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Dizziness,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Flatulence,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Hyperglycaemia,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Jaundice,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Pancreatic carcinoma,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Psychiatric symptom,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
139651196,13965119,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, EVERY 12 HOURS",,,U,,,,,,,TABLET,Q12H,2018,Q2,Weight decreased,,2018,Q2,6,F,20170806.0,20180403.0,20170913,20180406,EXP,,CO-ASTELLAS-2017US036244,ASTELLAS,,65.0,YR,,M,Y,,,20180406.0,,CN,CO,CO,2018,Q2,Elderly
140706404,14070640,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,100.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Obstructive pancreatitis,,2018,Q2,4,F,20170930.0,20180426.0,20171011,20180502,EXP,,CA-ASTRAZENECA-2017SF00150,ASTRAZENECA,,20940.0,DY,,F,Y,,,20180502.0,,MD,CA,CA,2018,Q2,Elderly
141565504,14156550,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,(),,,D,,,,,,,TABLET,,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171010.0,20180602.0,20171103,20180614,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20180614.0,,MD,GB,GB,2018,Q2,Elderly
141565504,14156550,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,(),,,D,,,,,,,TABLET,,2018,Q2,Epididymitis,,2018,Q2,4,F,20171010.0,20180602.0,20171103,20180614,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20180614.0,,MD,GB,GB,2018,Q2,Elderly
141565504,14156550,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,(),,,D,,,,,,,TABLET,,2018,Q2,Hypotension,,2018,Q2,4,F,20171010.0,20180602.0,20171103,20180614,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20180614.0,,MD,GB,GB,2018,Q2,Elderly
141604426,14160442,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Condition aggravated,,2018,Q2,6,F,20140201.0,20180412.0,20171104,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-42849,AUROBINDO,,54.0,YR,,M,Y,129.0,KG,20180426.0,,CN,IT,IT,2018,Q2,Adult
141604426,14160442,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,6,F,20140201.0,20180412.0,20171104,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-42849,AUROBINDO,,54.0,YR,,M,Y,129.0,KG,20180426.0,,CN,IT,IT,2018,Q2,Adult
141604426,14160442,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Drug ineffective,,2018,Q2,6,F,20140201.0,20180412.0,20171104,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-42849,AUROBINDO,,54.0,YR,,M,Y,129.0,KG,20180426.0,,CN,IT,IT,2018,Q2,Adult
141604426,14160442,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Glycosylated haemoglobin increased,,2018,Q2,6,F,20140201.0,20180412.0,20171104,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-42849,AUROBINDO,,54.0,YR,,M,Y,129.0,KG,20180426.0,,CN,IT,IT,2018,Q2,Adult
141604426,14160442,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Hyperglycaemia,,2018,Q2,6,F,20140201.0,20180412.0,20171104,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-42849,AUROBINDO,,54.0,YR,,M,Y,129.0,KG,20180426.0,,CN,IT,IT,2018,Q2,Adult
141604426,14160442,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q2,Weight increased,,2018,Q2,6,F,20140201.0,20180412.0,20171104,20180426,EXP,,IT-AUROBINDO-AUR-APL-2017-42849,AUROBINDO,,54.0,YR,,M,Y,129.0,KG,20180426.0,,CN,IT,IT,2018,Q2,Adult
141686062,14168606,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q2,Epididymitis,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q2,Feeling hot,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q2,Groin pain,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141686062,14168606,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q2,Hypotension,,2018,Q2,2,F,20171012.0,20180326.0,20171108,20180405,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20180405.0,,MD,GB,GB,2018,Q2,Elderly
141687316,14168731,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,6,F,20140601.0,20180614.0,20171107,20180626,EXP,IT-MINISAL02-433704,IT-MYLANLABS-2017M1068934,MYLAN,,63.0,YR,,F,Y,,,20180623.0,,CN,IT,IT,2018,Q2,Adult
141687316,14168731,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,6,F,20140601.0,20180614.0,20171107,20180626,EXP,IT-MINISAL02-433704,IT-MYLANLABS-2017M1068934,MYLAN,,63.0,YR,,F,Y,,,20180623.0,,CN,IT,IT,2018,Q2,Adult
141720007,14172000,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,7,F,20140101.0,20180614.0,20171108,20180626,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-101086,BRISTOL MYERS SQUIBB,BELVISO A. DAPAGLIFLOZIN: OLTRE IL CONTROLLO GLICEMICO IN UN PAZIENTE DIABETICO SCOMPENSATO. TUTTO DIABETE. 2017;17:162-3,63.0,YR,,F,Y,,,20180626.0,,OT,IT,IT,2018,Q2,Adult
141779704,14177970,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,, UNKNOWN,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171010.0,20180604.0,20171110,20180615,EXP,GB-MHRA-ADR 24225544,GB-LUPIN PHARMACEUTICALS INC.-2017-06387,LUPIN,,78.0,YR,,M,Y,,,20180615.0,,CN,GB,GB,2018,Q2,Elderly
141779704,14177970,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,, UNKNOWN,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,,2018,Q2,4,F,20171010.0,20180604.0,20171110,20180615,EXP,GB-MHRA-ADR 24225544,GB-LUPIN PHARMACEUTICALS INC.-2017-06387,LUPIN,,78.0,YR,,M,Y,,,20180615.0,,CN,GB,GB,2018,Q2,Elderly
141779704,14177970,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,, UNKNOWN,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,,2018,Q2,4,F,20171010.0,20180604.0,20171110,20180615,EXP,GB-MHRA-ADR 24225544,GB-LUPIN PHARMACEUTICALS INC.-2017-06387,LUPIN,,78.0,YR,,M,Y,,,20180615.0,,CN,GB,GB,2018,Q2,Elderly
141779704,14177970,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,, UNKNOWN,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171010.0,20180604.0,20171110,20180615,EXP,GB-MHRA-ADR 24225544,GB-LUPIN PHARMACEUTICALS INC.-2017-06387,LUPIN,,78.0,YR,,M,Y,,,20180615.0,,CN,GB,GB,2018,Q2,Elderly
141779704,14177970,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,, UNKNOWN,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,,2018,Q2,4,F,20171010.0,20180604.0,20171110,20180615,EXP,GB-MHRA-ADR 24225544,GB-LUPIN PHARMACEUTICALS INC.-2017-06387,LUPIN,,78.0,YR,,M,Y,,,20180615.0,,CN,GB,GB,2018,Q2,Elderly
141779704,14177970,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,, UNKNOWN,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,,2018,Q2,4,F,20171010.0,20180604.0,20171110,20180615,EXP,GB-MHRA-ADR 24225544,GB-LUPIN PHARMACEUTICALS INC.-2017-06387,LUPIN,,78.0,YR,,M,Y,,,20180615.0,,CN,GB,GB,2018,Q2,Elderly
142363367,14236336,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2018,Q2,Colitis,,2018,Q2,7,F,20170727.0,20180403.0,20171129,20180423,EXP,,US-ASTRAZENECA-2017SE78523,ASTRAZENECA,,74.0,YR,,F,Y,58.2,KG,20180423.0,,MD,US,US,2018,Q2,Elderly
142827414,14282741,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,4,F,20140101.0,20180624.0,20171213,20180629,EXP,IT-MINISAL02-433704,IT-BAUSCH-BL-2017-033187,BAUSCH AND LOMB,BELVISO A. DAPAGLIFLOZIN: BEYOND THE GLYCEMIC CONTROL IN A DECOMPENSATED DIABETIC PATIENT. ALL DIABETES. 2017;17:162-163.,63.0,YR,,F,Y,,,20180629.0,,OT,IT,IT,2018,Q2,Adult
142831994,14283199,2,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,TABLET,,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171010.0,20180521.0,20171213,20180525,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20180526.0,,MD,GB,GB,2018,Q2,Elderly
142831994,14283199,2,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,TABLET,,2018,Q2,Epididymitis,,2018,Q2,4,F,20171010.0,20180521.0,20171213,20180525,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20180526.0,,MD,GB,GB,2018,Q2,Elderly
142831994,14283199,2,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,TABLET,,2018,Q2,Hypotension,,2018,Q2,4,F,20171010.0,20180521.0,20171213,20180525,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20180526.0,,MD,GB,GB,2018,Q2,Elderly
142831994,14283199,3,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,TABLET,,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171010.0,20180521.0,20171213,20180525,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20180526.0,,MD,GB,GB,2018,Q2,Elderly
142831994,14283199,3,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,TABLET,,2018,Q2,Epididymitis,,2018,Q2,4,F,20171010.0,20180521.0,20171213,20180525,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20180526.0,,MD,GB,GB,2018,Q2,Elderly
142831994,14283199,3,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,TABLET,,2018,Q2,Hypotension,,2018,Q2,4,F,20171010.0,20180521.0,20171213,20180525,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20180526.0,,MD,GB,GB,2018,Q2,Elderly
143194322,14319432,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,,,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171012.0,20180612.0,20171222,20180620,EXP,GB-ASTRAZENECA-2017SF05024,GB-TEVA-2017-GB-835515,TEVA,,78.0,YR,,M,Y,,,20180620.0,,MD,GB,GB,2018,Q2,Elderly
143194322,14319432,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,,,,,2018,Q2,Hypotension,,2018,Q2,2,F,20171012.0,20180612.0,20171222,20180620,EXP,GB-ASTRAZENECA-2017SF05024,GB-TEVA-2017-GB-835515,TEVA,,78.0,YR,,M,Y,,,20180620.0,,MD,GB,GB,2018,Q2,Elderly
143685703,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Blood bicarbonate decreased,,2018,Q2,3,F,,20180528.0,20180109,20180604,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180604.0,,OT,IT,IT,2018,Q2,Adult
143685703,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Blood lactic acid increased,,2018,Q2,3,F,,20180528.0,20180109,20180604,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180604.0,,OT,IT,IT,2018,Q2,Adult
143685703,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,3,F,,20180528.0,20180109,20180604,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180604.0,,OT,IT,IT,2018,Q2,Adult
143685703,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Ketonuria,,2018,Q2,3,F,,20180528.0,20180109,20180604,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180604.0,,OT,IT,IT,2018,Q2,Adult
143685703,14368570,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2018,Q2,Metabolic acidosis,,2018,Q2,3,F,,20180528.0,20180109,20180604,EXP,IT-EMA-DD-20171219-KHAREEVHP-172910,IT-BAUSCH-BL-2017-036488,BAUSCH AND LOMB,"CASTELLINI M, DAFFINI L, MORETTI L, GIACOMELLI L, BULGARI G, AGGIUSTI C, TACCHETTI M, ETTORI S, ZANOLINI G, PAGANI A, SALA N. DIABETIC KETOACIDOSIS AND SODIUMGLUCOSE COTRANSPORTER 2 INHIBITORS: A CLINICAL CASE.. ITALIAN JOURNAL OF MEDICINE. 2016 MAY;10(S2):22.",61.0,YR,,M,Y,,,20180604.0,,OT,IT,IT,2018,Q2,Adult
144381974,14438197,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171001.0,20180604.0,20180125,20180607,EXP,,CA-ASTRAZENECA-2018SE01524,ASTRAZENECA,,28824.0,DY,,F,Y,,,20180607.0,,MD,CA,CA,2018,Q2,Elderly
144381974,14438197,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Wound,,2018,Q2,4,F,20171001.0,20180604.0,20180125,20180607,EXP,,CA-ASTRAZENECA-2018SE01524,ASTRAZENECA,,28824.0,DY,,F,Y,,,20180607.0,,MD,CA,CA,2018,Q2,Elderly
144381974,14438197,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20171001.0,20180604.0,20180125,20180607,EXP,,CA-ASTRAZENECA-2018SE01524,ASTRAZENECA,,28824.0,DY,,F,Y,,,20180607.0,,MD,CA,CA,2018,Q2,Elderly
144381974,14438197,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Wound,,2018,Q2,4,F,20171001.0,20180604.0,20180125,20180607,EXP,,CA-ASTRAZENECA-2018SE01524,ASTRAZENECA,,28824.0,DY,,F,Y,,,20180607.0,,MD,CA,CA,2018,Q2,Elderly
144595192,14459519,6,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7410.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Abdominal hernia,,2018,Q2,2,F,20171127.0,20180515.0,20180130,20180531,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180601.0,,MD,US,US,2018,Q2,Elderly
144595192,14459519,6,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7410.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171127.0,20180515.0,20180130,20180531,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180601.0,,MD,US,US,2018,Q2,Elderly
144595192,14459519,6,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7410.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Colitis,,2018,Q2,2,F,20171127.0,20180515.0,20180130,20180531,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180601.0,,MD,US,US,2018,Q2,Elderly
144595192,14459519,6,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7410.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Sepsis,,2018,Q2,2,F,20171127.0,20180515.0,20180130,20180531,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180601.0,,MD,US,US,2018,Q2,Elderly
144595192,14459519,6,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7410.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Small intestinal obstruction,,2018,Q2,2,F,20171127.0,20180515.0,20180130,20180531,EXP,,US-ASTRAZENECA-2018SE11277,ASTRAZENECA,,23500.0,DY,,M,Y,,,20180601.0,,MD,US,US,2018,Q2,Elderly
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Alcohol abuse,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Amnesia,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Anxiety,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Asthenia,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Cerebrovascular accident,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Diabetes mellitus,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Diplopia,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Disturbance in attention,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Drug ineffective,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Hypertension,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Job dissatisfaction,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Nausea,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Negative thoughts,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Panic disorder,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Panic reaction,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Paraesthesia,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Psychiatric symptom,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Suicidal ideation,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Tearfulness,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Thinking abnormal,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145259733,14525973,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, QD",,,D,,,,,5.0,MG,,QD,2018,Q2,Treatment noncompliance,,2018,Q2,3,F,20170317.0,20180419.0,20180213,20180501,EXP,,GB-MYLANLABS-2018M1008529,MYLAN,,57.0,YR,,M,Y,88.0,KG,20180501.0,,MD,GB,GB,2018,Q2,Adult
145264642,14526464,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14510.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Transitional cell carcinoma,,2018,Q2,2,F,20180126.0,20180615.0,20180213,20180620,EXP,,CA-ASTRAZENECA-2018SE17103,ASTRAZENECA,,68.0,YR,,M,Y,,,20180620.0,,MD,CA,CA,2018,Q2,Elderly
146351023,14635102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,3,F,20180217.0,20180507.0,20180314,20180515,EXP,,GB-ASTRAZENECA-2018SE28673,ASTRAZENECA,,81.0,YR,,F,Y,70.0,KG,20180515.0,,MD,GB,GB,2018,Q2,Elderly
146351023,14635102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Dyspnoea,,2018,Q2,3,F,20180217.0,20180507.0,20180314,20180515,EXP,,GB-ASTRAZENECA-2018SE28673,ASTRAZENECA,,81.0,YR,,F,Y,70.0,KG,20180515.0,,MD,GB,GB,2018,Q2,Elderly
146351023,14635102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Pneumonia,,2018,Q2,3,F,20180217.0,20180507.0,20180314,20180515,EXP,,GB-ASTRAZENECA-2018SE28673,ASTRAZENECA,,81.0,YR,,F,Y,70.0,KG,20180515.0,,MD,GB,GB,2018,Q2,Elderly
146351023,14635102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Sepsis,,2018,Q2,3,F,20180217.0,20180507.0,20180314,20180515,EXP,,GB-ASTRAZENECA-2018SE28673,ASTRAZENECA,,81.0,YR,,F,Y,70.0,KG,20180515.0,,MD,GB,GB,2018,Q2,Elderly
146351023,14635102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Vomiting,,2018,Q2,3,F,20180217.0,20180507.0,20180314,20180515,EXP,,GB-ASTRAZENECA-2018SE28673,ASTRAZENECA,,81.0,YR,,F,Y,70.0,KG,20180515.0,,MD,GB,GB,2018,Q2,Elderly
146387092,14638709,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2018,Q2,Diarrhoea,,2018,Q2,2,F,20170503.0,20180531.0,20180315,20180607,EXP,GB-MHRA-EYC 00172681,GB-TEVA-2018-GB-869437,TEVA,,65.0,YR,,M,Y,103.0,KG,20180607.0,,OT,GB,GB,2018,Q2,Elderly
146387092,14638709,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2018,Q2,Hypokalaemia,,2018,Q2,2,F,20170503.0,20180531.0,20180315,20180607,EXP,GB-MHRA-EYC 00172681,GB-TEVA-2018-GB-869437,TEVA,,65.0,YR,,M,Y,103.0,KG,20180607.0,,OT,GB,GB,2018,Q2,Elderly
146674232,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,TABLET,,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171011.0,20180426.0,20180322,20180511,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180511.0,,PH,GB,GB,2018,Q2,Elderly
146674232,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,TABLET,,2018,Q2,Arrhythmia,,2018,Q2,2,F,20171011.0,20180426.0,20180322,20180511,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180511.0,,PH,GB,GB,2018,Q2,Elderly
146674232,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,TABLET,,2018,Q2,Dehydration,,2018,Q2,2,F,20171011.0,20180426.0,20180322,20180511,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180511.0,,PH,GB,GB,2018,Q2,Elderly
146674232,14667423,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, DAILY",,,Y,U,,,,10.0,MG,TABLET,,2018,Q2,Metabolic acidosis,,2018,Q2,2,F,20171011.0,20180426.0,20180322,20180511,EXP,,GB-AUROBINDO-AUR-APL-2018-015204,AUROBINDO,,72.0,YR,,,Y,,,20180511.0,,PH,GB,GB,2018,Q2,Elderly
146738243,14673824,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Acute kidney injury,,2018,Q2,3,F,20171011.0,20180428.0,20180323,20180509,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-BAUSCH-BL-2018-006603,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20180509.0,,PH,GB,GB,2018,Q2,Elderly
146738243,14673824,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Arrhythmia,,2018,Q2,3,F,20171011.0,20180428.0,20180323,20180509,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-BAUSCH-BL-2018-006603,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20180509.0,,PH,GB,GB,2018,Q2,Elderly
146738243,14673824,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Dehydration,,2018,Q2,3,F,20171011.0,20180428.0,20180323,20180509,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-BAUSCH-BL-2018-006603,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20180509.0,,PH,GB,GB,2018,Q2,Elderly
146738243,14673824,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2018,Q2,Metabolic acidosis,,2018,Q2,3,F,20171011.0,20180428.0,20180323,20180509,EXP,GB-MHRA-MIDB-F990AAFF-A5B3-48A7-B203-DEAF9E7C1247,GB-BAUSCH-BL-2018-006603,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20180509.0,,PH,GB,GB,2018,Q2,Elderly
146806022,14680602,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14140.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Atrial flutter,,2018,Q2,2,F,20170915.0,20180420.0,20180326,20180426,EXP,,CA-ASTRAZENECA-2018SE35714,ASTRAZENECA,,76.0,YR,,M,Y,,,20180426.0,,MD,CA,CA,2018,Q2,Elderly
146806022,14680602,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14140.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Atrial flutter,,2018,Q2,2,F,20170915.0,20180420.0,20180326,20180426,EXP,,CA-ASTRAZENECA-2018SE35714,ASTRAZENECA,,76.0,YR,,M,Y,,,20180426.0,,MD,CA,CA,2018,Q2,Elderly
147059041,14705904,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q2,Diarrhoea,,2018,Q2,1,I,20171229.0,20180110.0,20180402,20180402,EXP,,CA-ASTRAZENECA-2018SE41170,ASTRAZENECA,,31396.0,DY,,F,Y,,,20180402.0,,MD,CA,CA,2018,Q2,Elderly
147059041,14705904,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2018,Q2,Diarrhoea,,2018,Q2,1,I,20171229.0,20180110.0,20180402,20180402,EXP,,CA-ASTRAZENECA-2018SE41170,ASTRAZENECA,,31396.0,DY,,F,Y,,,20180402.0,,MD,CA,CA,2018,Q2,Elderly
147102483,14710248,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypertension,,2018,Q2,3,F,20170703.0,20180605.0,20180403,20180614,EXP,,GB-JNJFOC-20180343968,JANSSEN,,46.0,YR,A,M,Y,,,20180614.0,,CN,GB,GB,2018,Q2,Adult
147102483,14710248,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Neoplasm,,2018,Q2,3,F,20170703.0,20180605.0,20180403,20180614,EXP,,GB-JNJFOC-20180343968,JANSSEN,,46.0,YR,A,M,Y,,,20180614.0,,CN,GB,GB,2018,Q2,Adult
147102483,14710248,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Oral candidiasis,,2018,Q2,3,F,20170703.0,20180605.0,20180403,20180614,EXP,,GB-JNJFOC-20180343968,JANSSEN,,46.0,YR,A,M,Y,,,20180614.0,,CN,GB,GB,2018,Q2,Adult
147102483,14710248,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Psoriasis,,2018,Q2,3,F,20170703.0,20180605.0,20180403,20180614,EXP,,GB-JNJFOC-20180343968,JANSSEN,,46.0,YR,A,M,Y,,,20180614.0,,CN,GB,GB,2018,Q2,Adult
147102483,14710248,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Psoriatic arthropathy,,2018,Q2,3,F,20170703.0,20180605.0,20180403,20180614,EXP,,GB-JNJFOC-20180343968,JANSSEN,,46.0,YR,A,M,Y,,,20180614.0,,CN,GB,GB,2018,Q2,Adult
147102483,14710248,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Tinnitus,,2018,Q2,3,F,20170703.0,20180605.0,20180403,20180614,EXP,,GB-JNJFOC-20180343968,JANSSEN,,46.0,YR,A,M,Y,,,20180614.0,,CN,GB,GB,2018,Q2,Adult
147127341,14712734,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Abnormal loss of weight,,2018,Q2,1,I,20171031.0,20180327.0,20180404,20180404,EXP,,GB-ASTRAZENECA-2018SE39107,ASTRAZENECA,,53.0,YR,,F,Y,75.0,KG,20180404.0,,,GB,GB,2018,Q2,Adult
147127341,14712734,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Arthralgia,,2018,Q2,1,I,20171031.0,20180327.0,20180404,20180404,EXP,,GB-ASTRAZENECA-2018SE39107,ASTRAZENECA,,53.0,YR,,F,Y,75.0,KG,20180404.0,,,GB,GB,2018,Q2,Adult
147127341,14712734,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Coma,,2018,Q2,1,I,20171031.0,20180327.0,20180404,20180404,EXP,,GB-ASTRAZENECA-2018SE39107,ASTRAZENECA,,53.0,YR,,F,Y,75.0,KG,20180404.0,,,GB,GB,2018,Q2,Adult
147127341,14712734,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20171031.0,20180327.0,20180404,20180404,EXP,,GB-ASTRAZENECA-2018SE39107,ASTRAZENECA,,53.0,YR,,F,Y,75.0,KG,20180404.0,,,GB,GB,2018,Q2,Adult
147127341,14712734,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Fall,,2018,Q2,1,I,20171031.0,20180327.0,20180404,20180404,EXP,,GB-ASTRAZENECA-2018SE39107,ASTRAZENECA,,53.0,YR,,F,Y,75.0,KG,20180404.0,,,GB,GB,2018,Q2,Adult
147187542,14718754,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13560.0,MG,N,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Bladder transitional cell carcinoma,,2018,Q2,2,F,20180206.0,20180419.0,20180405,20180425,EXP,,CA-ASTRAZENECA-2018SE40695,ASTRAZENECA,,67.0,YR,,M,Y,,,20180425.0,,MD,CA,CA,2018,Q2,Elderly
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Abdominal mass,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Alanine aminotransferase increased,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Blood glucose increased,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Bronchitis,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Hepatotoxicity,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Mass,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Neoplasm progression,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Osteonecrosis of jaw,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Pelvic mass,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Pneumonia bacterial,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Transaminases increased,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147381622,14738162,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, DAILY",,,,,,,,10.0,MG,,,2018,Q2,Type 2 diabetes mellitus,,2018,Q2,2,F,2012.0,20180410.0,20180409,20180410,EXP,,BG-PFIZER INC-2016527568,PFIZER,,4.0,DEC,,F,Y,,,20180410.0,,MD,BG,BG,2018,Q2,Child
147451611,14745161,1,PS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Bladder cancer,,2018,Q2,1,I,20140923.0,20141111.0,20180411,20180411,PER,,US-ASTRAZENECA-2014SE91011,ASTRAZENECA,,23889.0,DY,,F,Y,,,20180411.0,,CN,US,HU,2018,Q2,Elderly
147512801,14751280,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20180313.0,20180403.0,20180412,20180412,EXP,,GB-ASTRAZENECA-2018SE42333,ASTRAZENECA,,48.0,YR,,F,Y,,,20180412.0,,,GB,GB,2018,Q2,Adult
147574021,14757402,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11200.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Coronary artery disease,,2018,Q2,1,I,20170927.0,20180406.0,20180413,20180413,EXP,,CA-ASTRAZENECA-2018SE45354,ASTRAZENECA,,63.0,YR,,M,Y,,,20180413.0,,MD,CA,CA,2018,Q2,Adult
147586571,14758657,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,1,I,20171029.0,20180405.0,20180413,20180413,EXP,,US-ASTRAZENECA-2018SE44473,ASTRAZENECA,,62.0,YR,,F,Y,102.1,KG,20180413.0,,PH,US,US,2018,Q2,Adult
147586571,14758657,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20171029.0,20180405.0,20180413,20180413,EXP,,US-ASTRAZENECA-2018SE44473,ASTRAZENECA,,62.0,YR,,F,Y,102.1,KG,20180413.0,,PH,US,US,2018,Q2,Adult
147586571,14758657,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Upper respiratory tract infection,,2018,Q2,1,I,20171029.0,20180405.0,20180413,20180413,EXP,,US-ASTRAZENECA-2018SE44473,ASTRAZENECA,,62.0,YR,,F,Y,102.1,KG,20180413.0,,PH,US,US,2018,Q2,Adult
147629021,14762902,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Blood creatinine increased,,2018,Q2,1,I,20180224.0,,20180409,20180409,DIR,,,FDA-CTU,,58.0,YR,,F,N,91.6,KG,20180409.0,N,PH,US,US,2018,Q2,Adult
147791082,14779108,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14660.0,MG,N,U,,,,10.0,MG,TABLET,QD,2018,Q2,Humerus fracture,,2018,Q2,2,F,20180329.0,20180417.0,20180419,20180424,EXP,,CA-ASTRAZENECA-2018SE50663,ASTRAZENECA,,74.0,YR,,F,Y,,,20180424.0,,MD,CA,CA,2018,Q2,Elderly
147791082,14779108,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14660.0,MG,N,U,,,,10.0,MG,TABLET,QD,2018,Q2,Humerus fracture,,2018,Q2,2,F,20180329.0,20180417.0,20180419,20180424,EXP,,CA-ASTRAZENECA-2018SE50663,ASTRAZENECA,,74.0,YR,,F,Y,,,20180424.0,,MD,CA,CA,2018,Q2,Elderly
147812991,14781299,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1410.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Blood glucose increased,,2018,Q2,1,I,20180307.0,20180412.0,20180419,20180419,EXP,,AU-ASTRAZENECA-2018SE49083,ASTRAZENECA,,26839.0,DY,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Elderly
147812991,14781299,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1410.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Dehydration,,2018,Q2,1,I,20180307.0,20180412.0,20180419,20180419,EXP,,AU-ASTRAZENECA-2018SE49083,ASTRAZENECA,,26839.0,DY,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Elderly
147812991,14781299,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1410.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20180307.0,20180412.0,20180419,20180419,EXP,,AU-ASTRAZENECA-2018SE49083,ASTRAZENECA,,26839.0,DY,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Elderly
147812991,14781299,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1410.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Lethargy,,2018,Q2,1,I,20180307.0,20180412.0,20180419,20180419,EXP,,AU-ASTRAZENECA-2018SE49083,ASTRAZENECA,,26839.0,DY,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Elderly
147812991,14781299,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1410.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Pneumonia,,2018,Q2,1,I,20180307.0,20180412.0,20180419,20180419,EXP,,AU-ASTRAZENECA-2018SE49083,ASTRAZENECA,,26839.0,DY,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Elderly
147812991,14781299,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1410.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Tachycardia,,2018,Q2,1,I,20180307.0,20180412.0,20180419,20180419,EXP,,AU-ASTRAZENECA-2018SE49083,ASTRAZENECA,,26839.0,DY,,M,Y,,,20180420.0,,OT,AU,AU,2018,Q2,Elderly
147815431,14781543,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,710.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Anion gap increased,,2018,Q2,1,I,20160619.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE48447,ASTRAZENECA,,30107.0,DY,,M,Y,70.0,KG,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147815431,14781543,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,710.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20160619.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE48447,ASTRAZENECA,,30107.0,DY,,M,Y,70.0,KG,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147828661,14782866,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Metabolic acidosis,,2018,Q2,1,I,20160530.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE49114,ASTRAZENECA,,65.0,YR,,F,Y,,,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147838124,14783812,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12990.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,4,F,20180215.0,20180626.0,20180420,20180628,EXP,,SK-ASTRAZENECA-2018SE47407,ASTRAZENECA,,22049.0,DY,,M,Y,,,20180628.0,,MD,SK,SK,2018,Q2,Elderly
147838124,14783812,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12990.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Acute respiratory failure,,2018,Q2,4,F,20180215.0,20180626.0,20180420,20180628,EXP,,SK-ASTRAZENECA-2018SE47407,ASTRAZENECA,,22049.0,DY,,M,Y,,,20180628.0,,MD,SK,SK,2018,Q2,Elderly
147838124,14783812,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12990.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,General physical condition abnormal,,2018,Q2,4,F,20180215.0,20180626.0,20180420,20180628,EXP,,SK-ASTRAZENECA-2018SE47407,ASTRAZENECA,,22049.0,DY,,M,Y,,,20180628.0,,MD,SK,SK,2018,Q2,Elderly
147839891,14783989,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,,10.0,MG,TABLET,,2018,Q2,Metabolic acidosis,,2018,Q2,1,I,20171205.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE48883,ASTRAZENECA,,27532.0,DY,,M,Y,90.0,KG,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147842471,14784247,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG.,,,N,,,,202293.0,,,TABLET,,2018,Q2,Abdominal pain upper,,2018,Q2,1,I,20171106.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE48486,ASTRAZENECA,,20833.0,DY,,F,Y,,,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147842471,14784247,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG.,,,N,,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20171106.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE48486,ASTRAZENECA,,20833.0,DY,,F,Y,,,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147842471,14784247,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG.,,,N,,,,202293.0,,,TABLET,,2018,Q2,Nausea,,2018,Q2,1,I,20171106.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE48486,ASTRAZENECA,,20833.0,DY,,F,Y,,,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147842471,14784247,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG.,,,N,,,,202293.0,,,TABLET,,2018,Q2,Vomiting,,2018,Q2,1,I,20171106.0,20180412.0,20180420,20180420,EXP,,AU-ASTRAZENECA-2018SE48486,ASTRAZENECA,,20833.0,DY,,F,Y,,,20180420.0,,PH,AU,AU,2018,Q2,Elderly
147900432,14790043,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,Thrombocytopenia,,2018,Q2,2,F,20180216.0,20180525.0,20180423,20180530,EXP,,PHHY2018DK068949,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180530.0,,CN,DK,DK,2018,Q2,Elderly
147905991,14790599,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAMS,,,Y,,,,,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20180321.0,20180412.0,20180423,20180423,EXP,,GB-ASTRAZENECA-2018SE48090,ASTRAZENECA,,50.0,YR,,M,Y,109.0,KG,20180423.0,,PH,GB,GB,2018,Q2,Adult
147906731,14790673,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DAILY,,,U,,,,202293.0,,,TABLET,,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20171012.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48436,ASTRAZENECA,,63.0,YR,,F,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Adult
147906741,14790674,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,,10.0,MG,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20150714.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE49509,ASTRAZENECA,,99.0,YR,,M,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147906801,14790680,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20170703.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48468,ASTRAZENECA,,23034.0,DY,,F,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147906831,14790683,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,220.0,MG,U,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20151017.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48795,ASTRAZENECA,,18688.0,DY,,M,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147908061,14790806,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DAILY,,,U,,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20170614.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48855,ASTRAZENECA,,29206.0,DY,,M,Y,75.0,KG,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147908221,14790822,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSE UNSPEC,,,U,,,,,,,TABLET,,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20160105.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE49478,ASTRAZENECA,,19823.0,DY,,M,Y,118.0,KG,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147908261,14790826,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20151107.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE49457,ASTRAZENECA,,21666.0,DY,,M,Y,80.0,KG,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147908271,14790827,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48928,ASTRAZENECA,,63.0,YR,,M,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Adult
147908281,14790828,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20160725.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE49405,ASTRAZENECA,,62.0,YR,,M,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Adult
147908301,14790830,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,190.0,MG,N,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20151107.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48929,ASTRAZENECA,,18918.0,DY,,M,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147908311,14790831,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,U,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20160114.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE49069,ASTRAZENECA,,21019.0,DY,,F,Y,,,20180423.0,,PH,AU,AU,2018,Q2,Elderly
147909021,14790902,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,900.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20150516.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48941,ASTRAZENECA,,65.0,YR,,F,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147909031,14790903,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1890.0,MG,U,,,,,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20150308.0,20180412.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2018SE48935,ASTRAZENECA,,22846.0,DY,,F,Y,100.0,KG,20180423.0,,OT,AU,AU,2018,Q2,Elderly
147938941,14793894,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2018,Q2,Ketoacidosis,,2018,Q2,1,I,,20151216.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2015SF27524,ASTRAZENECA,,42.0,YR,,F,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Adult
147938941,14793894,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2018,Q2,Product use in unapproved indication,,2018,Q2,1,I,,20151216.0,20180423,20180423,EXP,,AU-ASTRAZENECA-2015SF27524,ASTRAZENECA,,42.0,YR,,F,Y,,,20180423.0,,OT,AU,AU,2018,Q2,Adult
148004501,14800450,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,15280.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,"Bladder cancer stage 0, with cancer in situ",,2018,Q2,1,I,20180313.0,20180326.0,20180424,20180424,EXP,,NL-ASTRAZENECA-2018SE38526,ASTRAZENECA,,891.0,MON,,M,Y,,,20180424.0,,MD,NL,NL,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,Blood potassium decreased,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,C-reactive protein increased,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,Cough,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,Fatigue,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,Influenza,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,Neutrophil count increased,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,Pyrexia,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148090162,14809016,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q2,White blood cell count increased,,2018,Q2,2,F,20180314.0,20180425.0,20180425,20180503,EXP,,PHHY2018DK069978,NOVARTIS,,74.0,YR,,M,Y,95.0,KG,20180503.0,,CN,US,DK,2018,Q2,Elderly
148136641,14813664,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13980.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Erysipelas,,2018,Q2,1,I,20180204.0,20180406.0,20180426,20180426,EXP,,NL-ASTRAZENECA-2018SE45480,ASTRAZENECA,,779.0,MON,,M,Y,,,20180426.0,,MD,NL,NL,2018,Q2,Elderly
148162442,14816244,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11840.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Limb injury,,2018,Q2,2,F,20171018.0,20180503.0,20180426,20180511,EXP,,NL-ASTRAZENECA-2018SE41659,ASTRAZENECA,,714.0,MON,,M,Y,,,20180511.0,,MD,NL,NL,2018,Q2,Elderly
148310642,14831064,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,459.583,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Abnormal loss of weight,,2018,Q2,2,F,20180409.0,20180511.0,20180501,20180518,EXP,,GB-ASTRAZENECA-2018SE55237,ASTRAZENECA,,75.0,YR,,F,Y,54.4,KG,20180518.0,,,GB,GB,2018,Q2,Elderly
148310642,14831064,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,459.583,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,2,F,20180409.0,20180511.0,20180501,20180518,EXP,,GB-ASTRAZENECA-2018SE55237,ASTRAZENECA,,75.0,YR,,F,Y,54.4,KG,20180518.0,,,GB,GB,2018,Q2,Elderly
148310642,14831064,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,459.583,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Lethargy,,2018,Q2,2,F,20180409.0,20180511.0,20180501,20180518,EXP,,GB-ASTRAZENECA-2018SE55237,ASTRAZENECA,,75.0,YR,,F,Y,54.4,KG,20180518.0,,,GB,GB,2018,Q2,Elderly
148310642,14831064,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,459.583,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q2,Malaise,,2018,Q2,2,F,20180409.0,20180511.0,20180501,20180518,EXP,,GB-ASTRAZENECA-2018SE55237,ASTRAZENECA,,75.0,YR,,F,Y,54.4,KG,20180518.0,,,GB,GB,2018,Q2,Elderly
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Decreased vibratory sense,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Gastrointestinal disorder,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Limb discomfort,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Neuropathy peripheral,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Pain in extremity,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Sensory disturbance,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Sleep disorder,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148354031,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,,QD,2018,Q2,Visual impairment,,2018,Q2,1,I,,20180306.0,20180502,20180502,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,HOLLENRIEDER V.. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE.. ARZTE WOCHE .. 2018;22:7-15,61.0,YR,,F,Y,,,20180502.0,,MD,DE,DE,2018,Q2,Adult
148365861,14836586,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAMS,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,,20180423.0,20180502,20180502,EXP,,GB-ASTRAZENECA-2018SE54784,ASTRAZENECA,,57.0,YR,,F,Y,,,20180502.0,,OT,GB,GB,2018,Q2,Adult
148401031,14840103,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN",,,,,,,,,,TABLET,,2018,Q2,Gout,,2018,Q2,1,I,,20180418.0,20180503,20180503,EXP,,DE-CONCORDIA PHARMACEUTICALS INC.-E2B_00011518,CONCORDIA,,66.0,YR,,M,Y,,,20180503.0,,OT,GB,DE,2018,Q2,Elderly
148401031,14840103,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN",,,,,,,,,,TABLET,,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,,20180418.0,20180503,20180503,EXP,,DE-CONCORDIA PHARMACEUTICALS INC.-E2B_00011518,CONCORDIA,,66.0,YR,,M,Y,,,20180503.0,,OT,GB,DE,2018,Q2,Elderly
148401031,14840103,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1-0-0-0, TABLETTEN",,,,,,,,,,TABLET,,2018,Q2,Pain in extremity,,2018,Q2,1,I,,20180418.0,20180503,20180503,EXP,,DE-CONCORDIA PHARMACEUTICALS INC.-E2B_00011518,CONCORDIA,,66.0,YR,,M,Y,,,20180503.0,,OT,GB,DE,2018,Q2,Elderly
148467581,14846758,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,U,,,,,5.0,MG,TABLET,,2018,Q2,Blood glucose fluctuation,,2018,Q2,1,I,20170912.0,20180426.0,20180504,20180504,EXP,,GB-ASTRAZENECA-2018SE56936,ASTRAZENECA,,72.0,YR,,F,Y,59.0,KG,20180504.0,,MD,GB,GB,2018,Q2,Elderly
148467581,14846758,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,U,,,,,5.0,MG,TABLET,,2018,Q2,Pruritus generalised,,2018,Q2,1,I,20170912.0,20180426.0,20180504,20180504,EXP,,GB-ASTRAZENECA-2018SE56936,ASTRAZENECA,,72.0,YR,,F,Y,59.0,KG,20180504.0,,MD,GB,GB,2018,Q2,Elderly
148502702,14850270,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12160.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171012.0,20180508.0,20180505,20180522,EXP,,GB-AUROBINDO-AUR-APL-2018-023700,AUROBINDO,,78.0,YR,,M,Y,,,20180522.0,,MD,GB,GB,2018,Q2,Elderly
148502702,14850270,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12160.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,,2018,Q2,2,F,20171012.0,20180508.0,20180505,20180522,EXP,,GB-AUROBINDO-AUR-APL-2018-023700,AUROBINDO,,78.0,YR,,M,Y,,,20180522.0,,MD,GB,GB,2018,Q2,Elderly
148502702,14850270,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12160.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,,2018,Q2,2,F,20171012.0,20180508.0,20180505,20180522,EXP,,GB-AUROBINDO-AUR-APL-2018-023700,AUROBINDO,,78.0,YR,,M,Y,,,20180522.0,,MD,GB,GB,2018,Q2,Elderly
148503771,14850377,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, DAILY",103.958,DF,,,,,,1.0,DF,,,2018,Q2,Lip swelling,,2018,Q2,1,I,20180411.0,20180421.0,20180505,20180505,EXP,,GB-AUROBINDO-AUR-APL-2018-023671,AUROBINDO,,73.0,YR,,M,Y,97.0,KG,20180505.0,,MD,GB,GB,2018,Q2,Elderly
148618121,14861812,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Gangrene,,2018,Q2,1,I,20171220.0,20180430.0,20180508,20180508,EXP,,CA-ASTRAZENECA-2018SE58713,ASTRAZENECA,,24361.0,DY,,M,Y,,,20180508.0,,MD,CA,CA,2018,Q2,Elderly
148618121,14861812,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,5.0,MG,TABLET,QD,2018,Q2,Gangrene,,2018,Q2,1,I,20171220.0,20180430.0,20180508,20180508,EXP,,CA-ASTRAZENECA-2018SE58713,ASTRAZENECA,,24361.0,DY,,M,Y,,,20180508.0,,MD,CA,CA,2018,Q2,Elderly
148713101,14871310,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2710.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Hyperkalaemia,,2018,Q2,1,I,20171230.0,20180501.0,20180509,20180509,EXP,,CA-ASTRAZENECA-2018SE58670,ASTRAZENECA,,24432.0,DY,,F,Y,,,20180509.0,,MD,CA,CA,2018,Q2,Elderly
148713101,14871310,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2710.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Hyperkalaemia,,2018,Q2,1,I,20171230.0,20180501.0,20180509,20180509,EXP,,CA-ASTRAZENECA-2018SE58670,ASTRAZENECA,,24432.0,DY,,F,Y,,,20180509.0,,MD,CA,CA,2018,Q2,Elderly
148858201,14885820,6,C,DAPAGLIFLOZIN/METFORMIN,,2,Unknown,,,,Y,, UNKNOWN,,,10.0,MG,UNKNOWN,,2018,Q2,Abnormal loss of weight,Abnormal loss of weight,2018,Q2,1,I,2016.0,20170911.0,20180512,20180512,PER,,US-ZYDUS-016704,ZYDUS PHARM,,41.0,YR,,F,Y,167.83,KG,20180512.0,,CN,US,US,2018,Q2,Adult
148858201,14885820,6,C,DAPAGLIFLOZIN/METFORMIN,,2,Unknown,,,,Y,, UNKNOWN,,,10.0,MG,UNKNOWN,,2018,Q2,Drug ineffective,Drug ineffective,2018,Q2,1,I,2016.0,20170911.0,20180512,20180512,PER,,US-ZYDUS-016704,ZYDUS PHARM,,41.0,YR,,F,Y,167.83,KG,20180512.0,,CN,US,US,2018,Q2,Adult
148858201,14885820,6,C,DAPAGLIFLOZIN/METFORMIN,,2,Unknown,,,,Y,, UNKNOWN,,,10.0,MG,UNKNOWN,,2018,Q2,Fatigue,Fatigue,2018,Q2,1,I,2016.0,20170911.0,20180512,20180512,PER,,US-ZYDUS-016704,ZYDUS PHARM,,41.0,YR,,F,Y,167.83,KG,20180512.0,,CN,US,US,2018,Q2,Adult
148858201,14885820,6,C,DAPAGLIFLOZIN/METFORMIN,,2,Unknown,,,,Y,, UNKNOWN,,,10.0,MG,UNKNOWN,,2018,Q2,Glycosylated haemoglobin decreased,Glycosylated haemoglobin decreased,2018,Q2,1,I,2016.0,20170911.0,20180512,20180512,PER,,US-ZYDUS-016704,ZYDUS PHARM,,41.0,YR,,F,Y,167.83,KG,20180512.0,,CN,US,US,2018,Q2,Adult
148858201,14885820,6,C,DAPAGLIFLOZIN/METFORMIN,,2,Unknown,,,,Y,, UNKNOWN,,,10.0,MG,UNKNOWN,,2018,Q2,Hypersomnia,Hypersomnia,2018,Q2,1,I,2016.0,20170911.0,20180512,20180512,PER,,US-ZYDUS-016704,ZYDUS PHARM,,41.0,YR,,F,Y,167.83,KG,20180512.0,,CN,US,US,2018,Q2,Adult
148858201,14885820,6,C,DAPAGLIFLOZIN/METFORMIN,,2,Unknown,,,,Y,, UNKNOWN,,,10.0,MG,UNKNOWN,,2018,Q2,Migraine,Migraine,2018,Q2,1,I,2016.0,20170911.0,20180512,20180512,PER,,US-ZYDUS-016704,ZYDUS PHARM,,41.0,YR,,F,Y,167.83,KG,20180512.0,,CN,US,US,2018,Q2,Adult
148880432,14888043,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10690.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Proteinuria,,2018,Q2,2,F,20171117.0,20180510.0,20180513,20180514,EXP,,IN-ASTRAZENECA-2018SE61974,ASTRAZENECA,,24490.0,DY,,M,Y,,,20180514.0,,MD,IN,IN,2018,Q2,Elderly
148880432,14888043,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10690.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Proteinuria,,2018,Q2,2,F,20171117.0,20180510.0,20180513,20180514,EXP,,IN-ASTRAZENECA-2018SE61974,ASTRAZENECA,,24490.0,DY,,M,Y,,,20180514.0,,MD,IN,IN,2018,Q2,Elderly
148927451,14892745,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Euglycaemic diabetic ketoacidosis,,2018,Q2,1,I,20180425.0,,20180426,20180426,DIR,,,FDA-CTU,,39.0,YR,,M,N,,,20180426.0,N,PH,US,US,2018,Q2,Adult
149069491,14906949,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,7010.0,MG,N,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Renal cancer,,2018,Q2,1,I,20180213.0,20180509.0,20180517,20180517,EXP,,GB-ASTRAZENECA-2018SE62320,ASTRAZENECA,,66.0,YR,,M,Y,81.0,KG,20180517.0,,,GB,GB,2018,Q2,Elderly
149074813,14907481,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,Acute kidney injury,2018,Q2,3,F,20171012.0,20180524.0,20180517,20180604,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20180604.0,,MD,GB,GB,2018,Q2,Elderly
149074813,14907481,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,Epididymitis,2018,Q2,3,F,20171012.0,20180524.0,20180517,20180604,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20180604.0,,MD,GB,GB,2018,Q2,Elderly
149074813,14907481,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,Hypotension,2018,Q2,3,F,20171012.0,20180524.0,20180517,20180604,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20180604.0,,MD,GB,GB,2018,Q2,Elderly
149074813,14907481,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,Acute kidney injury,2018,Q2,3,F,20171012.0,20180524.0,20180517,20180604,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20180604.0,,MD,GB,GB,2018,Q2,Elderly
149074813,14907481,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,Epididymitis,2018,Q2,3,F,20171012.0,20180524.0,20180517,20180604,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20180604.0,,MD,GB,GB,2018,Q2,Elderly
149074813,14907481,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,Hypotension,2018,Q2,3,F,20171012.0,20180524.0,20180517,20180604,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20180604.0,,MD,GB,GB,2018,Q2,Elderly
149075621,14907562,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11370.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Gastroenteritis,,2018,Q2,1,I,20171101.0,20180110.0,20180517,20180517,EXP,,DE-ASTRAZENECA-2018SE03684,ASTRAZENECA,,70.0,YR,,F,Y,,,20180517.0,,MD,DE,DE,2018,Q2,Elderly
149134091,14913409,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Peripheral ischaemia,,2018,Q2,1,I,,20180510.0,20180518,20180518,EXP,,GB-ASTRAZENECA-2018SE62739,ASTRAZENECA,,47.0,YR,,M,Y,,,20180518.0,,,GB,GB,2018,Q2,Adult
149336712,14933671,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171010.0,20180531.0,20180524,20180608,EXP,,GB-009507513-1711GBR012389,MERCK,,78.0,YR,,M,Y,,,20180608.0,,MD,GB,GB,2018,Q2,Elderly
149336712,14933671,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,,2018,Q2,2,F,20171010.0,20180531.0,20180524,20180608,EXP,,GB-009507513-1711GBR012389,MERCK,,78.0,YR,,M,Y,,,20180608.0,,MD,GB,GB,2018,Q2,Elderly
149336712,14933671,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,,2018,Q2,2,F,20171010.0,20180531.0,20180524,20180608,EXP,,GB-009507513-1711GBR012389,MERCK,,78.0,YR,,M,Y,,,20180608.0,,MD,GB,GB,2018,Q2,Elderly
149336712,14933671,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171010.0,20180531.0,20180524,20180608,EXP,,GB-009507513-1711GBR012389,MERCK,,78.0,YR,,M,Y,,,20180608.0,,MD,GB,GB,2018,Q2,Elderly
149336712,14933671,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,,2018,Q2,2,F,20171010.0,20180531.0,20180524,20180608,EXP,,GB-009507513-1711GBR012389,MERCK,,78.0,YR,,M,Y,,,20180608.0,,MD,GB,GB,2018,Q2,Elderly
149336712,14933671,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,,2018,Q2,2,F,20171010.0,20180531.0,20180524,20180608,EXP,,GB-009507513-1711GBR012389,MERCK,,78.0,YR,,M,Y,,,20180608.0,,MD,GB,GB,2018,Q2,Elderly
149347402,14934740,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,720.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Atrial flutter,,2018,Q2,2,F,20180418.0,20180607.0,20180524,20180615,EXP,,CA-ASTRAZENECA-2018SE61641,ASTRAZENECA,,29569.0,DY,,M,Y,,,20180615.0,,MD,CA,CA,2018,Q2,Elderly
149347402,14934740,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,720.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Deep vein thrombosis,,2018,Q2,2,F,20180418.0,20180607.0,20180524,20180615,EXP,,CA-ASTRAZENECA-2018SE61641,ASTRAZENECA,,29569.0,DY,,M,Y,,,20180615.0,,MD,CA,CA,2018,Q2,Elderly
149347402,14934740,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,720.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Hyperkalaemia,,2018,Q2,2,F,20180418.0,20180607.0,20180524,20180615,EXP,,CA-ASTRAZENECA-2018SE61641,ASTRAZENECA,,29569.0,DY,,M,Y,,,20180615.0,,MD,CA,CA,2018,Q2,Elderly
149364291,14936429,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14440.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Transient ischaemic attack,,2018,Q2,1,I,20180322.0,20180518.0,20180525,20180525,EXP,,NL-ASTRAZENECA-2018SE66704,ASTRAZENECA,,852.0,MON,,M,Y,,,20180525.0,,MD,NL,NL,2018,Q2,Elderly
149364792,14936479,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,Y,,,,202293.0,5.0,MG,TABLET,,2018,Q2,Chest pain,,2018,Q2,2,F,20180430.0,20180614.0,20180525,20180621,EXP,,GB-ASTRAZENECA-2018SE66171,ASTRAZENECA,,56.0,YR,,M,Y,,,20180621.0,,,GB,GB,2018,Q2,Adult
149364792,14936479,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,Y,,,,202293.0,5.0,MG,TABLET,,2018,Q2,Diabetic ketoacidosis,,2018,Q2,2,F,20180430.0,20180614.0,20180525,20180621,EXP,,GB-ASTRAZENECA-2018SE66171,ASTRAZENECA,,56.0,YR,,M,Y,,,20180621.0,,,GB,GB,2018,Q2,Adult
149364792,14936479,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,Y,,,,202293.0,5.0,MG,TABLET,,2018,Q2,Dyspnoea,,2018,Q2,2,F,20180430.0,20180614.0,20180525,20180621,EXP,,GB-ASTRAZENECA-2018SE66171,ASTRAZENECA,,56.0,YR,,M,Y,,,20180621.0,,,GB,GB,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Decreased vibratory sense,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Gastrointestinal disorder,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Limb discomfort,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Neuropathy peripheral,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Pain in extremity,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Sensory disturbance,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Sleep disorder,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149375991,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q2,Visual impairment,,2018,Q2,1,I,,20180517.0,20180525,20180525,EXP,,PHHY2018DE003343,SANDOZ,,61.0,YR,,F,Y,,,20180525.0,,OT,DE,DE,2018,Q2,Adult
149457661,14945766,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,,,,,,10.0,MG,TABLET,,2018,Q2,Drug ineffective,,2018,Q2,1,I,,20180130.0,20180529,20180529,EXP,,PHHY2017HU200838,SANDOZ,,66.0,YR,,M,Y,,,20180529.0,,OT,HU,HU,2018,Q2,Elderly
149457661,14945766,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,,,,,,10.0,MG,TABLET,,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180130.0,20180529,20180529,EXP,,PHHY2017HU200838,SANDOZ,,66.0,YR,,M,Y,,,20180529.0,,OT,HU,HU,2018,Q2,Elderly
149457661,14945766,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,,,,,,10.0,MG,TABLET,,2018,Q2,Therapeutic response decreased,,2018,Q2,1,I,,20180130.0,20180529,20180529,EXP,,PHHY2017HU200838,SANDOZ,,66.0,YR,,M,Y,,,20180529.0,,OT,HU,HU,2018,Q2,Elderly
149466271,14946627,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Ketoacidosis,,2018,Q2,1,I,,20180509.0,20180529,20180529,EXP,,CA-ASTRAZENECA-2018SE70260,ASTRAZENECA,,29.0,YR,,F,Y,,,20180529.0,,MD,CA,CA,2018,Q2,Young Adult
149466321,14946632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,TABLET,QD,2018,Q2,Ketoacidosis,,2018,Q2,1,I,,20180509.0,20180529,20180529,EXP,,CA-ASTRAZENECA-2018SE70275,ASTRAZENECA,,67.0,YR,,F,Y,,,20180529.0,,MD,CA,CA,2018,Q2,Elderly
149466351,14946635,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,,20180509.0,20180529,20180529,EXP,,CA-ASTRAZENECA-2018SE70268,ASTRAZENECA,,54.0,YR,,F,Y,,,20180529.0,,MD,CA,CA,2018,Q2,Adult
149712561,14971256,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,EVERY MORNING,,,Y,,,,,,,,,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20180508.0,20180528.0,20180604,20180604,EXP,GB-MHRA-EYC 00179613,GB-BAUSCH-BL-2018-015676,BAUSCH AND LOMB,,71.0,YR,,M,Y,100.3,KG,20180604.0,,MD,GB,GB,2018,Q2,Elderly
149749371,14974937,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1600.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Syncope,,2018,Q2,1,I,20180522.0,20180528.0,20180605,20180605,EXP,,AR-ASTRAZENECA-2018SE71093,ASTRAZENECA,,30668.0,DY,,F,Y,,,20180605.0,,MD,AR,AR,2018,Q2,Elderly
149751921,14975192,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, DAILY",,,,,,,,5.0,MG,,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,,20180524.0,20180605,20180605,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201805013018,ELI LILLY AND CO,,72.0,YR,,M,Y,53.0,KG,20180605.0,,CN,JP,JP,2018,Q2,Elderly
149753271,14975327,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1730.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Sepsis,,2018,Q2,1,I,20180430.0,20180530.0,20180605,20180605,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20180605.0,,MD,US,US,2018,Q2,Elderly
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Decreased vibratory sense,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Gastrointestinal disorder,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Limb discomfort,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Neuropathy peripheral,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Pain in extremity,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Sensory disturbance,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Sleep disorder,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Visual impairment,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Decreased vibratory sense,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Gastrointestinal disorder,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Limb discomfort,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Neuropathy peripheral,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Pain in extremity,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Sensory disturbance,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Sleep disorder,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149822381,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Visual impairment,,2018,Q2,1,I,,20180530.0,20180607,20180607,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,,,20180607.0,,MD,DE,DE,2018,Q2,Adult
149835701,14983570,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20180508.0,20180530.0,20180607,20180607,EXP,,GB-ASTRAZENECA-2018SE71405,ASTRAZENECA,,71.0,YR,,M,Y,100.3,KG,20180607.0,,,GB,GB,2018,Q2,Elderly
149845122,14984512,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Adverse drug reaction,,2018,Q2,2,F,20180322.0,20180614.0,20180607,20180621,EXP,,AU-ASTELLAS-2018US026058,ASTELLAS,,42.0,YR,,M,Y,,,20180621.0,,CN,GB,AU,2018,Q2,Adult
149845122,14984512,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Immune reconstitution inflammatory syndrome,,2018,Q2,2,F,20180322.0,20180614.0,20180607,20180621,EXP,,AU-ASTELLAS-2018US026058,ASTELLAS,,42.0,YR,,M,Y,,,20180621.0,,CN,GB,AU,2018,Q2,Adult
149845122,14984512,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Renal failure,,2018,Q2,2,F,20180322.0,20180614.0,20180607,20180621,EXP,,AU-ASTELLAS-2018US026058,ASTELLAS,,42.0,YR,,M,Y,,,20180621.0,,CN,GB,AU,2018,Q2,Adult
149845122,14984512,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q2,Respiratory failure,,2018,Q2,2,F,20180322.0,20180614.0,20180607,20180621,EXP,,AU-ASTELLAS-2018US026058,ASTELLAS,,42.0,YR,,M,Y,,,20180621.0,,CN,GB,AU,2018,Q2,Adult
149849572,14984957,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Cardiac failure,,2018,Q2,2,F,,20180620.0,20180607,20180627,EXP,,GR-PFIZER INC-2018224232,PFIZER,"NTALIANIS, A.. THE IMPORTANCE OF OPTIMAL TREATMENT IN TREATING HEART FAILURE PATIENTS WITH A REDUCED EJECTION FRACTION AND CARDIOMYOPATHY. 3RD 2-DAY WORKSHOP OF CARDIO-ONCOLOGY/CARDIAC FAILURE (BOOK OF PROCEEDINGS). 2018",43.0,YR,,M,Y,88.0,KG,20180627.0,,,COUNTRY NOT SPECIFIED,GR,2018,Q2,Adult
149869972,14986997,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,TABLET,,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171012.0,20180612.0,20180608,20180622,EXP,,GB-TEVA-820950ACC,TEVA,,78.0,YR,,M,Y,,,20180622.0,,MD,GB,GB,2018,Q2,Elderly
149869972,14986997,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,TABLET,,2018,Q2,Hypotension,,2018,Q2,2,F,20171012.0,20180612.0,20180608,20180622,EXP,,GB-TEVA-820950ACC,TEVA,,78.0,YR,,M,Y,,,20180622.0,,MD,GB,GB,2018,Q2,Elderly
149871652,14987165,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,Y,,,,,10.0,MG,TABLET,,2018,Q2,Acute kidney injury,,2018,Q2,2,F,20171011.0,20180610.0,20180608,20180615,EXP,GB-MHRA-MIDB-5D7BAF9E-39FA-4F07-8876-7D44C3541BAF,GB-TEVA-2018-GB-903042,TEVA,,72.0,YR,,,Y,,,20180615.0,,PH,GB,GB,2018,Q2,Elderly
149871652,14987165,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,Y,,,,,10.0,MG,TABLET,,2018,Q2,Arrhythmia,,2018,Q2,2,F,20171011.0,20180610.0,20180608,20180615,EXP,GB-MHRA-MIDB-5D7BAF9E-39FA-4F07-8876-7D44C3541BAF,GB-TEVA-2018-GB-903042,TEVA,,72.0,YR,,,Y,,,20180615.0,,PH,GB,GB,2018,Q2,Elderly
149871652,14987165,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,Y,,,,,10.0,MG,TABLET,,2018,Q2,Dehydration,,2018,Q2,2,F,20171011.0,20180610.0,20180608,20180615,EXP,GB-MHRA-MIDB-5D7BAF9E-39FA-4F07-8876-7D44C3541BAF,GB-TEVA-2018-GB-903042,TEVA,,72.0,YR,,,Y,,,20180615.0,,PH,GB,GB,2018,Q2,Elderly
149871652,14987165,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,Y,,,,,10.0,MG,TABLET,,2018,Q2,Metabolic acidosis,,2018,Q2,2,F,20171011.0,20180610.0,20180608,20180615,EXP,GB-MHRA-MIDB-5D7BAF9E-39FA-4F07-8876-7D44C3541BAF,GB-TEVA-2018-GB-903042,TEVA,,72.0,YR,,,Y,,,20180615.0,,PH,GB,GB,2018,Q2,Elderly
149880272,14988027,4,C,DAPAGLIFLOZINE,,2,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,,2018,Q2,Diabetes mellitus inadequate control,,2018,Q2,2,F,2009.0,20180602.0,20180608,20180608,EXP,,SK-BAUSCH-BL-2017-020345,BAUSCH AND LOMB,DONICOVA V. PACIENTS DIABETOM DRUHEHO TYPU S INTOLERANCIOU METFORMINU A KARDIOVASKULARYMI. INTERNA MEDICINA. 2017;17:25-26.,67.0,YR,,M,Y,85.0,KG,20180608.0,,OT,SK,SK,2018,Q2,Elderly
149880272,14988027,4,C,DAPAGLIFLOZINE,,2,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,2,F,2009.0,20180602.0,20180608,20180608,EXP,,SK-BAUSCH-BL-2017-020345,BAUSCH AND LOMB,DONICOVA V. PACIENTS DIABETOM DRUHEHO TYPU S INTOLERANCIOU METFORMINU A KARDIOVASKULARYMI. INTERNA MEDICINA. 2017;17:25-26.,67.0,YR,,M,Y,85.0,KG,20180608.0,,OT,SK,SK,2018,Q2,Elderly
149880272,14988027,4,C,DAPAGLIFLOZINE,,2,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,,2018,Q2,Diarrhoea,,2018,Q2,2,F,2009.0,20180602.0,20180608,20180608,EXP,,SK-BAUSCH-BL-2017-020345,BAUSCH AND LOMB,DONICOVA V. PACIENTS DIABETOM DRUHEHO TYPU S INTOLERANCIOU METFORMINU A KARDIOVASKULARYMI. INTERNA MEDICINA. 2017;17:25-26.,67.0,YR,,M,Y,85.0,KG,20180608.0,,OT,SK,SK,2018,Q2,Elderly
149880272,14988027,4,C,DAPAGLIFLOZINE,,2,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,,2018,Q2,Hypertension,,2018,Q2,2,F,2009.0,20180602.0,20180608,20180608,EXP,,SK-BAUSCH-BL-2017-020345,BAUSCH AND LOMB,DONICOVA V. PACIENTS DIABETOM DRUHEHO TYPU S INTOLERANCIOU METFORMINU A KARDIOVASKULARYMI. INTERNA MEDICINA. 2017;17:25-26.,67.0,YR,,M,Y,85.0,KG,20180608.0,,OT,SK,SK,2018,Q2,Elderly
149890331,14989033,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD EVERY MORNING",,,Y,,,,,10.0,MG,,QD,2018,Q2,Ketosis,,2018,Q2,1,I,20180508.0,20180528.0,20180608,20180608,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-051508,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,100.0,KG,20180608.0,,MD,GB,GB,2018,Q2,Elderly
149925481,14992548,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNKNOWN,,,10.0,MG,,QD,2018,Q2,Ketoacidosis,,2018,Q2,1,I,20180508.0,20180526.0,20180609,20180609,EXP,,GB-AUROBINDO-AUR-APL-2018-029908,AUROBINDO,,71.0,YR,,M,Y,100.3,KG,20180609.0,,MD,GB,GB,2018,Q2,Elderly
150006681,15000668,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,1 DOSAGE FORMS DAILY;,103.958336,DF,,,,,,1.0,DF,,,2018,Q2,Lip swelling,,2018,Q2,1,I,20180411.0,20180605.0,20180612,20180612,EXP,GB-MHRA-TPP28053812C1490846YC1523454482790,GB-TEVA-2018-GB-905389,TEVA,,73.0,YR,,M,Y,97.0,KG,20180612.0,,MD,GB,GB,2018,Q2,Elderly
150011231,15001123,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,TABLET,QD,2018,Q2,Gout,,2018,Q2,1,I,,20180604.0,20180612,20180612,EXP,,DE-TEVA-2018-DE-904534,TEVA,,66.0,YR,,M,Y,,,20180612.0,,MD,DE,DE,2018,Q2,Elderly
150011231,15001123,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,TABLET,QD,2018,Q2,Hyperglycaemia,,2018,Q2,1,I,,20180604.0,20180612,20180612,EXP,,DE-TEVA-2018-DE-904534,TEVA,,66.0,YR,,M,Y,,,20180612.0,,MD,DE,DE,2018,Q2,Elderly
150011231,15001123,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY; 1-0-0-0,,,,,,,,10.0,MG,TABLET,QD,2018,Q2,Pain in extremity,,2018,Q2,1,I,,20180604.0,20180612,20180612,EXP,,DE-TEVA-2018-DE-904534,TEVA,,66.0,YR,,M,Y,,,20180612.0,,MD,DE,DE,2018,Q2,Elderly
150096621,15009662,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q2,Blood creatine phosphokinase increased,,2018,Q2,1,I,20180503.0,20180601.0,20180614,20180614,EXP,,GB-AUROBINDO-AUR-APL-2018-030951,AUROBINDO,,60.0,YR,,F,Y,79.8,KG,20180614.0,,MD,GB,GB,2018,Q2,Adult
150096621,15009662,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q2,Confusional state,,2018,Q2,1,I,20180503.0,20180601.0,20180614,20180614,EXP,,GB-AUROBINDO-AUR-APL-2018-030951,AUROBINDO,,60.0,YR,,F,Y,79.8,KG,20180614.0,,MD,GB,GB,2018,Q2,Adult
150096621,15009662,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q2,Inhibitory drug interaction,,2018,Q2,1,I,20180503.0,20180601.0,20180614,20180614,EXP,,GB-AUROBINDO-AUR-APL-2018-030951,AUROBINDO,,60.0,YR,,F,Y,79.8,KG,20180614.0,,MD,GB,GB,2018,Q2,Adult
150096621,15009662,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q2,Neuroleptic malignant syndrome,,2018,Q2,1,I,20180503.0,20180601.0,20180614,20180614,EXP,,GB-AUROBINDO-AUR-APL-2018-030951,AUROBINDO,,60.0,YR,,F,Y,79.8,KG,20180614.0,,MD,GB,GB,2018,Q2,Adult
150150292,15015029,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5460.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Diabetic metabolic decompensation,,2018,Q2,2,F,20180510.0,20180625.0,20180615,20180628,EXP,,PL-ASTRAZENECA-2018SE76517,ASTRAZENECA,,25524.0,DY,,F,Y,,,20180628.0,,MD,PL,PL,2018,Q2,Elderly
150154831,15015483,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Hemiparesis,,2018,Q2,1,I,20180502.0,20180608.0,20180615,20180615,EXP,,GB-ASTRAZENECA-2018SE75797,ASTRAZENECA,,68.0,YR,,M,Y,94.5,KG,20180615.0,,,GB,GB,2018,Q2,Elderly
150154831,15015483,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Ischaemic stroke,,2018,Q2,1,I,20180502.0,20180608.0,20180615,20180615,EXP,,GB-ASTRAZENECA-2018SE75797,ASTRAZENECA,,68.0,YR,,M,Y,94.5,KG,20180615.0,,,GB,GB,2018,Q2,Elderly
150154831,15015483,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Speech disorder,,2018,Q2,1,I,20180502.0,20180608.0,20180615,20180615,EXP,,GB-ASTRAZENECA-2018SE75797,ASTRAZENECA,,68.0,YR,,M,Y,94.5,KG,20180615.0,,,GB,GB,2018,Q2,Elderly
150154831,15015483,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q2,Visual field defect,,2018,Q2,1,I,20180502.0,20180608.0,20180615,20180615,EXP,,GB-ASTRAZENECA-2018SE75797,ASTRAZENECA,,68.0,YR,,M,Y,94.5,KG,20180615.0,,,GB,GB,2018,Q2,Elderly
150154861,15015486,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,, NT643,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Pain in extremity,,2018,Q2,1,I,2015.0,20180607.0,20180615,20180615,EXP,,GB-ASTRAZENECA-2018SE75248,ASTRAZENECA,,61.0,YR,,F,Y,88.9,KG,20180615.0,,,GB,GB,2018,Q2,Adult
150154861,15015486,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,, NT643,,202293.0,10.0,MG,TABLET,QD,2018,Q2,Skin ulcer,,2018,Q2,1,I,2015.0,20180607.0,20180615,20180615,EXP,,GB-ASTRAZENECA-2018SE75248,ASTRAZENECA,,61.0,YR,,F,Y,88.9,KG,20180615.0,,,GB,GB,2018,Q2,Adult
150160311,15016031,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",160.0,MG,U,,,,,10.0,MG,,QD,2018,Q2,Cerebral haemorrhage,,2018,Q2,1,I,20151226.0,20180610.0,20180615,20180615,EXP,,PHHY2016DE186872,SANDOZ,,75.0,YR,,M,Y,102.2,KG,20180615.0,,OT,DE,DE,2018,Q2,Elderly
150160311,15016031,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",160.0,MG,U,,,,,10.0,MG,,QD,2018,Q2,Systemic inflammatory response syndrome,,2018,Q2,1,I,20151226.0,20180610.0,20180615,20180615,EXP,,PHHY2016DE186872,SANDOZ,,75.0,YR,,M,Y,102.2,KG,20180615.0,,OT,DE,DE,2018,Q2,Elderly
150160311,15016031,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",160.0,MG,U,,,,,10.0,MG,,QD,2018,Q2,Wound infection,,2018,Q2,1,I,20151226.0,20180610.0,20180615,20180615,EXP,,PHHY2016DE186872,SANDOZ,,75.0,YR,,M,Y,102.2,KG,20180615.0,,OT,DE,DE,2018,Q2,Elderly
150178331,15017833,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,16290.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Bile duct stone,,2018,Q2,1,I,20180519.0,20180523.0,20180615,20180615,EXP,,US-ASTRAZENECA-2018SE68923,ASTRAZENECA,,26981.0,DY,,F,Y,,,20180615.0,,MD,US,US,2018,Q2,Elderly
150178331,15017833,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,16290.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Cholangitis acute,,2018,Q2,1,I,20180519.0,20180523.0,20180615,20180615,EXP,,US-ASTRAZENECA-2018SE68923,ASTRAZENECA,,26981.0,DY,,F,Y,,,20180615.0,,MD,US,US,2018,Q2,Elderly
150178331,15017833,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,16290.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Chronic obstructive pulmonary disease,,2018,Q2,1,I,20180519.0,20180523.0,20180615,20180615,EXP,,US-ASTRAZENECA-2018SE68923,ASTRAZENECA,,26981.0,DY,,F,Y,,,20180615.0,,MD,US,US,2018,Q2,Elderly
150178331,15017833,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,16290.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Bile duct stone,,2018,Q2,1,I,20180519.0,20180523.0,20180615,20180615,EXP,,US-ASTRAZENECA-2018SE68923,ASTRAZENECA,,26981.0,DY,,F,Y,,,20180615.0,,MD,US,US,2018,Q2,Elderly
150178331,15017833,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,16290.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Cholangitis acute,,2018,Q2,1,I,20180519.0,20180523.0,20180615,20180615,EXP,,US-ASTRAZENECA-2018SE68923,ASTRAZENECA,,26981.0,DY,,F,Y,,,20180615.0,,MD,US,US,2018,Q2,Elderly
150178331,15017833,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,16290.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q2,Chronic obstructive pulmonary disease,,2018,Q2,1,I,20180519.0,20180523.0,20180615,20180615,EXP,,US-ASTRAZENECA-2018SE68923,ASTRAZENECA,,26981.0,DY,,F,Y,,,20180615.0,,MD,US,US,2018,Q2,Elderly
150267232,15026723,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,990.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Ischaemic stroke,,2018,Q2,2,F,20180528.0,20180628.0,20180618,20180629,EXP,,PE-ASTRAZENECA-2018SE76922,ASTRAZENECA,,24574.0,DY,,F,Y,,,20180629.0,,MD,PE,PE,2018,Q2,Elderly
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Decreased vibratory sense,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Gastrointestinal disorder,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Limb discomfort,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Neuropathy peripheral,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Pain in extremity,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Sensory disturbance,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Sleep disorder,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150283981,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q2,Visual impairment,,2018,Q2,1,I,,20180306.0,20180619,20180619,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180619.0,,MD,DE,DE,2018,Q2,Adult
150307581,15030758,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Acute hepatic failure,,2018,Q2,1,I,20180515.0,20180611.0,20180619,20180619,EXP,GB-MHRA-EYC 00179969,GB-BAYER-2018-110859,BAYER,,48.0,YR,A,F,Y,86.0,KG,20180619.0,,PH,GB,GB,2018,Q2,Adult
150365041,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q2,Blood creatine phosphokinase increased,,2018,Q2,1,I,20180503.0,20180606.0,20180620,20180620,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20180620.0,,MD,GB,GB,2018,Q2,Adult
150365041,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q2,Confusional state,,2018,Q2,1,I,20180503.0,20180606.0,20180620,20180620,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20180620.0,,MD,GB,GB,2018,Q2,Adult
150365041,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q2,Inhibitory drug interaction,,2018,Q2,1,I,20180503.0,20180606.0,20180620,20180620,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20180620.0,,MD,GB,GB,2018,Q2,Adult
150365041,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q2,Neuroleptic malignant syndrome,,2018,Q2,1,I,20180503.0,20180606.0,20180620,20180620,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20180620.0,,MD,GB,GB,2018,Q2,Adult
150478371,15047837,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,1,I,20171010.0,20180514.0,20180621,20180621,EXP,,GB-009507513-1805GBR006188,MERCK,,28563.0,DY,,M,Y,,,20180621.0,,MD,GB,GB,2018,Q2,Elderly
150478371,15047837,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,,2018,Q2,1,I,20171010.0,20180514.0,20180621,20180621,EXP,,GB-009507513-1805GBR006188,MERCK,,28563.0,DY,,M,Y,,,20180621.0,,MD,GB,GB,2018,Q2,Elderly
150478371,15047837,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,,2018,Q2,1,I,20171010.0,20180514.0,20180621,20180621,EXP,,GB-009507513-1805GBR006188,MERCK,,28563.0,DY,,M,Y,,,20180621.0,,MD,GB,GB,2018,Q2,Elderly
150478371,15047837,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Acute kidney injury,,2018,Q2,1,I,20171010.0,20180514.0,20180621,20180621,EXP,,GB-009507513-1805GBR006188,MERCK,,28563.0,DY,,M,Y,,,20180621.0,,MD,GB,GB,2018,Q2,Elderly
150478371,15047837,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Epididymitis,,2018,Q2,1,I,20171010.0,20180514.0,20180621,20180621,EXP,,GB-009507513-1805GBR006188,MERCK,,28563.0,DY,,M,Y,,,20180621.0,,MD,GB,GB,2018,Q2,Elderly
150478371,15047837,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q2,Hypotension,,2018,Q2,1,I,20171010.0,20180514.0,20180621,20180621,EXP,,GB-009507513-1805GBR006188,MERCK,,28563.0,DY,,M,Y,,,20180621.0,,MD,GB,GB,2018,Q2,Elderly
150773432,15077343,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,16440.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q2,Osteoarthritis,,2018,Q2,2,F,20180515.0,20180625.0,20180627,20180629,EXP,,US-ASTRAZENECA-2018SE82257,ASTRAZENECA,,25519.0,DY,,M,Y,,,20180629.0,,MD,US,US,2018,Q2,Elderly
150800651,15080065,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q2,Acute kidney injury,,2018,Q2,1,I,20171011.0,20180624.0,20180627,20180627,EXP,,PHHY2018GB031840,SANDOZ,,72.0,YR,,,Y,,,20180628.0,,OT,GB,GB,2018,Q2,Elderly
150800651,15080065,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q2,Arrhythmia,,2018,Q2,1,I,20171011.0,20180624.0,20180627,20180627,EXP,,PHHY2018GB031840,SANDOZ,,72.0,YR,,,Y,,,20180628.0,,OT,GB,GB,2018,Q2,Elderly
150800651,15080065,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q2,Dehydration,,2018,Q2,1,I,20171011.0,20180624.0,20180627,20180627,EXP,,PHHY2018GB031840,SANDOZ,,72.0,YR,,,Y,,,20180628.0,,OT,GB,GB,2018,Q2,Elderly
150800651,15080065,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q2,Metabolic acidosis,,2018,Q2,1,I,20171011.0,20180624.0,20180627,20180627,EXP,,PHHY2018GB031840,SANDOZ,,72.0,YR,,,Y,,,20180628.0,,OT,GB,GB,2018,Q2,Elderly
150845941,15084594,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD,10 MILLIGRAM DAILY;",,,D,,,,,10.0,MG,,QD,2018,Q2,Drug ineffective,,2018,Q2,1,I,,20180611.0,20180628,20180628,EXP,,HU-MYLANLABS-2018M1043479,MYLAN,,66.0,YR,,M,Y,,,20180628.0,,MD,HU,HU,2018,Q2,Elderly
150845941,15084594,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD,10 MILLIGRAM DAILY;",,,D,,,,,10.0,MG,,QD,2018,Q2,Hypoglycaemia,,2018,Q2,1,I,,20180611.0,20180628,20180628,EXP,,HU-MYLANLABS-2018M1043479,MYLAN,,66.0,YR,,M,Y,,,20180628.0,,MD,HU,HU,2018,Q2,Elderly
150901481,15090148,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Blood ketone body increased,,2018,Q2,1,I,20180530.0,20180622.0,20180629,20180629,EXP,,GB-ASTRAZENECA-2018SE82339,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20180629.0,,,GB,GB,2018,Q2,Adult
150901481,15090148,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Influenza like illness,,2018,Q2,1,I,20180530.0,20180622.0,20180629,20180629,EXP,,GB-ASTRAZENECA-2018SE82339,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20180629.0,,,GB,GB,2018,Q2,Adult
150901481,15090148,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Malaise,,2018,Q2,1,I,20180530.0,20180622.0,20180629,20180629,EXP,,GB-ASTRAZENECA-2018SE82339,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20180629.0,,,GB,GB,2018,Q2,Adult
150901481,15090148,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q2,Vomiting,,2018,Q2,1,I,20180530.0,20180622.0,20180629,20180629,EXP,,GB-ASTRAZENECA-2018SE82339,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20180629.0,,,GB,GB,2018,Q2,Adult
150922241,15092224,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2330.0,MEQ,Y,U,,,202293.0,10.0,MEQ,TABLET,QD,2018,Q2,Diabetic ketoacidosis,,2018,Q2,1,I,20180322.0,20180621.0,20180629,20180629,EXP,,ES-ASTRAZENECA-2018SE81254,ASTRAZENECA,,68.0,YR,,F,Y,58.7,KG,20180629.0,,MD,ES,ES,2018,Q2,Elderly
150927271,15092727,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Blood creatine phosphokinase increased,,2018,Q2,1,I,20180503.0,20180622.0,20180629,20180629,EXP,GB-MHRA-EYC 00179756,GB-TEVA-2018-GB-916457,TEVA,,60.0,YR,,F,Y,79.8,KG,20180629.0,,MD,GB,GB,2018,Q2,Adult
150927271,15092727,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Confusional state,,2018,Q2,1,I,20180503.0,20180622.0,20180629,20180629,EXP,GB-MHRA-EYC 00179756,GB-TEVA-2018-GB-916457,TEVA,,60.0,YR,,F,Y,79.8,KG,20180629.0,,MD,GB,GB,2018,Q2,Adult
150927271,15092727,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Inhibitory drug interaction,,2018,Q2,1,I,20180503.0,20180622.0,20180629,20180629,EXP,GB-MHRA-EYC 00179756,GB-TEVA-2018-GB-916457,TEVA,,60.0,YR,,F,Y,79.8,KG,20180629.0,,MD,GB,GB,2018,Q2,Adult
150927271,15092727,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q2,Neuroleptic malignant syndrome,,2018,Q2,1,I,20180503.0,20180622.0,20180629,20180629,EXP,GB-MHRA-EYC 00179756,GB-TEVA-2018-GB-916457,TEVA,,60.0,YR,,F,Y,79.8,KG,20180629.0,,MD,GB,GB,2018,Q2,Adult
150934181,15093418,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q2,Acute kidney injury,,2018,Q2,1,I,20171011.0,20180624.0,20180629,20180629,EXP,,PHHY2018GB031874,SANDOZ,,72.0,YR,,M,Y,,,20180629.0,,OT,GB,GB,2018,Q2,Elderly
150934181,15093418,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q2,Dehydration,,2018,Q2,1,I,20171011.0,20180624.0,20180629,20180629,EXP,,PHHY2018GB031874,SANDOZ,,72.0,YR,,M,Y,,,20180629.0,,OT,GB,GB,2018,Q2,Elderly
150934181,15093418,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q2,Metabolic acidosis,,2018,Q2,1,I,20171011.0,20180624.0,20180629,20180629,EXP,,PHHY2018GB031874,SANDOZ,,72.0,YR,,M,Y,,,20180629.0,,OT,GB,GB,2018,Q2,Elderly
107610894,10761089,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Atrioventricular block,,2018,Q3,4,F,20141209.0,20180627.0,20150204,20180705,EXP,,US-ASTRAZENECA-2015SE02746,ASTRAZENECA,,72.0,YR,,M,Y,,,20180705.0,,CN,CA,CA,2018,Q3,Elderly
107610894,10761089,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Subarachnoid haemorrhage,,2018,Q3,4,F,20141209.0,20180627.0,20150204,20180705,EXP,,US-ASTRAZENECA-2015SE02746,ASTRAZENECA,,72.0,YR,,M,Y,,,20180705.0,,CN,CA,CA,2018,Q3,Elderly
107610894,10761089,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Syncope,,2018,Q3,4,F,20141209.0,20180627.0,20150204,20180705,EXP,,US-ASTRAZENECA-2015SE02746,ASTRAZENECA,,72.0,YR,,M,Y,,,20180705.0,,CN,CA,CA,2018,Q3,Elderly
107610894,10761089,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Atrioventricular block,,2018,Q3,4,F,20141209.0,20180627.0,20150204,20180705,EXP,,US-ASTRAZENECA-2015SE02746,ASTRAZENECA,,72.0,YR,,M,Y,,,20180705.0,,CN,CA,CA,2018,Q3,Elderly
107610894,10761089,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Subarachnoid haemorrhage,,2018,Q3,4,F,20141209.0,20180627.0,20150204,20180705,EXP,,US-ASTRAZENECA-2015SE02746,ASTRAZENECA,,72.0,YR,,M,Y,,,20180705.0,,CN,CA,CA,2018,Q3,Elderly
107610894,10761089,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Syncope,,2018,Q3,4,F,20141209.0,20180627.0,20150204,20180705,EXP,,US-ASTRAZENECA-2015SE02746,ASTRAZENECA,,72.0,YR,,M,Y,,,20180705.0,,CN,CA,CA,2018,Q3,Elderly
109836593,10983659,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1740.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Gastrointestinal haemorrhage,,2018,Q3,3,F,20150324.0,20180917.0,20150403,20180925,EXP,,US-ASTRAZENECA-2015SE30179,ASTRAZENECA,,24032.0,DY,,M,Y,,,20180925.0,,MD,US,US,2018,Q3,Elderly
109836593,10983659,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1740.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Gastrointestinal haemorrhage,,2018,Q3,3,F,20150324.0,20180917.0,20150403,20180925,EXP,,US-ASTRAZENECA-2015SE30179,ASTRAZENECA,,24032.0,DY,,M,Y,,,20180925.0,,MD,US,US,2018,Q3,Elderly
109836593,10983659,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1740.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Gastrointestinal haemorrhage,,2018,Q3,3,F,20150324.0,20180917.0,20150403,20180925,EXP,,US-ASTRAZENECA-2015SE30179,ASTRAZENECA,,24032.0,DY,,M,Y,,,20180925.0,,MD,US,US,2018,Q3,Elderly
111225952,11122595,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q3,Bradycardia,,2018,Q3,2,F,20150415.0,20180917.0,20150519,20180926,EXP,,IT-PFIZER INC-2015165212,PFIZER,,75.0,YR,,M,Y,,,20180926.0,,MD,IT,IT,2018,Q3,Elderly
111225952,11122595,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q3,Urinary tract infection,,2018,Q3,2,F,20150415.0,20180917.0,20150519,20180926,EXP,,IT-PFIZER INC-2015165212,PFIZER,,75.0,YR,,M,Y,,,20180926.0,,MD,IT,IT,2018,Q3,Elderly
111225952,11122595,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q3,Bradycardia,,2018,Q3,2,F,20150415.0,20180917.0,20150519,20180926,EXP,,IT-PFIZER INC-2015165212,PFIZER,,75.0,YR,,M,Y,,,20180926.0,,MD,IT,IT,2018,Q3,Elderly
111225952,11122595,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2018,Q3,Urinary tract infection,,2018,Q3,2,F,20150415.0,20180917.0,20150519,20180926,EXP,,IT-PFIZER INC-2015165212,PFIZER,,75.0,YR,,M,Y,,,20180926.0,,MD,IT,IT,2018,Q3,Elderly
116387205,11638720,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5180.0,MG,N,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Prostate cancer,,2018,Q3,5,F,20150908.0,20180817.0,20151016,20180821,EXP,,RO-ASTRAZENECA-2015SE98200,ASTRAZENECA,,23327.0,DY,,M,Y,,,20180821.0,,MD,RO,RO,2018,Q3,Elderly
125248983,12524898,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Acute kidney injury,,2018,Q3,3,F,20140514.0,20180907.0,20160704,20180914,EXP,,US-ASTRAZENECA-2014SE36920,ASTRAZENECA,,25616.0,DY,,F,Y,,,20180914.0,,MD,RO,RO,2018,Q3,Elderly
125248983,12524898,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Disseminated intravascular coagulation,,2018,Q3,3,F,20140514.0,20180907.0,20160704,20180914,EXP,,US-ASTRAZENECA-2014SE36920,ASTRAZENECA,,25616.0,DY,,F,Y,,,20180914.0,,MD,RO,RO,2018,Q3,Elderly
125248983,12524898,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Sepsis,,2018,Q3,3,F,20140514.0,20180907.0,20160704,20180914,EXP,,US-ASTRAZENECA-2014SE36920,ASTRAZENECA,,25616.0,DY,,F,Y,,,20180914.0,,MD,RO,RO,2018,Q3,Elderly
125248983,12524898,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Urinary tract infection,,2018,Q3,3,F,20140514.0,20180907.0,20160704,20180914,EXP,,US-ASTRAZENECA-2014SE36920,ASTRAZENECA,,25616.0,DY,,F,Y,,,20180914.0,,MD,RO,RO,2018,Q3,Elderly
129149216,12914921,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1290.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Laryngitis,,2018,Q3,6,F,20161023.0,20180803.0,20161106,20180808,EXP,,MX-ASTRAZENECA-2016SF13754,ASTRAZENECA,,19202.0,DY,,F,Y,,,20180808.0,,MD,MX,MX,2018,Q3,Elderly
130601032,13060103,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,8640.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q3,Renal cancer,,2018,Q3,2,F,20161022.0,20180810.0,20161223,20180817,EXP,,US-ASTRAZENECA-2016SF34192,ASTRAZENECA,,22987.0,DY,,M,Y,,,20180817.0,,MD,US,US,2018,Q3,Elderly
134266617,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q3,Blood bicarbonate decreased,,2018,Q3,7,F,,20180620.0,20170411,20180702,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180702.0,,OT,GB,IT,2018,Q3,Adult
134266617,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q3,Blood lactic acid increased,,2018,Q3,7,F,,20180620.0,20170411,20180702,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180702.0,,OT,GB,IT,2018,Q3,Adult
134266617,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,7,F,,20180620.0,20170411,20180702,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180702.0,,OT,GB,IT,2018,Q3,Adult
134266617,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q3,Ketonuria,,2018,Q3,7,F,,20180620.0,20170411,20180702,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180702.0,,OT,GB,IT,2018,Q3,Adult
134266617,13426661,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q3,Metabolic acidosis,,2018,Q3,7,F,,20180620.0,20170411,20180702,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-137858,RANBAXY,,61.0,YR,,M,Y,,,20180702.0,,OT,GB,IT,2018,Q3,Adult
138816763,13881676,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13400.0,MG,D,,,,,10.0,MG,TABLET,QD,2018,Q3,Confusional state,,2018,Q3,3,F,20170803.0,20180917.0,20170818,20180925,EXP,,GB-ASTRAZENECA-2017SE82142,ASTRAZENECA,,30220.0,DY,,M,Y,,,20180925.0,,MD,GB,GB,2018,Q3,Elderly
139113814,13911381,20,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2018,Q3,Blood pressure increased,,2018,Q3,4,F,2016.0,20180919.0,20170828,20180926,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180925.0,,OT,CA,CA,2018,Q3,Elderly
139113814,13911381,20,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2018,Q3,Crohn's disease,,2018,Q3,4,F,2016.0,20180919.0,20170828,20180926,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180925.0,,OT,CA,CA,2018,Q3,Elderly
139113814,13911381,20,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2018,Q3,Fatigue,,2018,Q3,4,F,2016.0,20180919.0,20170828,20180926,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180925.0,,OT,CA,CA,2018,Q3,Elderly
139113814,13911381,20,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2018,Q3,Laceration,,2018,Q3,4,F,2016.0,20180919.0,20170828,20180926,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180925.0,,OT,CA,CA,2018,Q3,Elderly
139113814,13911381,20,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2018,Q3,Type 1 diabetes mellitus,,2018,Q3,4,F,2016.0,20180919.0,20170828,20180926,EXP,,CA-AMGEN-CANSP2016172409,AMGEN,,67.0,YR,E,M,Y,90.0,KG,20180925.0,,OT,CA,CA,2018,Q3,Elderly
139396605,13939660,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13580.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic foot infection,,2018,Q3,5,F,20170706.0,20180820.0,20170906,20180822,EXP,,CA-ASTRAZENECA-2017SE90337,ASTRAZENECA,,76.0,YR,,M,Y,,,20180822.0,,MD,CA,CA,2018,Q3,Elderly
139396605,13939660,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13580.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Skin ulcer,,2018,Q3,5,F,20170706.0,20180820.0,20170906,20180822,EXP,,CA-ASTRAZENECA-2017SE90337,ASTRAZENECA,,76.0,YR,,M,Y,,,20180822.0,,MD,CA,CA,2018,Q3,Elderly
139396605,13939660,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13580.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic foot infection,,2018,Q3,5,F,20170706.0,20180820.0,20170906,20180822,EXP,,CA-ASTRAZENECA-2017SE90337,ASTRAZENECA,,76.0,YR,,M,Y,,,20180822.0,,MD,CA,CA,2018,Q3,Elderly
139396605,13939660,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13580.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Skin ulcer,,2018,Q3,5,F,20170706.0,20180820.0,20170906,20180822,EXP,,CA-ASTRAZENECA-2017SE90337,ASTRAZENECA,,76.0,YR,,M,Y,,,20180822.0,,MD,CA,CA,2018,Q3,Elderly
140681633,14068163,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Hyponatraemia,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140681633,14068163,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Hypotension,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140681633,14068163,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Lethargy,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140681633,14068163,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Muscular weakness,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140681633,14068163,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Hyponatraemia,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140681633,14068163,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Hypotension,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140681633,14068163,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Lethargy,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140681633,14068163,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Muscular weakness,,2018,Q3,3,F,20170926.0,20180829.0,20171010,20180904,EXP,,HU-ROCHE-2004266,ROCHE,,66.0,YR,,M,Y,95.0,KG,20180904.0,,MD,HU,HU,2018,Q3,Elderly
140762228,14076222,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13470.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Acute kidney injury,,2018,Q3,8,F,20170712.0,20180917.0,20171011,20180925,EXP,,CA-ASTRAZENECA-2017SF01595,ASTRAZENECA,,72.0,YR,,M,Y,,,20180925.0,,MD,CA,CA,2018,Q3,Elderly
140762228,14076222,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13470.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Hepatic encephalopathy,,2018,Q3,8,F,20170712.0,20180917.0,20171011,20180925,EXP,,CA-ASTRAZENECA-2017SF01595,ASTRAZENECA,,72.0,YR,,M,Y,,,20180925.0,,MD,CA,CA,2018,Q3,Elderly
140762228,14076222,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13470.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Hypotension,,2018,Q3,8,F,20170712.0,20180917.0,20171011,20180925,EXP,,CA-ASTRAZENECA-2017SF01595,ASTRAZENECA,,72.0,YR,,M,Y,,,20180925.0,,MD,CA,CA,2018,Q3,Elderly
140762228,14076222,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,TABLET,,2018,Q3,Acute kidney injury,,2018,Q3,8,F,20170712.0,20180917.0,20171011,20180925,EXP,,CA-ASTRAZENECA-2017SF01595,ASTRAZENECA,,72.0,YR,,M,Y,,,20180925.0,,MD,CA,CA,2018,Q3,Elderly
140762228,14076222,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,TABLET,,2018,Q3,Hepatic encephalopathy,,2018,Q3,8,F,20170712.0,20180917.0,20171011,20180925,EXP,,CA-ASTRAZENECA-2017SF01595,ASTRAZENECA,,72.0,YR,,M,Y,,,20180925.0,,MD,CA,CA,2018,Q3,Elderly
140762228,14076222,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,TABLET,,2018,Q3,Hypotension,,2018,Q3,8,F,20170712.0,20180917.0,20171011,20180925,EXP,,CA-ASTRAZENECA-2017SF01595,ASTRAZENECA,,72.0,YR,,M,Y,,,20180925.0,,MD,CA,CA,2018,Q3,Elderly
140803026,14080302,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11210.0,MG,N,,,,,10.0,MG,TABLET,QD,2018,Q3,Acute kidney injury,,2018,Q3,6,F,20170912.0,20180730.0,20171012,20180802,EXP,,AU-ASTRAZENECA-2017SE94134,ASTRAZENECA,,28397.0,DY,,M,Y,,,20180802.0,,MD,AU,AU,2018,Q3,Elderly
140803026,14080302,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11210.0,MG,N,,,,,10.0,MG,TABLET,QD,2018,Q3,Urosepsis,,2018,Q3,6,F,20170912.0,20180730.0,20171012,20180802,EXP,,AU-ASTRAZENECA-2017SE94134,ASTRAZENECA,,28397.0,DY,,M,Y,,,20180802.0,,MD,AU,AU,2018,Q3,Elderly
141331512,14133151,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNWN DOSE10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2018,Q3,Pruritus,,2018,Q3,2,F,20170823.0,20180724.0,20171026,20180801,EXP,,GB-ASTRAZENECA-2017SF08188,ASTRAZENECA,,65.0,YR,,F,Y,87.0,KG,20180801.0,,OT,GB,GB,2018,Q3,Elderly
141331512,14133151,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNWN DOSE10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2018,Q3,Pruritus generalised,,2018,Q3,2,F,20170823.0,20180724.0,20171026,20180801,EXP,,GB-ASTRAZENECA-2017SF08188,ASTRAZENECA,,65.0,YR,,F,Y,87.0,KG,20180801.0,,OT,GB,GB,2018,Q3,Elderly
141331512,14133151,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNWN DOSE10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2018,Q3,Skin abrasion,,2018,Q3,2,F,20170823.0,20180724.0,20171026,20180801,EXP,,GB-ASTRAZENECA-2017SF08188,ASTRAZENECA,,65.0,YR,,F,Y,87.0,KG,20180801.0,,OT,GB,GB,2018,Q3,Elderly
141331512,14133151,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNWN DOSE10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2018,Q3,Vulvovaginal erythema,,2018,Q3,2,F,20170823.0,20180724.0,20171026,20180801,EXP,,GB-ASTRAZENECA-2017SF08188,ASTRAZENECA,,65.0,YR,,F,Y,87.0,KG,20180801.0,,OT,GB,GB,2018,Q3,Elderly
141331512,14133151,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNWN DOSE10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2018,Q3,Vulvovaginal pain,,2018,Q3,2,F,20170823.0,20180724.0,20171026,20180801,EXP,,GB-ASTRAZENECA-2017SF08188,ASTRAZENECA,,65.0,YR,,F,Y,87.0,KG,20180801.0,,OT,GB,GB,2018,Q3,Elderly
141439032,14143903,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2018,Q3,Hypocalcaemia,,2018,Q3,2,F,20170823.0,20180618.0,20171031,20180702,EXP,,GB-DEXPHARM-20171520,DEXCEL,,75.0,YR,E,M,Y,,,20180702.0,,OT,GB,GB,2018,Q3,Elderly
141439032,14143903,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2018,Q3,Hypomagnesaemia,,2018,Q3,2,F,20170823.0,20180618.0,20171031,20180702,EXP,,GB-DEXPHARM-20171520,DEXCEL,,75.0,YR,E,M,Y,,,20180702.0,,OT,GB,GB,2018,Q3,Elderly
141439032,14143903,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2018,Q3,Hypocalcaemia,,2018,Q3,2,F,20170823.0,20180618.0,20171031,20180702,EXP,,GB-DEXPHARM-20171520,DEXCEL,,75.0,YR,E,M,Y,,,20180702.0,,OT,GB,GB,2018,Q3,Elderly
141439032,14143903,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2018,Q3,Hypomagnesaemia,,2018,Q3,2,F,20170823.0,20180618.0,20171031,20180702,EXP,,GB-DEXPHARM-20171520,DEXCEL,,75.0,YR,E,M,Y,,,20180702.0,,OT,GB,GB,2018,Q3,Elderly
141687317,14168731,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,7,F,20140601.0,20180709.0,20171107,20180718,EXP,IT-MINISAL02-433704,IT-MYLANLABS-2017M1068934,MYLAN,,63.0,YR,,F,Y,,,20180715.0,,CN,IT,IT,2018,Q3,Adult
141687317,14168731,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,7,F,20140601.0,20180709.0,20171107,20180718,EXP,IT-MINISAL02-433704,IT-MYLANLABS-2017M1068934,MYLAN,,63.0,YR,,F,Y,,,20180715.0,,CN,IT,IT,2018,Q3,Adult
141720008,14172000,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,8,F,20140101.0,20180712.0,20171108,20180723,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-101086,BRISTOL MYERS SQUIBB,BELVISO A. DAPAGLIFLOZIN: OLTRE IL CONTROLLO GLICEMICO IN UN PAZIENTE DIABETICO SCOMPENSATO. TUTTO DIABETE. 2017?17:162?3,63.0,YR,,F,Y,,,20180723.0,,OT,IT,IT,2018,Q3,Adult
142689454,14268945,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,4,F,20140101.0,20180718.0,20171211,20180802,EXP,,IT-SA-2017SA239255,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20180802.0,,CN,IT,IT,2018,Q3,Adult
142689454,14268945,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,4,F,20140101.0,20180718.0,20171211,20180802,EXP,,IT-SA-2017SA239255,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20180802.0,,CN,IT,IT,2018,Q3,Adult
142745745,14274574,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,5,F,20140101.0,20180903.0,20171211,20180917,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-156275,RANBAXY,,63.0,YR,,F,Y,,,20180917.0,,CN,IT,IT,2018,Q3,Adult
143189226,14318922,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,6,F,20140101.0,20180702.0,20171222,20180705,EXP,,IT-TAKEDA-2017EPA006450AA,TAKEDA,,63.0,YR,,F,Y,,,20180705.0,,CN,IT,IT,2018,Q3,Adult
143225854,14322585,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,4,F,20140101.0,20180806.0,20171225,20180814,EXP,IT-MINISAL02-435827,PHHY2017IT192924,SANDOZ,,63.0,YR,,F,Y,,,20180814.0,,OT,IT,IT,2018,Q3,Adult
143225854,14322585,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,4,F,20140101.0,20180806.0,20171225,20180814,EXP,IT-MINISAL02-435827,PHHY2017IT192924,SANDOZ,,63.0,YR,,F,Y,,,20180814.0,,OT,IT,IT,2018,Q3,Adult
143271416,14327141,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q3,Acute kidney injury,,2018,Q3,6,F,20171012.0,20180724.0,20171227,20180801,EXP,,PHHY2017GB194207,SANDOZ,,78.0,YR,,M,Y,,,20180801.0,,MD,GB,GB,2018,Q3,Elderly
143271416,14327141,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q3,Epididymitis,,2018,Q3,6,F,20171012.0,20180724.0,20171227,20180801,EXP,,PHHY2017GB194207,SANDOZ,,78.0,YR,,M,Y,,,20180801.0,,MD,GB,GB,2018,Q3,Elderly
143271416,14327141,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q3,Hypotension,,2018,Q3,6,F,20171012.0,20180724.0,20171227,20180801,EXP,,PHHY2017GB194207,SANDOZ,,78.0,YR,,M,Y,,,20180801.0,,MD,GB,GB,2018,Q3,Elderly
143271416,14327141,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q3,Acute kidney injury,,2018,Q3,6,F,20171012.0,20180724.0,20171227,20180801,EXP,,PHHY2017GB194207,SANDOZ,,78.0,YR,,M,Y,,,20180801.0,,MD,GB,GB,2018,Q3,Elderly
143271416,14327141,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q3,Epididymitis,,2018,Q3,6,F,20171012.0,20180724.0,20171227,20180801,EXP,,PHHY2017GB194207,SANDOZ,,78.0,YR,,M,Y,,,20180801.0,,MD,GB,GB,2018,Q3,Elderly
143271416,14327141,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2018,Q3,Hypotension,,2018,Q3,6,F,20171012.0,20180724.0,20171227,20180801,EXP,,PHHY2017GB194207,SANDOZ,,78.0,YR,,M,Y,,,20180801.0,,MD,GB,GB,2018,Q3,Elderly
143497376,14349737,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,6,F,20140101.0,20180828.0,20180104,20180911,EXP,,IT-AUROBINDO-AUR-APL-2018-000066,AUROBINDO,,63.0,YR,,F,Y,,,20180911.0,,OT,IT,IT,2018,Q3,Adult
144327784,14432778,21,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,4,F,20140101.0,20180724.0,20180124,20180827,EXP,,PHHY2017IT155500,SANDOZ,,63.0,YR,,F,Y,,,20180828.0,,OT,IT,IT,2018,Q3,Adult
144327784,14432778,22,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,4,F,20140101.0,20180724.0,20180124,20180827,EXP,,PHHY2017IT155500,SANDOZ,,63.0,YR,,F,Y,,,20180828.0,,OT,IT,IT,2018,Q3,Adult
144499785,14449978,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Peripheral artery stenosis,,2018,Q3,5,F,20171208.0,20180626.0,20180129,20180704,EXP,,CA-ASTRAZENECA-2018SE01405,ASTRAZENECA,,28892.0,DY,,F,Y,,,20180704.0,,MD,CA,CA,2018,Q3,Elderly
144499785,14449978,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Peripheral ischaemia,,2018,Q3,5,F,20171208.0,20180626.0,20180129,20180704,EXP,,CA-ASTRAZENECA-2018SE01405,ASTRAZENECA,,28892.0,DY,,F,Y,,,20180704.0,,MD,CA,CA,2018,Q3,Elderly
144499785,14449978,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Postoperative wound infection,,2018,Q3,5,F,20171208.0,20180626.0,20180129,20180704,EXP,,CA-ASTRAZENECA-2018SE01405,ASTRAZENECA,,28892.0,DY,,F,Y,,,20180704.0,,MD,CA,CA,2018,Q3,Elderly
144499785,14449978,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Peripheral artery stenosis,,2018,Q3,5,F,20171208.0,20180626.0,20180129,20180704,EXP,,CA-ASTRAZENECA-2018SE01405,ASTRAZENECA,,28892.0,DY,,F,Y,,,20180704.0,,MD,CA,CA,2018,Q3,Elderly
144499785,14449978,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Peripheral ischaemia,,2018,Q3,5,F,20171208.0,20180626.0,20180129,20180704,EXP,,CA-ASTRAZENECA-2018SE01405,ASTRAZENECA,,28892.0,DY,,F,Y,,,20180704.0,,MD,CA,CA,2018,Q3,Elderly
144499785,14449978,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Postoperative wound infection,,2018,Q3,5,F,20171208.0,20180626.0,20180129,20180704,EXP,,CA-ASTRAZENECA-2018SE01405,ASTRAZENECA,,28892.0,DY,,F,Y,,,20180704.0,,MD,CA,CA,2018,Q3,Elderly
145264643,14526464,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14510.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Transitional cell carcinoma,,2018,Q3,3,F,20180126.0,20180727.0,20180213,20180731,EXP,,CA-ASTRAZENECA-2018SE17103,ASTRAZENECA,,68.0,YR,,M,Y,,,20180731.0,,MD,CA,CA,2018,Q3,Elderly
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Alcohol abuse,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Amnesia,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Anxiety,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Asthenia,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Cerebrovascular accident,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Diabetes mellitus,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Diplopia,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Disturbance in attention,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Drug ineffective,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Feeling of despair,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Hypertension,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Job dissatisfaction,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Nausea,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Negative thoughts,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Panic disorder,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Panic reaction,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Paraesthesia,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Psychiatric symptom,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Suicidal ideation,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Tearfulness,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Thinking abnormal,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146133933,14613393,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2018,Q3,Treatment noncompliance,,2018,Q3,3,F,2009.0,20180805.0,20180308,20180815,EXP,,GB-TEVA-2018-GB-865497,TEVA,,57.0,YR,,M,Y,88.0,KG,20180815.0,,OT,GB,GB,2018,Q3,Adult
146251762,14625176,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Hyperkalaemia,,2018,Q3,2,F,20180228.0,20180719.0,20180312,20180725,EXP,,KR-ASTRAZENECA-2018SE28119,ASTRAZENECA,,25553.0,DY,,F,Y,,,20180725.0,,MD,KR,KR,2018,Q3,Elderly
146251762,14625176,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Pubis fracture,,2018,Q3,2,F,20180228.0,20180719.0,20180312,20180725,EXP,,KR-ASTRAZENECA-2018SE28119,ASTRAZENECA,,25553.0,DY,,F,Y,,,20180725.0,,MD,KR,KR,2018,Q3,Elderly
146251762,14625176,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Scapula fracture,,2018,Q3,2,F,20180228.0,20180719.0,20180312,20180725,EXP,,KR-ASTRAZENECA-2018SE28119,ASTRAZENECA,,25553.0,DY,,F,Y,,,20180725.0,,MD,KR,KR,2018,Q3,Elderly
146806024,14680602,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13600.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Atrial flutter,,2018,Q3,4,F,20170915.0,20180726.0,20180326,20180730,EXP,,CA-ASTRAZENECA-2018SE35714,ASTRAZENECA,,76.0,YR,,M,Y,,,20180730.0,,MD,CA,CA,2018,Q3,Elderly
146806024,14680602,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13600.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Atrial flutter,,2018,Q3,4,F,20170915.0,20180726.0,20180326,20180730,EXP,,CA-ASTRAZENECA-2018SE35714,ASTRAZENECA,,76.0,YR,,M,Y,,,20180730.0,,MD,CA,CA,2018,Q3,Elderly
146831782,14683178,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,2,F,20140101.0,20180716.0,20180327,20180725,EXP,IT-MINISAL02-435560,IT-ACCORD-065153,ACCORD,,63.0,YR,,F,Y,,,20180725.0,,OT,IT,IT,2018,Q3,Adult
147187543,14718754,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13560.0,MG,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Bladder transitional cell carcinoma,,2018,Q3,3,F,20180206.0,20180817.0,20180405,20180822,EXP,,CA-ASTRAZENECA-2018SE40695,ASTRAZENECA,,67.0,YR,,M,Y,,,20180822.0,,MD,CA,CA,2018,Q3,Elderly
147791083,14779108,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2018,Q3,Humerus fracture,,2018,Q3,3,F,20180329.0,20180820.0,20180419,20180823,EXP,,CA-ASTRAZENECA-2018SE50663,ASTRAZENECA,,74.0,YR,,F,Y,,,20180823.0,,MD,CA,CA,2018,Q3,Elderly
147791083,14779108,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2018,Q3,Humerus fracture,,2018,Q3,3,F,20180329.0,20180820.0,20180419,20180823,EXP,,CA-ASTRAZENECA-2018SE50663,ASTRAZENECA,,74.0,YR,,F,Y,,,20180823.0,,MD,CA,CA,2018,Q3,Elderly
147791083,14779108,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2018,Q3,Humerus fracture,,2018,Q3,3,F,20180329.0,20180820.0,20180419,20180823,EXP,,CA-ASTRAZENECA-2018SE50663,ASTRAZENECA,,74.0,YR,,F,Y,,,20180823.0,,MD,CA,CA,2018,Q3,Elderly
147838125,14783812,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12990.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Acute kidney injury,,2018,Q3,5,F,20180215.0,20180719.0,20180420,20180723,EXP,,SK-ASTRAZENECA-2018SE47407,ASTRAZENECA,,22049.0,DY,,M,Y,,,20180724.0,,MD,SK,SK,2018,Q3,Elderly
147838125,14783812,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12990.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Acute respiratory failure,,2018,Q3,5,F,20180215.0,20180719.0,20180420,20180723,EXP,,SK-ASTRAZENECA-2018SE47407,ASTRAZENECA,,22049.0,DY,,M,Y,,,20180724.0,,MD,SK,SK,2018,Q3,Elderly
147838125,14783812,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12990.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,General physical condition abnormal,,2018,Q3,5,F,20180215.0,20180719.0,20180420,20180723,EXP,,SK-ASTRAZENECA-2018SE47407,ASTRAZENECA,,22049.0,DY,,M,Y,,,20180724.0,,MD,SK,SK,2018,Q3,Elderly
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Decreased vibratory sense,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Gastrointestinal disorder,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Limb discomfort,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Neuropathy peripheral,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Pain in extremity,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Sensory disturbance,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Sleep disorder,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Temperature perception test abnormal,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148354034,14835403,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, ONCE A DAY",,,Y,U, UNK,,,10.0,MG,TABLET,QD,2018,Q3,Visual impairment,,2018,Q3,4,F,2016.0,20180904.0,20180502,20180917,EXP,,DE-AUROBINDO-AUR-APL-2018-014909,AUROBINDO,,61.0,YR,,F,Y,97.0,KG,20180917.0,,OT,DE,DE,2018,Q3,Adult
148467582,14846758,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,U,,,,202293.0,5.0,MG,TABLET,,2018,Q3,Blood glucose fluctuation,,2018,Q3,2,F,20170912.0,20180807.0,20180504,20180814,EXP,,GB-ASTRAZENECA-2018SE56936,ASTRAZENECA,,72.0,YR,,F,Y,59.0,KG,20180815.0,,MD,GB,GB,2018,Q3,Elderly
148467582,14846758,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,U,,,,202293.0,5.0,MG,TABLET,,2018,Q3,Pruritus generalised,,2018,Q3,2,F,20170912.0,20180807.0,20180504,20180814,EXP,,GB-ASTRAZENECA-2018SE56936,ASTRAZENECA,,72.0,YR,,F,Y,59.0,KG,20180815.0,,MD,GB,GB,2018,Q3,Elderly
149316692,14931669,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,,,,,10.0,MG,,,2018,Q3,Blood glucose abnormal,,2018,Q3,2,F,20170426.0,20180625.0,20180524,20180704,EXP,,GB-ROCHE-2128866,ROCHE,,77.0,YR,,F,Y,74.0,KG,20180704.0,,OT,GB,GB,2018,Q3,Elderly
149347403,14934740,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,710.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Deep vein thrombosis,,2018,Q3,3,F,20180425.0,20180718.0,20180524,20180723,EXP,,CA-ASTRAZENECA-2018SE61641,ASTRAZENECA,,29576.0,DY,,M,Y,,,20180723.0,,MD,CA,CA,2018,Q3,Elderly
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Decreased vibratory sense,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Gastrointestinal disorder,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Limb discomfort,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Neuropathy peripheral,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Pain in extremity,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Sensory disturbance,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Sleep disorder,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149375992,14937599,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,,,,,10.0,MG,,,2018,Q3,Visual impairment,,2018,Q3,2,F,,20180827.0,20180525,20180903,EXP,,PHHY2018DE003343,SANDOZ,HOLLENRIEDER V. BEINSCHMERZEN WEGER GUTTER COMPLIANCE.. INFO DIABETOLOGIE. 2017?11(3):6?7,61.0,YR,,F,Y,97.0,KG,20180903.0,,OT,DE,DE,2018,Q3,Adult
149749372,14974937,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Syncope,,2018,Q3,2,F,20180522.0,20180823.0,20180605,20180828,EXP,,AR-ASTRAZENECA-2018SE71093,ASTRAZENECA,,30668.0,DY,,F,Y,,,20180828.0,,MD,AR,AR,2018,Q3,Elderly
149749372,14974937,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,TABLET,QD,2018,Q3,Syncope,,2018,Q3,2,F,20180522.0,20180823.0,20180605,20180828,EXP,,AR-ASTRAZENECA-2018SE71093,ASTRAZENECA,,30668.0,DY,,F,Y,,,20180828.0,,MD,AR,AR,2018,Q3,Elderly
149753273,14975327,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1610.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Cellulitis,,2018,Q3,3,F,20180430.0,20180817.0,20180605,20180822,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20180822.0,,MD,US,US,2018,Q3,Elderly
149753273,14975327,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1610.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Sepsis,,2018,Q3,3,F,20180430.0,20180817.0,20180605,20180822,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20180822.0,,MD,US,US,2018,Q3,Elderly
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Decreased vibratory sense,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Gastrointestinal disorder,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Limb discomfort,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Neuropathy peripheral,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Pain in extremity,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Sensory disturbance,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Sleep disorder,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Temperature perception test abnormal,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Visual impairment,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Decreased vibratory sense,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Gastrointestinal disorder,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Limb discomfort,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Neuropathy peripheral,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Pain in extremity,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Sensory disturbance,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Sleep disorder,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Temperature perception test abnormal,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149822382,14982238,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Visual impairment,,2018,Q3,2,F,,20180725.0,20180607,20180801,EXP,,DE-ASTRAZENECA-2018SE71439,ASTRAZENECA,,61.0,YR,,F,Y,97.0,KG,20180801.0,,OT,DE,DE,2018,Q3,Adult
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,Blood potassium decreased,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,C-reactive protein increased,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,Cough,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,Fatigue,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,Influenza,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,Neutrophil count increased,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,Pyrexia,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149855233,14985523,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2018,Q3,White blood cell count increased,,2018,Q3,3,F,20180314.0,20180702.0,20180607,20180716,EXP,,DK-PFIZER INC-2018226733,PFIZER,,74.0,YR,,M,Y,94.0,KG,20180716.0,,CN,US,DK,2018,Q3,Elderly
149869973,14986997,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,TABLET,,2018,Q3,Acute kidney injury,,2018,Q3,3,F,20171010.0,20180705.0,20180608,20180713,EXP,,GB-TEVA-820950ACC,TEVA,,78.0,YR,,M,Y,,,20180713.0,,MD,GB,GB,2018,Q3,Elderly
149869973,14986997,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,TABLET,,2018,Q3,Epididymitis,,2018,Q3,3,F,20171010.0,20180705.0,20180608,20180713,EXP,,GB-TEVA-820950ACC,TEVA,,78.0,YR,,M,Y,,,20180713.0,,MD,GB,GB,2018,Q3,Elderly
149869973,14986997,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,TABLET,,2018,Q3,Hypotension,,2018,Q3,3,F,20171010.0,20180705.0,20180608,20180713,EXP,,GB-TEVA-820950ACC,TEVA,,78.0,YR,,M,Y,,,20180713.0,,MD,GB,GB,2018,Q3,Elderly
149990363,14999036,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diverticulitis,,2018,Q3,3,F,20180509.0,20180723.0,20180612,20180726,EXP,,CA-ASTRAZENECA-2018SE72507,ASTRAZENECA,,31527.0,DY,,F,Y,,,20180726.0,,MD,CA,CA,2018,Q3,Elderly
149990363,14999036,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diverticulitis,,2018,Q3,3,F,20180509.0,20180723.0,20180612,20180726,EXP,,CA-ASTRAZENECA-2018SE72507,ASTRAZENECA,,31527.0,DY,,F,Y,,,20180726.0,,MD,CA,CA,2018,Q3,Elderly
149990363,14999036,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diverticulitis,,2018,Q3,3,F,20180509.0,20180723.0,20180612,20180726,EXP,,CA-ASTRAZENECA-2018SE72507,ASTRAZENECA,,31527.0,DY,,F,Y,,,20180726.0,,MD,CA,CA,2018,Q3,Elderly
150267233,15026723,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,990.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Ischaemic stroke,,2018,Q3,3,F,20180528.0,20180802.0,20180618,20180803,EXP,,PE-ASTRAZENECA-2018SE76922,ASTRAZENECA,,24574.0,DY,,F,Y,,,20180803.0,,MD,PE,PE,2018,Q3,Elderly
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Decreased vibratory sense,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Gastrointestinal disorder,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Limb discomfort,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Neuropathy peripheral,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Pain in extremity,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Sensory disturbance,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Sleep disorder,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Temperature perception test abnormal,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150283982,15028398,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QID",,,Y,,,,,10.0,MG,,QID,2018,Q3,Visual impairment,,2018,Q3,2,F,,20180716.0,20180619,20180727,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-031577,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,97.0,KG,20180727.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Decreased vibratory sense,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Gastrointestinal disorder,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Limb discomfort,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Neuropathy peripheral,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Pain in extremity,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Sensory disturbance,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Sleep disorder,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Temperature perception test abnormal,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,TABLET,,2018,Q3,Visual impairment,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Decreased vibratory sense,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Gastrointestinal disorder,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Limb discomfort,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Neuropathy peripheral,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Pain in extremity,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Sensory disturbance,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Sleep disorder,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Temperature perception test abnormal,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150353733,15035373,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,DOSE REDUCED,,,Y,,,,,,,TABLET,,2018,Q3,Visual impairment,,2018,Q3,3,F,2016.0,20180716.0,20180620,20180723,EXP,,DE-BAUSCH-BL-2018-008616,BAUSCH AND LOMB,HOLLENRIEDER V. SPECIAL DIABETES MELLITUS. LEG PAIN BECAUSE OF GOOD COMPLIANCE. DOCTORS WEEK. 2018 FEB 15?7 (22):.,61.0,YR,,F,Y,97.0,KG,20180723.0,,MD,DE,DE,2018,Q3,Adult
150499092,15049909,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q3,Aortic dilatation,,2018,Q3,2,F,20170808.0,20180620.0,20180622,20180629,EXP,,AU-SUNOVION-2018DSP007185,SUNOVION,,56.0,YR,,F,Y,93.6,KG,20180629.0,,CN,AU,AU,2018,Q3,Adult
150499092,15049909,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q3,Aortic valve incompetence,,2018,Q3,2,F,20170808.0,20180620.0,20180622,20180629,EXP,,AU-SUNOVION-2018DSP007185,SUNOVION,,56.0,YR,,F,Y,93.6,KG,20180629.0,,CN,AU,AU,2018,Q3,Adult
150499092,15049909,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q3,Mitral valve incompetence,,2018,Q3,2,F,20170808.0,20180620.0,20180622,20180629,EXP,,AU-SUNOVION-2018DSP007185,SUNOVION,,56.0,YR,,F,Y,93.6,KG,20180629.0,,CN,AU,AU,2018,Q3,Adult
150499092,15049909,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q3,Tricuspid valve incompetence,,2018,Q3,2,F,20170808.0,20180620.0,20180622,20180629,EXP,,AU-SUNOVION-2018DSP007185,SUNOVION,,56.0,YR,,F,Y,93.6,KG,20180629.0,,CN,AU,AU,2018,Q3,Adult
151002612,15100261,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,2,F,2017.0,20180702.0,20180703,20180709,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2018-BI-033544",BOEHRINGER INGELHEIM,,6.0,DEC,,F,Y,,,20180709.0,,OT,AU,AU,2018,Q3,Child
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Arthritis,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Blood cholesterol increased,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Cervical spinal stenosis,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Cystic lung disease,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Diabetes mellitus,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Dyspnoea,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Ejection fraction decreased,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Hypotension,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Musculoskeletal pain,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Myocardial infarction,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Oropharyngeal pain,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Peripheral swelling,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Spinal osteoarthritis,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Spondylitis,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Tachycardia,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Therapy cessation,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Throat irritation,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151036941,15103694,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,FILM-COATED TABLET,QD,2018,Q3,Vitamin D decreased,,2018,Q3,1,I,20170912.0,20141212.0,20180703,20180703,EXP,,US-ASTRAZENECA-2015SE00527,ASTRAZENECA,,21813.0,DY,,M,Y,92.0,KG,20180703.0,,CN,US,US,2018,Q3,Elderly
151147281,15114728,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,11570.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Angina unstable,,2018,Q3,1,I,20170216.0,20180629.0,20180706,20180706,EXP,,CA-ASTRAZENECA-2018SE85308,ASTRAZENECA,,60.0,YR,,M,Y,,,20180706.0,,MD,CA,CA,2018,Q3,Adult
151204211,15120421,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20180407.0,20180629.0,20180709,20180709,EXP,,GB-ASTRAZENECA-2018SE84602,ASTRAZENECA,,47.0,YR,,F,Y,,,20180709.0,,PH,GB,GB,2018,Q3,Adult
151291301,15129130,7,C,Farxdiga (Dapagliflozin),,2,,,,,,,,,,,,,,2018,Q3,Cellulitis,,2018,Q3,1,I,20171010.0,,20180614,20180614,DIR,,,FDA-CTU,,60.0,YR,,M,N,116.1,KG,20180614.0,N,CN,US,US,2018,Q3,Adult
151291301,15129130,7,C,Farxdiga (Dapagliflozin),,2,,,,,,,,,,,,,,2018,Q3,Drug effect decreased,,2018,Q3,1,I,20171010.0,,20180614,20180614,DIR,,,FDA-CTU,,60.0,YR,,M,N,116.1,KG,20180614.0,N,CN,US,US,2018,Q3,Adult
151291301,15129130,7,C,Farxdiga (Dapagliflozin),,2,,,,,,,,,,,,,,2018,Q3,Drug ineffective,,2018,Q3,1,I,20171010.0,,20180614,20180614,DIR,,,FDA-CTU,,60.0,YR,,M,N,116.1,KG,20180614.0,N,CN,US,US,2018,Q3,Adult
151291301,15129130,7,C,Farxdiga (Dapagliflozin),,2,,,,,,,,,,,,,,2018,Q3,Pain,,2018,Q3,1,I,20171010.0,,20180614,20180614,DIR,,,FDA-CTU,,60.0,YR,,M,N,116.1,KG,20180614.0,N,CN,US,US,2018,Q3,Adult
151340862,15134086,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD (1?0?0?0)",,,,,,,,10.0,MG,TABLET,QD,2018,Q3,Gout,,2018,Q3,2,F,,20180630.0,20180712,20180712,EXP,,PHHY2018DE038339,NOVARTIS,,66.0,YR,,M,Y,,,20180712.0,,OT,DE,DE,2018,Q3,Elderly
151340862,15134086,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD (1?0?0?0)",,,,,,,,10.0,MG,TABLET,QD,2018,Q3,Hyperglycaemia,,2018,Q3,2,F,,20180630.0,20180712,20180712,EXP,,PHHY2018DE038339,NOVARTIS,,66.0,YR,,M,Y,,,20180712.0,,OT,DE,DE,2018,Q3,Elderly
151340862,15134086,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD (1?0?0?0)",,,,,,,,10.0,MG,TABLET,QD,2018,Q3,Pain in extremity,,2018,Q3,2,F,,20180630.0,20180712,20180712,EXP,,PHHY2018DE038339,NOVARTIS,,66.0,YR,,M,Y,,,20180712.0,,OT,DE,DE,2018,Q3,Elderly
151346752,15134675,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, IN THE MORNING",,,U,,,,,10.0,MG,,,2018,Q3,Lower respiratory tract infection,,2018,Q3,2,F,20180102.0,20180911.0,20180712,20180917,EXP,,PHHO2018GB000903,NOVARTIS,,62.0,YR,,M,Y,99.1,KG,20180917.0,,OT,GB,GB,2018,Q3,Adult
151346752,15134675,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, IN THE MORNING",,,U,,,,,10.0,MG,,,2018,Q3,Pancreatitis acute,,2018,Q3,2,F,20180102.0,20180911.0,20180712,20180917,EXP,,PHHO2018GB000903,NOVARTIS,,62.0,YR,,M,Y,99.1,KG,20180917.0,,OT,GB,GB,2018,Q3,Adult
151423861,15142386,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Androgenetic alopecia,,2018,Q3,1,I,,20180503.0,20180713,20180713,PER,,US-ASTELLAS-2018US021422,ASTELLAS,,67.0,YR,,F,Y,,,20180713.0,,CN,US,US,2018,Q3,Elderly
151423861,15142386,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,D,U,,,,,,FORMULATION UNKNOWN,,2018,Q3,Treatment noncompliance,,2018,Q3,1,I,,20180503.0,20180713,20180713,PER,,US-ASTELLAS-2018US021422,ASTELLAS,,67.0,YR,,F,Y,,,20180713.0,,CN,US,US,2018,Q3,Elderly
151434071,15143407,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q3,Ketosis,,2018,Q3,1,I,20180627.0,20180711.0,20180713,20180713,EXP,,GB-ASTRAZENECA-2018SE89192,ASTRAZENECA,,39.0,YR,,F,Y,76.0,KG,20180713.0,,,GB,GB,2018,Q3,Adult
151550421,15155042,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Blood viscosity increased,,2018,Q3,1,I,20180506.0,20180711.0,20180717,20180717,EXP,,GB-ASTRAZENECA-2018SE89314,ASTRAZENECA,,73.0,YR,,F,Y,96.0,KG,20180717.0,,,GB,GB,2018,Q3,Elderly
151550421,15155042,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Platelet count decreased,,2018,Q3,1,I,20180506.0,20180711.0,20180717,20180717,EXP,,GB-ASTRAZENECA-2018SE89314,ASTRAZENECA,,73.0,YR,,F,Y,96.0,KG,20180717.0,,,GB,GB,2018,Q3,Elderly
151550421,15155042,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Rash,,2018,Q3,1,I,20180506.0,20180711.0,20180717,20180717,EXP,,GB-ASTRAZENECA-2018SE89314,ASTRAZENECA,,73.0,YR,,F,Y,96.0,KG,20180717.0,,,GB,GB,2018,Q3,Elderly
151551381,15155138,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,29.0,DF,,,,,202293.0,1.0,DF,TABLET,QD,2018,Q3,Mobility decreased,,2018,Q3,1,I,20180419.0,20180711.0,20180717,20180717,EXP,,ES-ASTRAZENECA-2018SE89359,ASTRAZENECA,,64.0,YR,,F,Y,,,20180717.0,,MD,ES,ES,2018,Q3,Adult
151551381,15155138,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,29.0,DF,,,,,202293.0,1.0,DF,TABLET,QD,2018,Q3,Myalgia,,2018,Q3,1,I,20180419.0,20180711.0,20180717,20180717,EXP,,ES-ASTRAZENECA-2018SE89359,ASTRAZENECA,,64.0,YR,,F,Y,,,20180717.0,,MD,ES,ES,2018,Q3,Adult
151694015,15169401,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2980.0,MG,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Acute myocardial infarction,,2018,Q3,5,F,20180625.0,20180906.0,20180720,20180907,EXP,,GB-ASTRAZENECA-2018SE86569,ASTRAZENECA,,28664.0,DY,,M,Y,,,20180907.0,,MD,GB,GB,2018,Q3,Elderly
151694015,15169401,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2980.0,MG,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Lower limb fracture,,2018,Q3,5,F,20180625.0,20180906.0,20180720,20180907,EXP,,GB-ASTRAZENECA-2018SE86569,ASTRAZENECA,,28664.0,DY,,M,Y,,,20180907.0,,MD,GB,GB,2018,Q3,Elderly
151723501,15172350,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,1,I,20140101.0,20180712.0,20180720,20180720,EXP,IT-EMA-DD-20180612-SROYP-134349,IT-NOVOPROD-611228,NOVO NORDISK,,63.0,YR,A,F,Y,,,20180720.0,,OT,IT,IT,2018,Q3,Adult
151723501,15172350,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,20140101.0,20180712.0,20180720,20180720,EXP,IT-EMA-DD-20180612-SROYP-134349,IT-NOVOPROD-611228,NOVO NORDISK,,63.0,YR,A,F,Y,,,20180720.0,,OT,IT,IT,2018,Q3,Adult
151730692,15173069,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2210.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Femur fracture,,2018,Q3,2,F,20180629.0,20180807.0,20180720,20180814,EXP,,SE-ASTRAZENECA-2018SE88293,ASTRAZENECA,,29413.0,DY,,F,Y,,,20180814.0,,MD,SE,SE,2018,Q3,Elderly
151818521,15181852,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,U,,,,,,,,2018,Q3,Blood bicarbonate decreased,,2018,Q3,1,I,,20180709.0,20180723,20180723,EXP,,IT-MYLANLABS-2018M1052303,MYLAN,,61.0,YR,,M,Y,,,20180723.0,,OT,IT,IT,2018,Q3,Adult
151818521,15181852,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,U,,,,,,,,2018,Q3,Blood lactic acid increased,,2018,Q3,1,I,,20180709.0,20180723,20180723,EXP,,IT-MYLANLABS-2018M1052303,MYLAN,,61.0,YR,,M,Y,,,20180723.0,,OT,IT,IT,2018,Q3,Adult
151818521,15181852,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,U,,,,,,,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,,20180709.0,20180723,20180723,EXP,,IT-MYLANLABS-2018M1052303,MYLAN,,61.0,YR,,M,Y,,,20180723.0,,OT,IT,IT,2018,Q3,Adult
151818521,15181852,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,U,,,,,,,,2018,Q3,Ketonuria,,2018,Q3,1,I,,20180709.0,20180723,20180723,EXP,,IT-MYLANLABS-2018M1052303,MYLAN,,61.0,YR,,M,Y,,,20180723.0,,OT,IT,IT,2018,Q3,Adult
151818521,15181852,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,Y,U,,,,,,,,2018,Q3,Metabolic acidosis,,2018,Q3,1,I,,20180709.0,20180723,20180723,EXP,,IT-MYLANLABS-2018M1052303,MYLAN,,61.0,YR,,M,Y,,,20180723.0,,OT,IT,IT,2018,Q3,Adult
151901363,15190136,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,3100.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Pyelonephritis,,2018,Q3,3,F,20180718.0,20180816.0,20180724,20180822,EXP,,BR-ASTRAZENECA-2018SE93650,ASTRAZENECA,,27699.0,DY,,F,Y,,,20180822.0,,MD,BR,BR,2018,Q3,Elderly
151910274,15191027,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Hyponatraemia,,2018,Q3,4,F,20180718.0,20180910.0,20180724,20180920,EXP,,JP-ASTRAZENECA-2018SE93906,ASTRAZENECA,,28985.0,DY,,M,Y,,,20180920.0,,MD,JP,JP,2018,Q3,Elderly
151910274,15191027,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Hyponatraemia,,2018,Q3,4,F,20180718.0,20180910.0,20180724,20180920,EXP,,JP-ASTRAZENECA-2018SE93906,ASTRAZENECA,,28985.0,DY,,M,Y,,,20180920.0,,MD,JP,JP,2018,Q3,Elderly
151910274,15191027,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,TABLET,QD,2018,Q3,Hyponatraemia,,2018,Q3,4,F,20180718.0,20180910.0,20180724,20180920,EXP,,JP-ASTRAZENECA-2018SE93906,ASTRAZENECA,,28985.0,DY,,M,Y,,,20180920.0,,MD,JP,JP,2018,Q3,Elderly
152006311,15200631,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Peripheral swelling,,2018,Q3,1,I,,20180718.0,20180726,20180726,EXP,GB-MHRA-EYC 00181609,GB-TEVA-2018-GB-930421,TEVA,,70.0,YR,,F,Y,82.55,KG,20180726.0,,CN,GB,GB,2018,Q3,Elderly
152047201,15204720,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD(EVERY MORNING)",,,Y,,,,,10.0,MG,,QD,2018,Q3,Ketoacidosis,,2018,Q3,1,I,20180508.0,20180722.0,20180726,20180726,EXP,,PHHY2018GB056093,SANDOZ,,71.0,YR,,M,Y,100.3,KG,20180726.0,,OT,GB,GB,2018,Q3,Elderly
152078682,15207868,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,600.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Gastroenteritis,,2018,Q3,2,F,20180723.0,20180807.0,20180727,20180809,EXP,,IN-ASTRAZENECA-2018SE95236,ASTRAZENECA,,16274.0,DY,,F,Y,,,20180810.0,,MD,IN,IN,2018,Q3,Elderly
152094811,15209481,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q3,Muscle spasms,,2018,Q3,1,I,20180501.0,20180720.0,20180727,20180727,EXP,,GB-ASTRAZENECA-2018SE94197,ASTRAZENECA,,74.0,YR,,F,Y,75.0,KG,20180727.0,,,GB,GB,2018,Q3,Elderly
152094811,15209481,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q3,Vulvovaginal pruritus,,2018,Q3,1,I,20180501.0,20180720.0,20180727,20180727,EXP,,GB-ASTRAZENECA-2018SE94197,ASTRAZENECA,,74.0,YR,,F,Y,75.0,KG,20180727.0,,,GB,GB,2018,Q3,Elderly
152154042,15215404,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Skin ulcer,,2018,Q3,2,F,20180531.0,20180807.0,20180730,20180814,EXP,,ES-ASTRAZENECA-2018SE96229,ASTRAZENECA,,72.0,YR,,F,Y,,,20180814.0,,MD,ES,ES,2018,Q3,Elderly
152156621,15215662,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2018,Q3,Peripheral swelling,,2018,Q3,1,I,,20180723.0,20180730,20180730,EXP,GB-MHRA-EYC 00181609,GB-PFIZER INC-2018296629,PFIZER,,70.0,YR,,F,Y,82.55,KG,20180730.0,,CN,GB,GB,2018,Q3,Elderly
152218631,15221863,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q3,Peripheral swelling,,2018,Q3,1,I,,20180719.0,20180731,20180731,EXP,GB-MHRA-EYC 00181609,GB-DRREDDYS-GER/UKI/18/0102618,DR REDDYS,,70.0,YR,,F,Y,82.55,KG,20180731.0,,CN,GB,GB,2018,Q3,Elderly
152221311,15222131,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2018,Q3,Blood creatine phosphokinase increased,,2018,Q3,1,I,20180503.0,20180722.0,20180731,20180731,EXP,,PHHY2018GB056186,SANDOZ,,60.0,YR,,F,Y,79.8,KG,20180731.0,,OT,GB,GB,2018,Q3,Adult
152221311,15222131,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2018,Q3,Confusional state,,2018,Q3,1,I,20180503.0,20180722.0,20180731,20180731,EXP,,PHHY2018GB056186,SANDOZ,,60.0,YR,,F,Y,79.8,KG,20180731.0,,OT,GB,GB,2018,Q3,Adult
152221311,15222131,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2018,Q3,Inhibitory drug interaction,,2018,Q3,1,I,20180503.0,20180722.0,20180731,20180731,EXP,,PHHY2018GB056186,SANDOZ,,60.0,YR,,F,Y,79.8,KG,20180731.0,,OT,GB,GB,2018,Q3,Adult
152221311,15222131,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2018,Q3,Neuroleptic malignant syndrome,,2018,Q3,1,I,20180503.0,20180722.0,20180731,20180731,EXP,,PHHY2018GB056186,SANDOZ,,60.0,YR,,F,Y,79.8,KG,20180731.0,,OT,GB,GB,2018,Q3,Adult
152311421,15231142,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,, NOT REPORTED,,,10.0,MG,TABLET,QD,2018,Q3,Back pain,,2018,Q3,1,I,,20180703.0,20180802,20180802,PER,,US-ASTRAZENECA-2018SE87060,ASTRAZENECA,,60.0,YR,,M,Y,,,20180802.0,,MD,US,US,2018,Q3,Adult
152311971,15231197,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,QD,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,1,I,2009.0,20180722.0,20180802,20180802,EXP,,PHHY2018SK056999,SANDOZ,,67.0,YR,,M,Y,85.0,KG,20180802.0,,OT,SK,SK,2018,Q3,Elderly
152311971,15231197,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,QD,2018,Q3,Diabetic metabolic decompensation,,2018,Q3,1,I,2009.0,20180722.0,20180802,20180802,EXP,,PHHY2018SK056999,SANDOZ,,67.0,YR,,M,Y,85.0,KG,20180802.0,,OT,SK,SK,2018,Q3,Elderly
152311971,15231197,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,QD,2018,Q3,Diarrhoea,,2018,Q3,1,I,2009.0,20180722.0,20180802,20180802,EXP,,PHHY2018SK056999,SANDOZ,,67.0,YR,,M,Y,85.0,KG,20180802.0,,OT,SK,SK,2018,Q3,Elderly
152311971,15231197,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD IN THE MORNING",,,U,,,,,10.0,MG,,QD,2018,Q3,Hypertension,,2018,Q3,1,I,2009.0,20180722.0,20180802,20180802,EXP,,PHHY2018SK056999,SANDOZ,,67.0,YR,,M,Y,85.0,KG,20180802.0,,OT,SK,SK,2018,Q3,Elderly
152466021,15246602,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,1.0,DF,,,,,,,,,,2018,Q3,Abdominal discomfort,,2018,Q3,1,I,20180712.0,20180802.0,20180806,20180806,EXP,GB-MHRA-TPP31785357C3907341YC1531689116707,GB-BAUSCH-BL-2018-020859,BAUSCH AND LOMB,,52.0,YR,,F,Y,82.0,KG,20180806.0,,MD,GB,GB,2018,Q3,Adult
152466021,15246602,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,1.0,DF,,,,,,,,,,2018,Q3,Abdominal pain,,2018,Q3,1,I,20180712.0,20180802.0,20180806,20180806,EXP,GB-MHRA-TPP31785357C3907341YC1531689116707,GB-BAUSCH-BL-2018-020859,BAUSCH AND LOMB,,52.0,YR,,F,Y,82.0,KG,20180806.0,,MD,GB,GB,2018,Q3,Adult
152466021,15246602,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,1.0,DF,,,,,,,,,,2018,Q3,Diarrhoea,,2018,Q3,1,I,20180712.0,20180802.0,20180806,20180806,EXP,GB-MHRA-TPP31785357C3907341YC1531689116707,GB-BAUSCH-BL-2018-020859,BAUSCH AND LOMB,,52.0,YR,,F,Y,82.0,KG,20180806.0,,MD,GB,GB,2018,Q3,Adult
152466021,15246602,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,1.0,DF,,,,,,,,,,2018,Q3,Drug intolerance,,2018,Q3,1,I,20180712.0,20180802.0,20180806,20180806,EXP,GB-MHRA-TPP31785357C3907341YC1531689116707,GB-BAUSCH-BL-2018-020859,BAUSCH AND LOMB,,52.0,YR,,F,Y,82.0,KG,20180806.0,,MD,GB,GB,2018,Q3,Adult
152477231,15247723,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,1.0,DF,U,U,,,,1.0,DF,,,2018,Q3,Abdominal discomfort,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-AUROBINDO-AUR-APL-2018-039150,AUROBINDO,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152477231,15247723,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,1.0,DF,U,U,,,,1.0,DF,,,2018,Q3,Abdominal pain,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-AUROBINDO-AUR-APL-2018-039150,AUROBINDO,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152477231,15247723,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,1.0,DF,U,U,,,,1.0,DF,,,2018,Q3,Diarrhoea,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-AUROBINDO-AUR-APL-2018-039150,AUROBINDO,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152477231,15247723,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,1.0,DF,U,U,,,,1.0,DF,,,2018,Q3,Drug intolerance,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-AUROBINDO-AUR-APL-2018-039150,AUROBINDO,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152478701,15247870,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2018,Q3,Abdominal discomfort,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-072147,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152478701,15247870,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2018,Q3,Abdominal pain,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-072147,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152478701,15247870,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2018,Q3,Diarrhoea,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-072147,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152478701,15247870,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2018,Q3,Drug intolerance,,2018,Q3,1,I,20180712.0,20180725.0,20180807,20180807,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-072147,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,82.0,KG,20180807.0,,MD,GB,GB,2018,Q3,Adult
152540421,15254042,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2100.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2018,Q3,Transient ischaemic attack,,2018,Q3,1,I,20180627.0,20180802.0,20180808,20180808,EXP,,ES-ASTRAZENECA-2018SE98453,ASTRAZENECA,,21535.0,DY,,M,Y,,,20180808.0,,MD,ES,ES,2018,Q3,Elderly
152855601,15285560,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Cardiac failure,,2018,Q3,1,I,,20180809.0,20180816,20180816,EXP,,PHHY2018GR072463,SANDOZ,,43.0,YR,,M,Y,88.0,KG,20180816.0,,OT,GR,GR,2018,Q3,Adult
152859901,15285990,3,C,Dapagliflozin 5 mg QD,,2,,,,,,,,,,,,,,2018,Q3,Thrombocytopenic purpura,,2018,Q3,1,I,20180623.0,,20180802,20180802,DIR,,,FDA-CTU,,55.0,YR,,M,N,111.0,KG,20180802.0,N,PH,US,US,2018,Q3,Adult
152877282,15287728,4,C,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2018,Q3,Pneumonia,,2018,Q3,2,F,201808.0,20180821.0,20180817,20180824,EXP,,CA-ABBVIE-18K-028-2452450-00,ABBVIE,,63.0,YR,,M,Y,68.1,KG,20180824.0,,MD,CA,CA,2018,Q3,Adult
152877282,15287728,4,C,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2018,Q3,Product use in unapproved indication,,2018,Q3,2,F,201808.0,20180821.0,20180817,20180824,EXP,,CA-ABBVIE-18K-028-2452450-00,ABBVIE,,63.0,YR,,M,Y,68.1,KG,20180824.0,,MD,CA,CA,2018,Q3,Adult
152877282,15287728,4,C,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2018,Q3,Sepsis,,2018,Q3,2,F,201808.0,20180821.0,20180817,20180824,EXP,,CA-ABBVIE-18K-028-2452450-00,ABBVIE,,63.0,YR,,M,Y,68.1,KG,20180824.0,,MD,CA,CA,2018,Q3,Adult
152877282,15287728,4,C,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2018,Q3,T-cell prolymphocytic leukaemia,,2018,Q3,2,F,201808.0,20180821.0,20180817,20180824,EXP,,CA-ABBVIE-18K-028-2452450-00,ABBVIE,,63.0,YR,,M,Y,68.1,KG,20180824.0,,MD,CA,CA,2018,Q3,Adult
152907221,15290722,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,14210.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Tonsil cancer,,2018,Q3,1,I,20180403.0,20180717.0,20180817,20180817,EXP,,US-ASTRAZENECA-2018SE92598,ASTRAZENECA,,24142.0,DY,,M,Y,,,20180817.0,,MD,US,US,2018,Q3,Elderly
152973292,15297329,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,15280.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q3,Albumin urine present,,2018,Q3,2,F,20180712.0,20180816.0,20180820,20180822,EXP,,US-ASTRAZENECA-2018SF03924,ASTRAZENECA,,28595.0,DY,,F,Y,,,20180822.0,,MD,US,US,2018,Q3,Elderly
152977881,15297788,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1260.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Ketonuria,,2018,Q3,1,I,20140404.0,20180815.0,20180820,20180820,EXP,,US-ASTRAZENECA-2018SF04654,ASTRAZENECA,,23451.0,DY,,F,Y,,,20180820.0,,MD,US,US,2018,Q3,Elderly
153024371,15302437,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,TABLET,,2018,Q3,Pruritus,,2018,Q3,1,I,20171210.0,20180820.0,20180821,20180821,EXP,,GB-ASTRAZENECA-2018SF05612,ASTRAZENECA,,68.0,YR,,M,Y,95.2,KG,20180821.0,,,GB,GB,2018,Q3,Elderly
153174221,15317422,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q3,Angina pectoris,,2018,Q3,1,I,,20180816.0,20180824,20180824,EXP,,DE-ASTRAZENECA-2018SF06120,ASTRAZENECA,,57.0,YR,,M,Y,,,20180824.0,,MD,DE,DE,2018,Q3,Adult
153174221,15317422,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q3,Coronary artery occlusion,,2018,Q3,1,I,,20180816.0,20180824,20180824,EXP,,DE-ASTRAZENECA-2018SF06120,ASTRAZENECA,,57.0,YR,,M,Y,,,20180824.0,,MD,DE,DE,2018,Q3,Adult
153174221,15317422,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q3,Diabetic retinopathy,,2018,Q3,1,I,,20180816.0,20180824,20180824,EXP,,DE-ASTRAZENECA-2018SF06120,ASTRAZENECA,,57.0,YR,,M,Y,,,20180824.0,,MD,DE,DE,2018,Q3,Adult
153174221,15317422,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q3,Glaucoma,,2018,Q3,1,I,,20180816.0,20180824,20180824,EXP,,DE-ASTRAZENECA-2018SF06120,ASTRAZENECA,,57.0,YR,,M,Y,,,20180824.0,,MD,DE,DE,2018,Q3,Adult
153174221,15317422,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2018,Q3,Myocardial infarction,,2018,Q3,1,I,,20180816.0,20180824,20180824,EXP,,DE-ASTRAZENECA-2018SF06120,ASTRAZENECA,,57.0,YR,,M,Y,,,20180824.0,,MD,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Decreased vibratory sense,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Gastrointestinal disorder,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Limb discomfort,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Neuropathy peripheral,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Pain in extremity,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Sensory disturbance,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Sleep disorder,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Temperature perception test abnormal,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153245583,15324558,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,Y,, UNKNOWN,,,10.0,MG,,,2018,Q3,Visual impairment,,2018,Q3,3,F,2016.0,20180903.0,20180828,20180912,EXP,DE-EMA-DD-20180608-ISHAEVHP-143511,DE-TORRENT-00009642,TORRENT,,61.0,YR,A,F,Y,97.0,KG,20180912.0,,OT,DE,DE,2018,Q3,Adult
153297681,15329768,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20180730.0,20180822.0,20180829,20180829,EXP,,GB-ASTRAZENECA-2018SF06516,ASTRAZENECA,,62.0,YR,,F,Y,54.0,KG,20180829.0,,PH,GB,GB,2018,Q3,Adult
153306331,15330633,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF (UG/LITRE), QD",1.0,DF,U,,,,,1.0,DF,,QD,2018,Q3,Abdominal discomfort,,2018,Q3,1,I,20180712.0,20180819.0,20180829,20180829,EXP,,PHHY2018GB081504,SANDOZ,,52.0,YR,,F,Y,82.0,KG,20180829.0,,OT,GB,GB,2018,Q3,Adult
153306331,15330633,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF (UG/LITRE), QD",1.0,DF,U,,,,,1.0,DF,,QD,2018,Q3,Abdominal pain,,2018,Q3,1,I,20180712.0,20180819.0,20180829,20180829,EXP,,PHHY2018GB081504,SANDOZ,,52.0,YR,,F,Y,82.0,KG,20180829.0,,OT,GB,GB,2018,Q3,Adult
153306331,15330633,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF (UG/LITRE), QD",1.0,DF,U,,,,,1.0,DF,,QD,2018,Q3,Diarrhoea,,2018,Q3,1,I,20180712.0,20180819.0,20180829,20180829,EXP,,PHHY2018GB081504,SANDOZ,,52.0,YR,,F,Y,82.0,KG,20180829.0,,OT,GB,GB,2018,Q3,Adult
153306331,15330633,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF (UG/LITRE), QD",1.0,DF,U,,,,,1.0,DF,,QD,2018,Q3,Drug intolerance,,2018,Q3,1,I,20180712.0,20180819.0,20180829,20180829,EXP,,PHHY2018GB081504,SANDOZ,,52.0,YR,,F,Y,82.0,KG,20180829.0,,OT,GB,GB,2018,Q3,Adult
153323101,15332310,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,,10.0,MG,TABLET,,2018,Q3,Asphyxia,,2018,Q3,1,I,20180731.0,20180821.0,20180829,20180829,EXP,,GB-ASTRAZENECA-2018SF06062,ASTRAZENECA,,37.0,YR,,F,Y,,,20180830.0,,,GB,GB,2018,Q3,Adult
153327661,15332766,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Feeding disorder,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF08654,ASTRAZENECA,,58.0,YR,,F,Y,,,20180830.0,,OT,CN,CN,2018,Q3,Adult
153327661,15332766,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Glucose urine present,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF08654,ASTRAZENECA,,58.0,YR,,F,Y,,,20180830.0,,OT,CN,CN,2018,Q3,Adult
153327661,15332766,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Nausea,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF08654,ASTRAZENECA,,58.0,YR,,F,Y,,,20180830.0,,OT,CN,CN,2018,Q3,Adult
153327661,15332766,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Urine ketone body present,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF08654,ASTRAZENECA,,58.0,YR,,F,Y,,,20180830.0,,OT,CN,CN,2018,Q3,Adult
153327661,15332766,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Vomiting,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF08654,ASTRAZENECA,,58.0,YR,,F,Y,,,20180830.0,,OT,CN,CN,2018,Q3,Adult
153339251,15333925,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q3,Diarrhoea,,2018,Q3,1,I,20180729.0,20180827.0,20180830,20180830,EXP,,GB-ASTRAZENECA-2018SF08397,ASTRAZENECA,,66.0,YR,,M,Y,105.8,KG,20180830.0,,OT,GB,GB,2018,Q3,Elderly
153339251,15333925,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q3,Gastrointestinal disorder,,2018,Q3,1,I,20180729.0,20180827.0,20180830,20180830,EXP,,GB-ASTRAZENECA-2018SF08397,ASTRAZENECA,,66.0,YR,,M,Y,105.8,KG,20180830.0,,OT,GB,GB,2018,Q3,Elderly
153339251,15333925,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q3,Malaise,,2018,Q3,1,I,20180729.0,20180827.0,20180830,20180830,EXP,,GB-ASTRAZENECA-2018SF08397,ASTRAZENECA,,66.0,YR,,M,Y,105.8,KG,20180830.0,,OT,GB,GB,2018,Q3,Elderly
153339251,15333925,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q3,Vomiting,,2018,Q3,1,I,20180729.0,20180827.0,20180830,20180830,EXP,,GB-ASTRAZENECA-2018SF08397,ASTRAZENECA,,66.0,YR,,M,Y,105.8,KG,20180830.0,,OT,GB,GB,2018,Q3,Elderly
153340731,15334073,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Ketoacidosis,,2018,Q3,1,I,20180805.0,20180821.0,20180830,20180830,EXP,,GB-ASTRAZENECA-2018SF06103,ASTRAZENECA,,79.0,YR,,F,Y,,,20180830.0,,,GB,GB,2018,Q3,Elderly
153340741,15334074,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20180807.0,20180821.0,20180830,20180830,EXP,,GB-ASTRAZENECA-2018SF06141,ASTRAZENECA,,56.0,YR,,M,Y,,,20180830.0,,,GB,GB,2018,Q3,Adult
153347721,15334772,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,TABLET,QD,2018,Q3,Glucose urine present,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF07912,ASTRAZENECA,,25.0,YR,,F,Y,57.0,KG,20180830.0,,OT,CN,CN,2018,Q3,Young Adult
153347721,15334772,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,TABLET,QD,2018,Q3,Nausea,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF07912,ASTRAZENECA,,25.0,YR,,F,Y,57.0,KG,20180830.0,,OT,CN,CN,2018,Q3,Young Adult
153347721,15334772,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,TABLET,QD,2018,Q3,Urine ketone body present,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF07912,ASTRAZENECA,,25.0,YR,,F,Y,57.0,KG,20180830.0,,OT,CN,CN,2018,Q3,Young Adult
153347721,15334772,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,TABLET,QD,2018,Q3,Vomiting,,2018,Q3,1,I,,20180822.0,20180830,20180830,EXP,,CN-ASTRAZENECA-2018SF07912,ASTRAZENECA,,25.0,YR,,F,Y,57.0,KG,20180830.0,,OT,CN,CN,2018,Q3,Young Adult
153384191,15338419,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20160824.0,20180824.0,20180831,20180831,EXP,,GB-ASTRAZENECA-2018SF08156,ASTRAZENECA,,20690.0,DY,,F,Y,,,20180831.0,,MD,GB,GB,2018,Q3,Elderly
153392671,15339267,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,Y,,,,202293.0,5.0,MG,TABLET,,2018,Q3,Metabolic acidosis,,2018,Q3,1,I,20180717.0,20180823.0,20180831,20180831,EXP,,DE-ASTRAZENECA-2018SF07090,ASTRAZENECA,,69.0,YR,,F,Y,,,20180831.0,,,DE,DE,2018,Q3,Elderly
153508551,15350855,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,TABLET,,2018,Q3,Blood glucose abnormal,,2018,Q3,1,I,20180722.0,20180831.0,20180905,20180905,EXP,,IE-ASTRAZENECA-2018SF11253,ASTRAZENECA,,80.0,YR,,M,Y,90.0,KG,20180905.0,,MD,IE,IE,2018,Q3,Elderly
153508551,15350855,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,TABLET,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20180722.0,20180831.0,20180905,20180905,EXP,,IE-ASTRAZENECA-2018SF11253,ASTRAZENECA,,80.0,YR,,M,Y,90.0,KG,20180905.0,,MD,IE,IE,2018,Q3,Elderly
153508551,15350855,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,TABLET,,2018,Q3,Ketonuria,,2018,Q3,1,I,20180722.0,20180831.0,20180905,20180905,EXP,,IE-ASTRAZENECA-2018SF11253,ASTRAZENECA,,80.0,YR,,M,Y,90.0,KG,20180905.0,,MD,IE,IE,2018,Q3,Elderly
153508551,15350855,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,TABLET,,2018,Q3,Loss of consciousness,,2018,Q3,1,I,20180722.0,20180831.0,20180905,20180905,EXP,,IE-ASTRAZENECA-2018SF11253,ASTRAZENECA,,80.0,YR,,M,Y,90.0,KG,20180905.0,,MD,IE,IE,2018,Q3,Elderly
153513891,15351389,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5219.584,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180730.0,20180827.0,20180905,20180905,EXP,,GB-ASTRAZENECA-2018SF08460,ASTRAZENECA,,50.0,YR,,F,Y,,,20180905.0,,,GB,GB,2018,Q3,Adult
153513891,15351389,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5219.584,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20180730.0,20180827.0,20180905,20180905,EXP,,GB-ASTRAZENECA-2018SF08460,ASTRAZENECA,,50.0,YR,,F,Y,,,20180905.0,,,GB,GB,2018,Q3,Adult
153561771,15356177,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MILLIGRAM DAILY;,,,,,,,,5.0,MG,TABLET,,2018,Q3,Atrial fibrillation,,2018,Q3,1,I,,20180905.0,20180906,20180906,EXP,GB-MHRA-MIDB-04AA736C-88D2-4BC6-B34D-1EBC7B351F5E,GB-TEVA-2018-GB-951852,TEVA,,63.0,YR,,M,Y,,,20180906.0,,PH,GB,GB,2018,Q3,Adult
153561771,15356177,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MILLIGRAM DAILY;,,,,,,,,5.0,MG,TABLET,,2018,Q3,Nodal arrhythmia,,2018,Q3,1,I,,20180905.0,20180906,20180906,EXP,GB-MHRA-MIDB-04AA736C-88D2-4BC6-B34D-1EBC7B351F5E,GB-TEVA-2018-GB-951852,TEVA,,63.0,YR,,M,Y,,,20180906.0,,PH,GB,GB,2018,Q3,Adult
153561991,15356199,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Subcutaneous,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,,20180829.0,20180906,20180906,EXP,,GB-ASTRAZENECA-2018SF09699,ASTRAZENECA,,69.0,YR,,M,Y,,,20180906.0,,,GB,GB,2018,Q3,Elderly
153561991,15356199,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Subcutaneous,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Escherichia infection,,2018,Q3,1,I,,20180829.0,20180906,20180906,EXP,,GB-ASTRAZENECA-2018SF09699,ASTRAZENECA,,69.0,YR,,M,Y,,,20180906.0,,,GB,GB,2018,Q3,Elderly
153561991,15356199,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Subcutaneous,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Liver disorder,,2018,Q3,1,I,,20180829.0,20180906,20180906,EXP,,GB-ASTRAZENECA-2018SF09699,ASTRAZENECA,,69.0,YR,,M,Y,,,20180906.0,,,GB,GB,2018,Q3,Elderly
153561991,15356199,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Subcutaneous,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Loss of consciousness,,2018,Q3,1,I,,20180829.0,20180906,20180906,EXP,,GB-ASTRAZENECA-2018SF09699,ASTRAZENECA,,69.0,YR,,M,Y,,,20180906.0,,,GB,GB,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Acetonaemia,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Blood pressure systolic increased,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Hypoglycaemia,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Malaise,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Mucous membrane disorder,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Pyrexia,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Somnolence,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Staphylococcal infection,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Urethral abscess,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Urosepsis,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153570791,15357079,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2018,Q3,Vomiting,,2018,Q3,1,I,,20180824.0,20180906,20180906,EXP,,TH-SA-2018SA239103,SANOFI AVENTIS,"THEWJITCHAROEN Y., WANOTHAYAROJ E., TAMMAWIWAT C., MALIDAENG A., YENSEUNG N., NAKASATIEN S., ET AL.. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I?ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT?OF?CARE BLOOD KETONE TESTING.. J. CLIN. TRANSL. ENDOCRINOL. CASE REP.. 2018?UNK:8?10.",87.0,YR,E,M,Y,,,20180906.0,,OT,TH,TH,2018,Q3,Elderly
153652801,15365280,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,,,,,,10.0,MG,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180809.0,20180906.0,20180910,20180910,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083276,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,79.8,KG,20180910.0,,OT,GB,GB,2018,Q3,Elderly
153718781,15371878,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,,,,,,,,,,2018,Q3,Anaemia,,2018,Q3,1,I,20180419.0,20180710.0,20180911,20180911,EXP,,AT-ASTRAZENECA-2018SF16280,ASTRAZENECA,,26839.0,DY,,M,Y,,,20180911.0,,MD,AT,AT,2018,Q3,Elderly
153742601,15374260,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2018,Q3,Facial paralysis,,2018,Q3,1,I,,20180905.0,20180912,20180912,EXP,,SG-ASTRAZENECA-2018SF12426,ASTRAZENECA,,66.0,YR,,M,Y,,,20180912.0,,CN,SG,SG,2018,Q3,Elderly
153742601,15374260,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2018,Q3,Hyperglycaemia,,2018,Q3,1,I,,20180905.0,20180912,20180912,EXP,,SG-ASTRAZENECA-2018SF12426,ASTRAZENECA,,66.0,YR,,M,Y,,,20180912.0,,CN,SG,SG,2018,Q3,Elderly
153742601,15374260,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2018,Q3,Urinary tract infection,,2018,Q3,1,I,,20180905.0,20180912,20180912,EXP,,SG-ASTRAZENECA-2018SF12426,ASTRAZENECA,,66.0,YR,,M,Y,,,20180912.0,,CN,SG,SG,2018,Q3,Elderly
153845501,15384550,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,13349.583,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,20180801.0,20180906.0,20180914,20180914,EXP,,GB-ASTRAZENECA-2018SF12740,ASTRAZENECA,,61.0,YR,,F,Y,73.0,KG,20180914.0,,,GB,GB,2018,Q3,Adult
153866201,15386620,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,,, UNKNOWN,,,10.0,MG,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180809.0,20180910.0,20180914,20180914,EXP,,GB-PERRIGO-18GB009311,PERRIGO,,73.0,YR,,M,Y,79.8,KG,20180914.0,,OT,GB,GB,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Abdominal pain,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Acetonaemia,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Cholecystitis acute,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Ketonuria,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Metabolic acidosis,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Nervous system disorder,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,Vomiting,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
153960341,15396034,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q3,White blood cell count increased,,2018,Q3,1,I,,20180910.0,20180918,20180918,EXP,,PHHY2018PT100569,SANDOZ,"FERREIRA JL, PRINCIPE RM, GUEDES C. POSTERS ? CONGRESSO PORTUGUES DE ENDOCRINOLOGIA ? 69 REUNIAO ANUAL DA SPEDM",66.0,YR,,M,Y,,,20180918.0,,OT,PT,PT,2018,Q3,Elderly
154019161,15401916,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,,20180910.0,20180919,20180919,EXP,,TH-ASTRAZENECA-2018SF17527,ASTRAZENECA,,75.0,YR,,M,Y,,,20180919.0,,OT,TH,TH,2018,Q3,Elderly
154019171,15401917,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,,20180910.0,20180919,20180919,EXP,,TH-ASTRAZENECA-2018SF17550,ASTRAZENECA,,87.0,YR,,M,Y,,,20180919.0,,OT,TH,TH,2018,Q3,Elderly
154019171,15401917,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Urosepsis,,2018,Q3,1,I,,20180910.0,20180919,20180919,EXP,,TH-ASTRAZENECA-2018SF17550,ASTRAZENECA,,87.0,YR,,M,Y,,,20180919.0,,OT,TH,TH,2018,Q3,Elderly
154019181,15401918,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2018,Q3,Diabetic ketoacidosis,,2018,Q3,1,I,,20180910.0,20180919,20180919,EXP,,TH-ASTRAZENECA-2018SF17555,ASTRAZENECA,,60.0,YR,,F,Y,,,20180919.0,,OT,TH,TH,2018,Q3,Adult
154044061,15404406,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180809.0,20180913.0,20180919,20180919,EXP,,GB-BAUSCH-BL-2018-025518,BAUSCH AND LOMB,,73.0,YR,,M,Y,79.8,KG,20180919.0,,OT,GB,GB,2018,Q3,Elderly
154066571,15406657,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2240.0,MG,N,U,,,,10.0,MG,TABLET,QD,2018,Q3,Vascular procedure complication,,2018,Q3,1,I,20180910.0,20180918.0,20180920,20180920,EXP,,DE-ASTRAZENECA-2018SF19638,ASTRAZENECA,,71.0,YR,,M,Y,,,20180920.0,,MD,DE,DE,2018,Q3,Elderly
154126751,15412675,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, UNK",,,U,,,,,10.0,MG,,,2018,Q3,Anaemia,,2018,Q3,1,I,20180801.0,20180917.0,20180921,20180921,EXP,,PHHY2018DE103416,SANDOZ,,56.0,YR,,M,Y,152.0,KG,20180921.0,,OT,DE,DE,2018,Q3,Adult
154126751,15412675,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, UNK",,,U,,,,,10.0,MG,,,2018,Q3,General physical health deterioration,,2018,Q3,1,I,20180801.0,20180917.0,20180921,20180921,EXP,,PHHY2018DE103416,SANDOZ,,56.0,YR,,M,Y,152.0,KG,20180921.0,,OT,DE,DE,2018,Q3,Adult
154193241,15419324,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,10.0,MG,UNSPECIFIED,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180809.0,20180913.0,20180924,20180924,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083276,GB-JNJFOC-20180915013,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,79.8,KG,20180924.0,,OT,GB,GB,2018,Q3,Elderly
154238181,15423818,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,, UNK,,,10.0,MG,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180809.0,20180911.0,20180925,20180925,EXP,,GB-AUROBINDO-AUR-APL-2018-046965,AUROBINDO,,73.0,YR,,M,Y,79.8,KG,20180925.0,,OT,GB,GB,2018,Q3,Elderly
154272451,15427245,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,,,,,,10.0,MG,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180809.0,20180914.0,20180925,20180925,EXP,,PHHY2018GB100606,SANDOZ,,73.0,YR,,M,Y,79.8,KG,20180925.0,,OT,GB,GB,2018,Q3,Elderly
154316931,15431693,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,10.0,MG,TABLET,QD,2018,Q3,Acute myocardial infarction,,2018,Q3,1,I,20141127.0,20141208.0,20180926,20180926,EXP,,PL-ASTRAZENECA-2014BM17385,ASTRAZENECA,,23064.0,DY,,F,Y,,,20180926.0,,CN,US,PL,2018,Q3,Elderly
154317531,15431753,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2018,Q3,Diverticulitis,,2018,Q3,1,I,20141111.0,20141123.0,20180926,20180926,PER,,US-ASTRAZENECA-2014SE92774,ASTRAZENECA,,28158.0,DY,,M,Y,,,20180926.0,,MD,AU,AU,2018,Q3,Elderly
154328081,15432808,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2018,Q3,Necrotising fasciitis,,2018,Q3,1,I,20180817.0,20180921.0,20180927,20180927,EXP,,DE-ASTRAZENECA-2018SF23970,ASTRAZENECA,,39.0,YR,,M,Y,160.0,KG,20180927.0,,,DE,DE,2018,Q3,Adult
154364161,15436416,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,,,,,,10.0,MG,,,2018,Q3,Acute kidney injury,,2018,Q3,1,I,20180809.0,20180921.0,20180927,20180927,EXP,,GB-PFIZER INC-2018384322,PFIZER,,73.0,YR,,M,Y,79.8,KG,20180927.0,,OT,GB,GB,2018,Q3,Elderly
154432511,15443251,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q3,Suicidal ideation,,2018,Q3,1,I,20180901.0,20180927.0,20180928,20180928,EXP,GB-MHRA-EYC 00185060,GB-TEVA-2018-GB-959247,TEVA,,56.0,YR,,F,Y,117.47,KG,20180928.0,,CN,GB,GB,2018,Q3,Adult
154433081,15443308,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,880.0,MG,N,U,,,,10.0,MG,TABLET,QD,2018,Q3,Acute myocardial infarction,,2018,Q3,1,I,20180913.0,20180914.0,20180928,20180928,EXP,,JP-ASTRAZENECA-2018SF25341,ASTRAZENECA,,21149.0,DY,,M,Y,,,20180928.0,,MD,JP,JP,2018,Q3,Elderly
154459191,15445919,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q3,Euglycaemic diabetic ketoacidosis,,2018,Q3,1,I,,20180918.0,20180928,20180928,EXP,,"US-IMPAX LABORATORIES, INC-2018-IPXL-03102",IMPAX,"BADWAL K, TARIQ T, PEIRCE D. DAPAGLIFLOZIN?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT PRESENTING WITH ACUTE PANCREATITIS. CASE REP ENDOCRINOL. 2018?1?4",25.0,YR,,M,Y,,,20180928.0,,MD,US,US,2018,Q3,Young Adult
154459191,15445919,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2018,Q3,Pancreatitis acute,,2018,Q3,1,I,,20180918.0,20180928,20180928,EXP,,"US-IMPAX LABORATORIES, INC-2018-IPXL-03102",IMPAX,"BADWAL K, TARIQ T, PEIRCE D. DAPAGLIFLOZIN?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT PRESENTING WITH ACUTE PANCREATITIS. CASE REP ENDOCRINOL. 2018?1?4",25.0,YR,,M,Y,,,20180928.0,,MD,US,US,2018,Q3,Young Adult
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Abdominal pain,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Acetonaemia,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Cholecystitis acute,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Diabetes mellitus inadequate control,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Ketonuria,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Metabolic acidosis,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Nervous system disorder,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,Vomiting,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
154460471,15446047,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q3,White blood cell count increased,,2018,Q3,1,I,,20180921.0,20180928,20180928,EXP,,PT-BAUSCH-BL-2018-026166,BAUSCH AND LOMB,"FERREIRA J, PRINCIPE R, GUEDES C. UNSPECIFIED. 69 ANNUAL MEETING OF SPEDM.",66.0,YR,,M,Y,,,20180928.0,,OT,PT,PT,2018,Q3,Elderly
126865074,12686507,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q4,Blood bicarbonate decreased,,2018,Q4,4,F,,20181015.0,20160825,20181018,EXP,,IT-MYLANLABS-2016M1035489,MYLAN,,61.0,YR,,M,Y,,,20181018.0,,CN,IT,IT,2018,Q4,Adult
126865074,12686507,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q4,Blood lactic acid increased,,2018,Q4,4,F,,20181015.0,20160825,20181018,EXP,,IT-MYLANLABS-2016M1035489,MYLAN,,61.0,YR,,M,Y,,,20181018.0,,CN,IT,IT,2018,Q4,Adult
126865074,12686507,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,4,F,,20181015.0,20160825,20181018,EXP,,IT-MYLANLABS-2016M1035489,MYLAN,,61.0,YR,,M,Y,,,20181018.0,,CN,IT,IT,2018,Q4,Adult
126865074,12686507,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q4,Ketonuria,,2018,Q4,4,F,,20181015.0,20160825,20181018,EXP,,IT-MYLANLABS-2016M1035489,MYLAN,,61.0,YR,,M,Y,,,20181018.0,,CN,IT,IT,2018,Q4,Adult
126865074,12686507,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2018,Q4,Metabolic acidosis,,2018,Q4,4,F,,20181015.0,20160825,20181018,EXP,,IT-MYLANLABS-2016M1035489,MYLAN,,61.0,YR,,M,Y,,,20181018.0,,CN,IT,IT,2018,Q4,Adult
141687243,14168724,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Condition aggravated,,2018,Q4,3,F,20140201.0,20181105.0,20171107,20181109,EXP,IT-MINISAL02-433715,IT-MYLANLABS-2017M1068935,MYLAN,,54.0,YR,,M,Y,129.0,KG,20181108.0,,CN,IT,IT,2018,Q4,Adult
141687243,14168724,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Diabetes mellitus inadequate control,,2018,Q4,3,F,20140201.0,20181105.0,20171107,20181109,EXP,IT-MINISAL02-433715,IT-MYLANLABS-2017M1068935,MYLAN,,54.0,YR,,M,Y,129.0,KG,20181108.0,,CN,IT,IT,2018,Q4,Adult
141687243,14168724,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Drug ineffective,,2018,Q4,3,F,20140201.0,20181105.0,20171107,20181109,EXP,IT-MINISAL02-433715,IT-MYLANLABS-2017M1068935,MYLAN,,54.0,YR,,M,Y,129.0,KG,20181108.0,,CN,IT,IT,2018,Q4,Adult
141687243,14168724,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Glycosylated haemoglobin increased,,2018,Q4,3,F,20140201.0,20181105.0,20171107,20181109,EXP,IT-MINISAL02-433715,IT-MYLANLABS-2017M1068935,MYLAN,,54.0,YR,,M,Y,129.0,KG,20181108.0,,CN,IT,IT,2018,Q4,Adult
141687243,14168724,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Hyperglycaemia,,2018,Q4,3,F,20140201.0,20181105.0,20171107,20181109,EXP,IT-MINISAL02-433715,IT-MYLANLABS-2017M1068935,MYLAN,,54.0,YR,,M,Y,129.0,KG,20181108.0,,CN,IT,IT,2018,Q4,Adult
141687243,14168724,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Overdose,,2018,Q4,3,F,20140201.0,20181105.0,20171107,20181109,EXP,IT-MINISAL02-433715,IT-MYLANLABS-2017M1068935,MYLAN,,54.0,YR,,M,Y,129.0,KG,20181108.0,,CN,IT,IT,2018,Q4,Adult
141687243,14168724,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Weight increased,,2018,Q4,3,F,20140201.0,20181105.0,20171107,20181109,EXP,IT-MINISAL02-433715,IT-MYLANLABS-2017M1068935,MYLAN,,54.0,YR,,M,Y,129.0,KG,20181108.0,,CN,IT,IT,2018,Q4,Adult
141720009,14172000,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q4,Diabetic metabolic decompensation,,2018,Q4,9,F,20140101.0,20181029.0,20171108,20181110,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-101086,BRISTOL MYERS SQUIBB,,63.0,YR,,F,Y,,,20181110.0,,CN,IT,IT,2018,Q4,Adult
143263042,14326304,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,TABLET,QD,2018,Q4,Acute kidney injury,,2018,Q4,2,F,20140318.0,20181114.0,20171226,20181122,EXP,,US-ASTRAZENECA-2017SF30332,ASTRAZENECA,,19644.0,DY,,M,Y,,,20181122.0,,,US,US,2018,Q4,Elderly
143263042,14326304,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,TABLET,QD,2018,Q4,Chronic kidney disease,,2018,Q4,2,F,20140318.0,20181114.0,20171226,20181122,EXP,,US-ASTRAZENECA-2017SF30332,ASTRAZENECA,,19644.0,DY,,M,Y,,,20181122.0,,,US,US,2018,Q4,Elderly
143263042,14326304,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,TABLET,QD,2018,Q4,Type 2 diabetes mellitus,,2018,Q4,2,F,20140318.0,20181114.0,20171226,20181122,EXP,,US-ASTRAZENECA-2017SF30332,ASTRAZENECA,,19644.0,DY,,M,Y,,,20181122.0,,,US,US,2018,Q4,Elderly
145193492,14519349,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Myocardial infarction,,2018,Q4,2,F,20180208.0,20181016.0,20180212,20181017,EXP,,PL-ASTRAZENECA-2018SE17897,ASTRAZENECA,,25602.0,DY,,M,Y,,,20181017.0,,MD,PL,PL,2018,Q4,Elderly
145193492,14519349,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Myocardial infarction,,2018,Q4,2,F,20180208.0,20181016.0,20180212,20181017,EXP,,PL-ASTRAZENECA-2018SE17897,ASTRAZENECA,,25602.0,DY,,M,Y,,,20181017.0,,MD,PL,PL,2018,Q4,Elderly
149074814,14907481,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q4,Acute kidney injury,Acute kidney injury,2018,Q4,4,F,20171012.0,20180917.0,20180517,20181001,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20181001.0,,MD,GB,GB,2018,Q4,Elderly
149074814,14907481,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q4,Epididymitis,Epididymitis,2018,Q4,4,F,20171012.0,20180917.0,20180517,20181001,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20181001.0,,MD,GB,GB,2018,Q4,Elderly
149074814,14907481,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,,,,,,10.0,MG,TABLET,QD,2018,Q4,Hypotension,Hypotension,2018,Q4,4,F,20171012.0,20180917.0,20180517,20181001,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20181001.0,,MD,GB,GB,2018,Q4,Elderly
149074814,14907481,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q4,Acute kidney injury,Acute kidney injury,2018,Q4,4,F,20171012.0,20180917.0,20180517,20181001,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20181001.0,,MD,GB,GB,2018,Q4,Elderly
149074814,14907481,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q4,Epididymitis,Epididymitis,2018,Q4,4,F,20171012.0,20180917.0,20180517,20181001,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20181001.0,,MD,GB,GB,2018,Q4,Elderly
149074814,14907481,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,TABLET,QD,2018,Q4,Hypotension,Hypotension,2018,Q4,4,F,20171012.0,20180917.0,20180517,20181001,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20181001.0,,MD,GB,GB,2018,Q4,Elderly
150267234,15026723,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,990.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Ischaemic stroke,,2018,Q4,4,F,20180528.0,20181205.0,20180618,20181207,EXP,,PE-ASTRAZENECA-2018SE76922,ASTRAZENECA,,24574.0,DY,,F,Y,,,20181207.0,,MD,PE,PE,2018,Q4,Elderly
150365042,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q4,Blood creatine phosphokinase increased,,2018,Q4,2,F,20180503.0,20180606.0,20180620,20181130,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20181130.0,,MD,GB,GB,2018,Q4,Adult
150365042,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q4,Confusional state,,2018,Q4,2,F,20180503.0,20180606.0,20180620,20181130,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20181130.0,,MD,GB,GB,2018,Q4,Adult
150365042,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q4,Inhibitory drug interaction,,2018,Q4,2,F,20180503.0,20180606.0,20180620,20181130,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20181130.0,,MD,GB,GB,2018,Q4,Adult
150365042,15036504,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2018,Q4,Neuroleptic malignant syndrome,,2018,Q4,2,F,20180503.0,20180606.0,20180620,20181130,EXP,GB-MHRA-EYC 00179756,GB-SA-2018SA153332,SANOFI AVENTIS,,60.0,YR,A,F,Y,79.8,KG,20181130.0,,MD,GB,GB,2018,Q4,Adult
151316992,15131699,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,D,,,,,10.0,MG,TABLET,QD,2018,Q4,Drug ineffective,,2018,Q4,2,F,,20180928.0,20180711,20181004,EXP,,HU-MYLANLABS-2018M1048722,MYLAN,,66.0,YR,,M,Y,,,20181004.0,,MD,HU,HU,2018,Q4,Elderly
151316992,15131699,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,D,,,,,10.0,MG,TABLET,QD,2018,Q4,Hypoglycaemia,,2018,Q4,2,F,,20180928.0,20180711,20181004,EXP,,HU-MYLANLABS-2018M1048722,MYLAN,,66.0,YR,,M,Y,,,20181004.0,,MD,HU,HU,2018,Q4,Elderly
151316992,15131699,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,D,,,,,10.0,MG,TABLET,QD,2018,Q4,Therapeutic response decreased,,2018,Q4,2,F,,20180928.0,20180711,20181004,EXP,,HU-MYLANLABS-2018M1048722,MYLAN,,66.0,YR,,M,Y,,,20181004.0,,MD,HU,HU,2018,Q4,Elderly
151730693,15173069,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2210.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Femoral neck fracture,,2018,Q4,3,F,20180629.0,20181120.0,20180720,20181126,EXP,,SE-ASTRAZENECA-2018SE88293,ASTRAZENECA,,29413.0,DY,,F,Y,,,20181126.0,,MD,SE,SE,2018,Q4,Elderly
153617185,15361718,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1390.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Myocardial ischaemia,,2018,Q4,5,F,20180825.0,20181207.0,20180907,20181212,EXP,,VN-ASTRAZENECA-2018SF09892,ASTRAZENECA,,30005.0,DY,,F,Y,,,20181212.0,,MD,VN,VN,2018,Q4,Elderly
153617185,15361718,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1390.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Spinal compression fracture,,2018,Q4,5,F,20180825.0,20181207.0,20180907,20181212,EXP,,VN-ASTRAZENECA-2018SF09892,ASTRAZENECA,,30005.0,DY,,F,Y,,,20181212.0,,MD,VN,VN,2018,Q4,Elderly
153718782,15371878,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,,,,,,,,,,2018,Q4,Anaemia,,2018,Q4,2,F,20180419.0,20181105.0,20180911,20181112,EXP,,AT-ASTRAZENECA-2018SF16280,ASTRAZENECA,,26839.0,DY,,M,Y,,,20181112.0,,MD,AT,AT,2018,Q4,Elderly
154066574,15406657,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2240.0,MG,N,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Aortic aneurysm,,2018,Q4,4,F,20180910.0,20181120.0,20180920,20181122,EXP,,DE-ASTRAZENECA-2018SF19638,ASTRAZENECA,,71.0,YR,,M,Y,,,20181122.0,,MD,DE,DE,2018,Q4,Elderly
154066574,15406657,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2240.0,MG,N,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Graft infection,,2018,Q4,4,F,20180910.0,20181120.0,20180920,20181122,EXP,,DE-ASTRAZENECA-2018SF19638,ASTRAZENECA,,71.0,YR,,M,Y,,,20181122.0,,MD,DE,DE,2018,Q4,Elderly
154126752,15412675,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q4,Anaemia,,2018,Q4,2,F,20180801.0,20181203.0,20180921,20181210,EXP,,PHHY2018DE103416,SANDOZ,,56.0,YR,,M,Y,,,20181211.0,,OT,DE,DE,2018,Q4,Adult
154126752,15412675,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2018,Q4,General physical health deterioration,,2018,Q4,2,F,20180801.0,20181203.0,20180921,20181210,EXP,,PHHY2018DE103416,SANDOZ,,56.0,YR,,M,Y,,,20181211.0,,OT,DE,DE,2018,Q4,Adult
154178202,15417820,29,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MG, UNK",,,U,,,,,5.0,MG,,,2018,Q4,Fructosamine increased,,2018,Q4,2,F,20170830.0,20181011.0,20180924,20181018,EXP,,PHJP2018JP015380,NOVARTIS,,35.0,YR,,F,Y,,,20181018.0,,MD,JP,JP,2018,Q4,Adult
154178202,15417820,29,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MG, UNK",,,U,,,,,5.0,MG,,,2018,Q4,Hyperglycaemia,,2018,Q4,2,F,20170830.0,20181011.0,20180924,20181018,EXP,,PHJP2018JP015380,NOVARTIS,,35.0,YR,,F,Y,,,20181018.0,,MD,JP,JP,2018,Q4,Adult
154433082,15443308,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,870.0,MG,,U,,,,10.0,MG,TABLET,QD,2018,Q4,Acute myocardial infarction,,2018,Q4,2,F,20180912.0,20181017.0,20180928,20181018,EXP,,JP-ASTRAZENECA-2018SF25341,ASTRAZENECA,,21149.0,DY,,M,Y,,,20181018.0,,MD,JP,JP,2018,Q4,Elderly
154568061,15456806,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, DAILY",,,Y,,,,,10.0,MG,,QD,2018,Q4,Vulvovaginal candidiasis,,2018,Q4,1,I,,20180921.0,20181002,20181002,EXP,,"TR-IMPAX LABORATORIES, INC-2018-IPXL-03179",IMPAX,"IMGA NN, CATAK M, BERKER D. DAPAGLIFLOZIN-INDUCED VULVOVAGINITIS IN AN ATOPIC PATIENT WITH TYPE 2 DIABETES MELLITUS. TURK J ENDOCRINOL METAB. 2018;22(3):1-7",48.0,YR,,F,Y,,,20181002.0,,OT,TR,TR,2018,Q4,Adult
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Abdominal pain,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Acetonaemia,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Cholecystitis acute,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Diabetes mellitus inadequate control,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Ketonuria,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Metabolic acidosis,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Nervous system disorder,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,Vomiting,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154576421,15457642,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2018,Q4,White blood cell count increased,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088987,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Abdominal pain,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Acetonaemia,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Cholecystitis acute,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Diabetes mellitus inadequate control,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Ketonuria,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Metabolic acidosis,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Nervous system disorder,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,Vomiting,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154584991,15458499,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,, UNK,,,,,,,2018,Q4,White blood cell count increased,,2018,Q4,1,I,,20180919.0,20181003,20181003,EXP,,PT-AUROBINDO-AUR-APL-2018-048264,AUROBINDO,,66.0,YR,,M,Y,,,20181003.0,,OT,PT,PT,2018,Q4,Elderly
154746751,15474675,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20180911.0,20181001.0,20181008,20181008,EXP,,GB-ASTRAZENECA-2018SF27850,ASTRAZENECA,,75.0,YR,,F,Y,72.0,KG,20181008.0,,,GB,GB,2018,Q4,Elderly
154746751,15474675,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q4,Gastroenteritis,,2018,Q4,1,I,20180911.0,20181001.0,20181008,20181008,EXP,,GB-ASTRAZENECA-2018SF27850,ASTRAZENECA,,75.0,YR,,F,Y,72.0,KG,20181008.0,,,GB,GB,2018,Q4,Elderly
154831021,15483102,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20141013.0,20180929.0,20181010,20181010,EXP,,NL-BAUSCH-BL-2018-027006,BAUSCH AND LOMB,,58.0,YR,,F,Y,,,20181010.0,,CN,US,NL,2018,Q4,Adult
154831021,15483102,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20141013.0,20180929.0,20181010,20181010,EXP,,NL-BAUSCH-BL-2018-027006,BAUSCH AND LOMB,,58.0,YR,,F,Y,,,20181010.0,,CN,US,NL,2018,Q4,Adult
154836371,15483637,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q4,Metabolic acidosis,,2018,Q4,1,I,201807.0,20181002.0,20181010,20181010,EXP,,GB-ASTRAZENECA-2018SF28350,ASTRAZENECA,,69.0,YR,,M,Y,91.7,KG,20181010.0,,,GB,GB,2018,Q4,Elderly
154865851,15486585,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, DAILY, INTRPTD ON: 14OCT14",,,,,,,,10.0,MG,TABLET,,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20141013.0,20180927.0,20181011,20181011,EXP,,NL-AUROBINDO-AUR-APL-2018-049264,AUROBINDO,,58.0,YR,,F,Y,,,20181011.0,,CN,US,NL,2018,Q4,Adult
154865851,15486585,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, DAILY, INTRPTD ON: 14OCT14",,,,,,,,10.0,MG,TABLET,,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20141013.0,20180927.0,20181011,20181011,EXP,,NL-AUROBINDO-AUR-APL-2018-049264,AUROBINDO,,58.0,YR,,F,Y,,,20181011.0,,CN,US,NL,2018,Q4,Adult
154926641,15492664,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,U,,,202293.0,10.0,MG,TABLET,,2018,Q4,Deep vein thrombosis,,2018,Q4,1,I,20180824.0,20181008.0,20181012,20181012,EXP,,GB-ASTRAZENECA-2018SF31155,ASTRAZENECA,,49.0,YR,,F,Y,105.0,KG,20181012.0,,MD,GB,GB,2018,Q4,Adult
154938431,15493843,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,,20181003.0,20181012,20181012,EXP,,GB-ASTRAZENECA-2018SF30012,ASTRAZENECA,,61.0,YR,,M,Y,85.2,KG,20181012.0,,,GB,GB,2018,Q4,Adult
154989721,15498972,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,TABLET,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,,20181004.0,20181015,20181015,EXP,,GB-ASTRAZENECA-2018SF29395,ASTRAZENECA,,57.0,YR,,M,Y,76.8,KG,20181015.0,,OT,GB,GB,2018,Q4,Adult
155002701,15500270,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE DAILY",,,Y,,,,,10.0,MG,,QD,2018,Q4,Euglycaemic diabetic ketoacidosis,,2018,Q4,1,I,,20181008.0,20181015,20181015,EXP,,"TW-IMPAX LABORATORIES, INC-2018-IPXL-03390",IMPAX,,61.0,YR,,F,Y,,,20181015.0,,MD,TW,TW,2018,Q4,Adult
155002701,15500270,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE DAILY",,,Y,,,,,10.0,MG,,QD,2018,Q4,Hypophagia,,2018,Q4,1,I,,20181008.0,20181015,20181015,EXP,,"TW-IMPAX LABORATORIES, INC-2018-IPXL-03390",IMPAX,,61.0,YR,,F,Y,,,20181015.0,,MD,TW,TW,2018,Q4,Adult
155002701,15500270,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE DAILY",,,Y,,,,,10.0,MG,,QD,2018,Q4,Toothache,,2018,Q4,1,I,,20181008.0,20181015,20181015,EXP,,"TW-IMPAX LABORATORIES, INC-2018-IPXL-03390",IMPAX,,61.0,YR,,F,Y,,,20181015.0,,MD,TW,TW,2018,Q4,Adult
155004352,15500435,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,2460.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Cardiac failure congestive,,2018,Q4,2,F,20181011.0,20181023.0,20181015,20181030,EXP,,IN-ASTRAZENECA-2018SF32909,ASTRAZENECA,,22047.0,DY,,M,Y,,,20181030.0,,MD,IN,IN,2018,Q4,Elderly
155166263,15516626,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2018,Q4,Chronic kidney disease,,2018,Q4,3,F,20171120.0,20181030.0,20181017,20181101,EXP,,ES-ASTRAZENECA-2017SF18500,ASTRAZENECA,,27632.0,DY,,F,Y,,,20181101.0,,MD,ES,ES,2018,Q4,Elderly
155166263,15516626,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2018,Q4,Monoclonal gammopathy,,2018,Q4,3,F,20171120.0,20181030.0,20181017,20181101,EXP,,ES-ASTRAZENECA-2017SF18500,ASTRAZENECA,,27632.0,DY,,F,Y,,,20181101.0,,MD,ES,ES,2018,Q4,Elderly
155166263,15516626,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2018,Q4,Normochromic normocytic anaemia,,2018,Q4,3,F,20171120.0,20181030.0,20181017,20181101,EXP,,ES-ASTRAZENECA-2017SF18500,ASTRAZENECA,,27632.0,DY,,F,Y,,,20181101.0,,MD,ES,ES,2018,Q4,Elderly
155185921,15518592,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q4,Duodenal ulcer haemorrhage,,2018,Q4,1,I,20180720.0,20181010.0,20181017,20181017,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-094991,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,143.5,KG,20181017.0,,PH,GB,GB,2018,Q4,Elderly
155185921,15518592,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q4,Fatigue,,2018,Q4,1,I,20180720.0,20181010.0,20181017,20181017,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-094991,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,143.5,KG,20181017.0,,PH,GB,GB,2018,Q4,Elderly
155185921,15518592,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q4,Haematuria,,2018,Q4,1,I,20180720.0,20181010.0,20181017,20181017,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-094991,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,143.5,KG,20181017.0,,PH,GB,GB,2018,Q4,Elderly
155185921,15518592,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q4,Haemoglobin decreased,,2018,Q4,1,I,20180720.0,20181010.0,20181017,20181017,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-094991,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,143.5,KG,20181017.0,,PH,GB,GB,2018,Q4,Elderly
155185921,15518592,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q4,Labelled drug-drug interaction medication error,,2018,Q4,1,I,20180720.0,20181010.0,20181017,20181017,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-094991,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,143.5,KG,20181017.0,,PH,GB,GB,2018,Q4,Elderly
155185921,15518592,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q4,Melaena,,2018,Q4,1,I,20180720.0,20181010.0,20181017,20181017,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-094991,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,143.5,KG,20181017.0,,PH,GB,GB,2018,Q4,Elderly
155185921,15518592,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,, UNKNOWN,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,20180720.0,20181010.0,20181017,20181017,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-094991,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,143.5,KG,20181017.0,,PH,GB,GB,2018,Q4,Elderly
155441891,15544189,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q4,Neoplasm,,2018,Q4,1,I,,20181016.0,20181024,20181024,EXP,,NL-ASTRAZENECA-2018SF38672,ASTRAZENECA,,70.0,YR,,M,Y,,,20181024.0,,CN,NL,NL,2018,Q4,Elderly
155463241,15546324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20181015.0,,20181023,20181023,DIR,,,FDA-CTU,,69.0,YR,,M,N,78.75,KG,20181023.0,N,MD,US,US,2018,Q4,Elderly
155463241,15546324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2018,Q4,Tubulointerstitial nephritis,,2018,Q4,1,I,20181015.0,,20181023,20181023,DIR,,,FDA-CTU,,69.0,YR,,M,N,78.75,KG,20181023.0,N,MD,US,US,2018,Q4,Elderly
155469391,15546939,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,UNSPECIFIED,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20160127.0,20181019.0,20181024,20181024,EXP,,US-JNJFOC-20181032069,JANSSEN,,43.0,YR,A,F,Y,,,20181024.0,,CN,US,US,2018,Q4,Adult
155486481,15548648,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,GB-AUROBINDO-AUR-APL-2018-051596,AUROBINDO,,66.0,YR,,M,Y,143.5,KG,20181025.0,,PH,GB,GB,2018,Q4,Elderly
155486481,15548648,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Duodenal ulcer haemorrhage,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,GB-AUROBINDO-AUR-APL-2018-051596,AUROBINDO,,66.0,YR,,M,Y,143.5,KG,20181025.0,,PH,GB,GB,2018,Q4,Elderly
155486481,15548648,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Fatigue,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,GB-AUROBINDO-AUR-APL-2018-051596,AUROBINDO,,66.0,YR,,M,Y,143.5,KG,20181025.0,,PH,GB,GB,2018,Q4,Elderly
155486481,15548648,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Haematuria,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,GB-AUROBINDO-AUR-APL-2018-051596,AUROBINDO,,66.0,YR,,M,Y,143.5,KG,20181025.0,,PH,GB,GB,2018,Q4,Elderly
155486481,15548648,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Haemoglobin decreased,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,GB-AUROBINDO-AUR-APL-2018-051596,AUROBINDO,,66.0,YR,,M,Y,143.5,KG,20181025.0,,PH,GB,GB,2018,Q4,Elderly
155486481,15548648,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Melaena,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,GB-AUROBINDO-AUR-APL-2018-051596,AUROBINDO,,66.0,YR,,M,Y,143.5,KG,20181025.0,,PH,GB,GB,2018,Q4,Elderly
155486481,15548648,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,GB-AUROBINDO-AUR-APL-2018-051596,AUROBINDO,,66.0,YR,,M,Y,143.5,KG,20181025.0,,PH,GB,GB,2018,Q4,Elderly
155513272,15551327,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2018,Q4,Post-traumatic headache,,2018,Q4,2,F,20181009.0,20181025.0,20181025,20181026,EXP,,PL-ASTRAZENECA-2018SF37784,ASTRAZENECA,,23657.0,DY,,M,Y,,,20181026.0,,MD,PL,PL,2018,Q4,Elderly
155517261,15551726,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,"GB-CANTON LABORATORIES, LLC-2057981",CANTON LABORATORIES,,66.0,YR,,M,Y,143.5,KG,20181025.0,,OT,GB,GB,2018,Q4,Elderly
155517261,15551726,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Duodenal ulcer haemorrhage,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,"GB-CANTON LABORATORIES, LLC-2057981",CANTON LABORATORIES,,66.0,YR,,M,Y,143.5,KG,20181025.0,,OT,GB,GB,2018,Q4,Elderly
155517261,15551726,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Fatigue,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,"GB-CANTON LABORATORIES, LLC-2057981",CANTON LABORATORIES,,66.0,YR,,M,Y,143.5,KG,20181025.0,,OT,GB,GB,2018,Q4,Elderly
155517261,15551726,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Haematuria,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,"GB-CANTON LABORATORIES, LLC-2057981",CANTON LABORATORIES,,66.0,YR,,M,Y,143.5,KG,20181025.0,,OT,GB,GB,2018,Q4,Elderly
155517261,15551726,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Haemoglobin decreased,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,"GB-CANTON LABORATORIES, LLC-2057981",CANTON LABORATORIES,,66.0,YR,,M,Y,143.5,KG,20181025.0,,OT,GB,GB,2018,Q4,Elderly
155517261,15551726,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Melaena,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,"GB-CANTON LABORATORIES, LLC-2057981",CANTON LABORATORIES,,66.0,YR,,M,Y,143.5,KG,20181025.0,,OT,GB,GB,2018,Q4,Elderly
155517261,15551726,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,20180720.0,20181010.0,20181025,20181025,EXP,,"GB-CANTON LABORATORIES, LLC-2057981",CANTON LABORATORIES,,66.0,YR,,M,Y,143.5,KG,20181025.0,,OT,GB,GB,2018,Q4,Elderly
155518271,15551827,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2018,Q4,Haemorrhagic transformation stroke,,2018,Q4,1,I,20181007.0,20181022.0,20181025,20181025,EXP,,BR-ASTRAZENECA-2018SF39200,ASTRAZENECA,,27767.0,DY,,F,Y,,,20181025.0,,MD,BR,BR,2018,Q4,Elderly
155518271,15551827,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2018,Q4,Subdural haematoma,,2018,Q4,1,I,20181007.0,20181022.0,20181025,20181025,EXP,,BR-ASTRAZENECA-2018SF39200,ASTRAZENECA,,27767.0,DY,,F,Y,,,20181025.0,,MD,BR,BR,2018,Q4,Elderly
155518271,15551827,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2018,Q4,Haemorrhagic transformation stroke,,2018,Q4,1,I,20181007.0,20181022.0,20181025,20181025,EXP,,BR-ASTRAZENECA-2018SF39200,ASTRAZENECA,,27767.0,DY,,F,Y,,,20181025.0,,MD,BR,BR,2018,Q4,Elderly
155518271,15551827,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2018,Q4,Subdural haematoma,,2018,Q4,1,I,20181007.0,20181022.0,20181025,20181025,EXP,,BR-ASTRAZENECA-2018SF39200,ASTRAZENECA,,27767.0,DY,,F,Y,,,20181025.0,,MD,BR,BR,2018,Q4,Elderly
155520391,15552039,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Blood creatine phosphokinase increased,,2018,Q4,1,I,20180503.0,20181023.0,20181025,20181025,EXP,GB-MHRA-EYC 00179756,GB-MYLANLABS-2018M1080195,MYLAN,,60.0,YR,,F,Y,79.8,KG,20181025.0,,MD,GB,GB,2018,Q4,Adult
155520391,15552039,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Confusional state,,2018,Q4,1,I,20180503.0,20181023.0,20181025,20181025,EXP,GB-MHRA-EYC 00179756,GB-MYLANLABS-2018M1080195,MYLAN,,60.0,YR,,F,Y,79.8,KG,20181025.0,,MD,GB,GB,2018,Q4,Adult
155520391,15552039,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Inhibitory drug interaction,,2018,Q4,1,I,20180503.0,20181023.0,20181025,20181025,EXP,GB-MHRA-EYC 00179756,GB-MYLANLABS-2018M1080195,MYLAN,,60.0,YR,,F,Y,79.8,KG,20181025.0,,MD,GB,GB,2018,Q4,Adult
155520391,15552039,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2018,Q4,Neuroleptic malignant syndrome,,2018,Q4,1,I,20180503.0,20181023.0,20181025,20181025,EXP,GB-MHRA-EYC 00179756,GB-MYLANLABS-2018M1080195,MYLAN,,60.0,YR,,F,Y,79.8,KG,20181025.0,,MD,GB,GB,2018,Q4,Adult
155554151,15555415,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,,20181011.0,20181026,20181026,EXP,,"IE-IMPAX LABORATORIES, INC-2018-IPXL-03450",IMPAX,"GARRAHY A, BYRNE MM. UNEXPECTED DIABETIC KETOACIDOSIS IN TWO PATIENTS WITH TYPE 2 DIABETES, CAUSE OR COINCIDENCE WITH USE OF SGLT2 INHIBITORS: A REPORT OF TWO CASES. IR J MED SCI. 2017;186(9 SUPPL 1):S365",52.0,YR,,F,Y,,,20181026.0,,OT,IE,IE,2018,Q4,Adult
155554151,15555415,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2018,Q4,Renal impairment,,2018,Q4,1,I,,20181011.0,20181026,20181026,EXP,,"IE-IMPAX LABORATORIES, INC-2018-IPXL-03450",IMPAX,"GARRAHY A, BYRNE MM. UNEXPECTED DIABETIC KETOACIDOSIS IN TWO PATIENTS WITH TYPE 2 DIABETES, CAUSE OR COINCIDENCE WITH USE OF SGLT2 INHIBITORS: A REPORT OF TWO CASES. IR J MED SCI. 2017;186(9 SUPPL 1):S365",52.0,YR,,F,Y,,,20181026.0,,OT,IE,IE,2018,Q4,Adult
155606001,15560600,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20181002.0,20181024.0,20181029,20181029,EXP,,GB-ASTRAZENECA-2018SF40045,ASTRAZENECA,,40.0,YR,,M,Y,116.0,KG,20181029.0,,,GB,GB,2018,Q4,Adult
155636561,15563656,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Drug interaction,,2018,Q4,1,I,20180720.0,20181024.0,20181029,20181029,EXP,GB-MHRA-EYC 00186607,GB-TEVA-2018-GB-970009,TEVA,,66.0,YR,,M,Y,143.5,KG,20181029.0,,PH,GB,GB,2018,Q4,Elderly
155636561,15563656,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Duodenal ulcer haemorrhage,,2018,Q4,1,I,20180720.0,20181024.0,20181029,20181029,EXP,GB-MHRA-EYC 00186607,GB-TEVA-2018-GB-970009,TEVA,,66.0,YR,,M,Y,143.5,KG,20181029.0,,PH,GB,GB,2018,Q4,Elderly
155636561,15563656,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Fatigue,,2018,Q4,1,I,20180720.0,20181024.0,20181029,20181029,EXP,GB-MHRA-EYC 00186607,GB-TEVA-2018-GB-970009,TEVA,,66.0,YR,,M,Y,143.5,KG,20181029.0,,PH,GB,GB,2018,Q4,Elderly
155636561,15563656,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Haematuria,,2018,Q4,1,I,20180720.0,20181024.0,20181029,20181029,EXP,GB-MHRA-EYC 00186607,GB-TEVA-2018-GB-970009,TEVA,,66.0,YR,,M,Y,143.5,KG,20181029.0,,PH,GB,GB,2018,Q4,Elderly
155636561,15563656,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Haemoglobin decreased,,2018,Q4,1,I,20180720.0,20181024.0,20181029,20181029,EXP,GB-MHRA-EYC 00186607,GB-TEVA-2018-GB-970009,TEVA,,66.0,YR,,M,Y,143.5,KG,20181029.0,,PH,GB,GB,2018,Q4,Elderly
155636561,15563656,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Melaena,,2018,Q4,1,I,20180720.0,20181024.0,20181029,20181029,EXP,GB-MHRA-EYC 00186607,GB-TEVA-2018-GB-970009,TEVA,,66.0,YR,,M,Y,143.5,KG,20181029.0,,PH,GB,GB,2018,Q4,Elderly
155636561,15563656,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,20180720.0,20181024.0,20181029,20181029,EXP,GB-MHRA-EYC 00186607,GB-TEVA-2018-GB-970009,TEVA,,66.0,YR,,M,Y,143.5,KG,20181029.0,,PH,GB,GB,2018,Q4,Elderly
155657001,15565700,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",40.0,MG,,,,,,10.0,MG,,QD,2018,Q4,Electrocardiogram ST segment depression,,2018,Q4,1,I,20180706.0,20181019.0,20181030,20181030,EXP,,CN-NOVOPROD-628500,NOVO NORDISK,,62.0,YR,A,M,Y,90.0,KG,20181030.0,,OT,CN,CN,2018,Q4,Adult
155657001,15565700,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",40.0,MG,,,,,,10.0,MG,,QD,2018,Q4,Electrocardiogram T wave inversion,,2018,Q4,1,I,20180706.0,20181019.0,20181030,20181030,EXP,,CN-NOVOPROD-628500,NOVO NORDISK,,62.0,YR,A,M,Y,90.0,KG,20181030.0,,OT,CN,CN,2018,Q4,Adult
155657081,15565708,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q4,Electrocardiogram ST segment depression,,2018,Q4,1,I,,20181019.0,20181030,20181030,EXP,,CN-NOVOPROD-629064,NOVO NORDISK,,62.0,YR,A,M,Y,90.0,KG,20181030.0,,OT,CN,CN,2018,Q4,Adult
155657081,15565708,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2018,Q4,Electrocardiogram T wave inversion,,2018,Q4,1,I,,20181019.0,20181030,20181030,EXP,,CN-NOVOPROD-629064,NOVO NORDISK,,62.0,YR,A,M,Y,90.0,KG,20181030.0,,OT,CN,CN,2018,Q4,Adult
155708301,15570830,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Euglycaemic diabetic ketoacidosis,,2018,Q4,1,I,20181008.0,20181023.0,20181031,20181031,EXP,,GB-ASTRAZENECA-2018SF39648,ASTRAZENECA,,48.0,YR,,M,Y,110.0,KG,20181031.0,,,GB,GB,2018,Q4,Adult
155708301,15570830,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Fatigue,,2018,Q4,1,I,20181008.0,20181023.0,20181031,20181031,EXP,,GB-ASTRAZENECA-2018SF39648,ASTRAZENECA,,48.0,YR,,M,Y,110.0,KG,20181031.0,,,GB,GB,2018,Q4,Adult
155708301,15570830,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Polydipsia,,2018,Q4,1,I,20181008.0,20181023.0,20181031,20181031,EXP,,GB-ASTRAZENECA-2018SF39648,ASTRAZENECA,,48.0,YR,,M,Y,110.0,KG,20181031.0,,,GB,GB,2018,Q4,Adult
155708301,15570830,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Polyuria,,2018,Q4,1,I,20181008.0,20181023.0,20181031,20181031,EXP,,GB-ASTRAZENECA-2018SF39648,ASTRAZENECA,,48.0,YR,,M,Y,110.0,KG,20181031.0,,,GB,GB,2018,Q4,Adult
155713721,15571372,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Candida infection,,2018,Q4,1,I,,20181023.0,20181031,20181031,EXP,,GB-ASTRAZENECA-2018SF39280,ASTRAZENECA,,50.0,YR,,F,Y,94.0,KG,20181031.0,,,GB,GB,2018,Q4,Adult
155746561,15574656,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20180920.0,20181018.0,20181101,20181101,EXP,,TR-ASTRAZENECA-2018SF39312,ASTRAZENECA,,24003.0,DY,,F,Y,53.0,KG,20181101.0,,MD,TR,TR,2018,Q4,Elderly
155757301,15575730,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,U,,,,202293.0,5.0,MG,TABLET,,2018,Q4,Microembolism,,2018,Q4,1,I,20181011.0,20181026.0,20181101,20181101,EXP,,GB-ASTRAZENECA-2018SF41517,ASTRAZENECA,,39.0,YR,,F,Y,125.0,KG,20181101.0,,OT,GB,GB,2018,Q4,Adult
155757301,15575730,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,1.0,DF,,QD,2018,Q4,Microembolism,,2018,Q4,1,I,20181011.0,20181026.0,20181101,20181101,EXP,,GB-ASTRAZENECA-2018SF41517,ASTRAZENECA,,39.0,YR,,F,Y,125.0,KG,20181101.0,,OT,GB,GB,2018,Q4,Adult
155865371,15586537,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2018,Q4,Hyperglycaemia,,2018,Q4,1,I,20141013.0,20181025.0,20181105,20181105,EXP,,NL-PURDUE PHARMA-GBR-2018-0061028,PURDUE,,58.0,YR,,F,Y,,,20181101.0,,CN,NL,NL,2018,Q4,Adult
155865371,15586537,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2018,Q4,Hypoglycaemia,,2018,Q4,1,I,20141013.0,20181025.0,20181105,20181105,EXP,,NL-PURDUE PHARMA-GBR-2018-0061028,PURDUE,,58.0,YR,,F,Y,,,20181101.0,,CN,NL,NL,2018,Q4,Adult
155909351,15590935,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,N,,,,202293.0,10.0,MG,TABLET,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20180820.0,20181030.0,20181107,20181107,EXP,,GB-ASTRAZENECA-2018SF42646,ASTRAZENECA,,51.0,YR,,M,Y,,,20181107.0,,OT,GB,GB,2018,Q4,Adult
155932961,15593296,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,1,I,20180807.0,,20181107,20181107,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20181107.0,N,PH,US,US,2018,Q4,Adult
155932961,15593296,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q4,Euglycaemic diabetic ketoacidosis,,2018,Q4,1,I,20180807.0,,20181107,20181107,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20181107.0,N,PH,US,US,2018,Q4,Adult
155932961,15593296,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2018,Q4,Therapy change,,2018,Q4,1,I,20180807.0,,20181107,20181107,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20181107.0,N,PH,US,US,2018,Q4,Adult
155987241,15598724,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q4,Decreased appetite,,2018,Q4,1,I,201705.0,20181031.0,20181108,20181108,EXP,,ES-ASTRAZENECA-2018SF43333,ASTRAZENECA,,79.0,YR,,F,Y,,,20181108.0,,MD,ES,ES,2018,Q4,Elderly
155987241,15598724,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q4,Memory impairment,,2018,Q4,1,I,201705.0,20181031.0,20181108,20181108,EXP,,ES-ASTRAZENECA-2018SF43333,ASTRAZENECA,,79.0,YR,,F,Y,,,20181108.0,,MD,ES,ES,2018,Q4,Elderly
155987241,15598724,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2018,Q4,Somnolence,,2018,Q4,1,I,201705.0,20181031.0,20181108,20181108,EXP,,ES-ASTRAZENECA-2018SF43333,ASTRAZENECA,,79.0,YR,,F,Y,,,20181108.0,,MD,ES,ES,2018,Q4,Elderly
156045062,15604506,13,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,2,F,,20181203.0,20181110,20181210,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20181211.0,,OT,PT,PT,2018,Q4,Adult
156045062,15604506,13,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,2,F,,20181203.0,20181110,20181210,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20181211.0,,OT,PT,PT,2018,Q4,Adult
156383791,15638379,12,C,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,2018.0,20181113.0,20181120,20181120,EXP,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20181120.0,,PH,PT,PT,2018,Q4,Adult
156383791,15638379,12,C,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,2018.0,20181113.0,20181120,20181120,EXP,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20181120.0,,PH,PT,PT,2018,Q4,Adult
156425151,15642515,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2018,Q4,Pancreatitis,,2018,Q4,1,I,,20181114.0,20181121,20181121,EXP,,AU-ASTRAZENECA-2018SF51348,ASTRAZENECA,,45.0,YR,,F,Y,,,20181121.0,,MD,AU,AU,2018,Q4,Adult
156428241,15642824,3,C,Dapagliflozin 10 mg PO daily,,2,,,,,,,,,,,,,,2018,Q4,Cardiac failure acute,,2018,Q4,1,I,20181115.0,,20181120,20181120,DIR,,,FDA-CTU,,43.0,YR,,M,N,170.0,KG,20181120.0,N,PH,US,US,2018,Q4,Adult
156428241,15642824,3,C,Dapagliflozin 10 mg PO daily,,2,,,,,,,,,,,,,,2018,Q4,Cardiac failure congestive,,2018,Q4,1,I,20181115.0,,20181120,20181120,DIR,,,FDA-CTU,,43.0,YR,,M,N,170.0,KG,20181120.0,N,PH,US,US,2018,Q4,Adult
156428241,15642824,3,C,Dapagliflozin 10 mg PO daily,,2,,,,,,,,,,,,,,2018,Q4,Drug ineffective,,2018,Q4,1,I,20181115.0,,20181120,20181120,DIR,,,FDA-CTU,,43.0,YR,,M,N,170.0,KG,20181120.0,N,PH,US,US,2018,Q4,Adult
156444342,15644434,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,TABLET,,2018,Q4,Chest pain,,2018,Q4,2,F,,20181211.0,20181121,20181217,EXP,,PT-ASTRAZENECA-2018SF50815,ASTRAZENECA,,54.0,YR,,F,Y,,,20181218.0,,CN,PT,PT,2018,Q4,Adult
156444342,15644434,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,TABLET,,2018,Q4,Ischaemic stroke,,2018,Q4,2,F,,20181211.0,20181121,20181217,EXP,,PT-ASTRAZENECA-2018SF50815,ASTRAZENECA,,54.0,YR,,F,Y,,,20181218.0,,CN,PT,PT,2018,Q4,Adult
156560431,15656043,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,,20181115.0,20181126,20181126,EXP,,QA-ASTRAZENECA-2018SF51212,ASTRAZENECA,ALKHIYAMI D. RISK OF DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE II DIABETES MELLITUS UPON DAPAGLIFLOZIN INITIATION. MIDYEAR CLINICAL MEETING OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) 2018;,61.0,YR,,F,Y,,,20181126.0,,OT,QA,QA,2018,Q4,Adult
156579641,15657964,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"UNK UNK, UNK",,,U,,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,,20181114.0,20181126,20181126,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20181126.0,,PH,PT,PT,2018,Q4,Adult
156579641,15657964,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"UNK UNK, UNK",,,U,,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181114.0,20181126,20181126,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20181126.0,,PH,PT,PT,2018,Q4,Adult
156592841,15659284,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,,20181119.0,20181127,20181127,EXP,,IL-TEVA-2018-IL-980108,TEVA,"PERLMAN A, HEYMAN SN, STOKAR J, DARMON D, MUSZKAT M, SZALAT A. CLINICAL SPECTRUM AND MECHANISM OF ACUTE KIDNEY INJURY IN PATIENTS WITH DIABETES MELLITUS ON SGLT-2 INHIBITORS. ISR-MED-ASSOC-J 2018;20(8):513-516.",54.0,YR,,F,Y,,,20181127.0,,MD,IL,IL,2018,Q4,Adult
156659132,15665913,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,UNKNOWN,,2018,Q4,Chest pain,,2018,Q4,2,F,,20181210.0,20181128,20181212,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20181212.0,,OT,GB,PT,2018,Q4,Adult
156659132,15665913,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,UNKNOWN,,2018,Q4,Ischaemic stroke,,2018,Q4,2,F,,20181210.0,20181128,20181212,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20181212.0,,OT,GB,PT,2018,Q4,Adult
156663091,15666309,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,D,,,,5.0,MG,,QD,2018,Q4,Pancreatitis acute,,2018,Q4,1,I,20181118.0,,20181128,20181128,DIR,,,FDA-CTU,,47.0,YR,,M,N,136.0,KG,20181128.0,N,PH,US,US,2018,Q4,Adult
156930681,15693068,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2018,Q4,Immune-mediated hepatitis,,2018,Q4,1,I,,20181202.0,20181206,20181206,EXP,,CA-TEVA-2018-CA-983715,TEVA,,65.0,YR,,M,Y,,,20181206.0,,MD,CA,CA,2018,Q4,Elderly
156962331,15696233,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1110.417,MG,U,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Dehydration,,2018,Q4,1,I,20181115.0,20181130.0,20181206,20181206,EXP,,GB-ASTRAZENECA-2018SF58607,ASTRAZENECA,,70.0,YR,,M,Y,112.0,KG,20181206.0,,,GB,GB,2018,Q4,Elderly
156962331,15696233,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1110.417,MG,U,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Ketonuria,,2018,Q4,1,I,20181115.0,20181130.0,20181206,20181206,EXP,,GB-ASTRAZENECA-2018SF58607,ASTRAZENECA,,70.0,YR,,M,Y,112.0,KG,20181206.0,,,GB,GB,2018,Q4,Elderly
156962331,15696233,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1110.417,MG,U,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Dehydration,,2018,Q4,1,I,20181115.0,20181130.0,20181206,20181206,EXP,,GB-ASTRAZENECA-2018SF58607,ASTRAZENECA,,70.0,YR,,M,Y,112.0,KG,20181206.0,,,GB,GB,2018,Q4,Elderly
156962331,15696233,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1110.417,MG,U,,,,202293.0,10.0,MG,TABLET,QD,2018,Q4,Ketonuria,,2018,Q4,1,I,20181115.0,20181130.0,20181206,20181206,EXP,,GB-ASTRAZENECA-2018SF58607,ASTRAZENECA,,70.0,YR,,M,Y,112.0,KG,20181206.0,,,GB,GB,2018,Q4,Elderly
156998341,15699834,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,TABLET,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20181108.0,20181128.0,20181207,20181207,EXP,,GB-ASTRAZENECA-2018SF56319,ASTRAZENECA,,47.0,YR,,F,Y,,,20181207.0,,,GB,GB,2018,Q4,Adult
157035621,15703562,9,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,,20181127.0,20181210,20181210,EXP,,PT-AUROBINDO-AUR-APL-2018-059436,AUROBINDO,,54.0,YR,,F,Y,,,20181210.0,,PH,PT,PT,2018,Q4,Adult
157035621,15703562,9,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181127.0,20181210,20181210,EXP,,PT-AUROBINDO-AUR-APL-2018-059436,AUROBINDO,,54.0,YR,,F,Y,,,20181210.0,,PH,PT,PT,2018,Q4,Adult
157041061,15704106,11,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,,20181130.0,20181210,20181210,EXP,,PHHY2018PT173656,SANDOZ,,54.0,YR,,F,Y,,,20181210.0,,OT,PT,PT,2018,Q4,Adult
157041061,15704106,11,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181130.0,20181210,20181210,EXP,,PHHY2018PT173656,SANDOZ,,54.0,YR,,F,Y,,,20181210.0,,OT,PT,PT,2018,Q4,Adult
157042871,15704287,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2018,Q4,Acute kidney injury,,2018,Q4,1,I,20180908.0,,20181210,20181210,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20181210.0,N,,US,US,2018,Q4,Elderly
157042871,15704287,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,D,D,,,,,,,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20180908.0,,20181210,20181210,DIR,,,FDA-CTU,,66.0,YR,,M,N,,,20181210.0,N,,US,US,2018,Q4,Elderly
157134101,15713410,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2018,Q4,Euglycaemic diabetic ketoacidosis,,2018,Q4,1,I,20180519.0,,20181129,20181129,DIR,,,FDA-CTU,,58.0,YR,,M,N,72.3,KG,20180817.0,N,PH,US,US,2018,Q4,Adult
157236481,15723648,8,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q4,Chest pain,,2018,Q4,1,I,,20181212.0,20181214,20181214,EXP,,PT-BAYER-2018-233039,BAYER,,54.0,YR,A,F,Y,,,20181214.0,,OT,GB,PT,2018,Q4,Adult
157236481,15723648,8,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2018,Q4,Ischaemic stroke,,2018,Q4,1,I,,20181212.0,20181214,20181214,EXP,,PT-BAYER-2018-233039,BAYER,,54.0,YR,A,F,Y,,,20181214.0,,OT,GB,PT,2018,Q4,Adult
157310181,15731018,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,, UNKNOWN,,,,,,,2018,Q4,Drug-induced liver injury,,2018,Q4,1,I,20181207.0,20181209.0,20181217,20181217,EXP,,BR-NOVOPROD-638160,NOVO NORDISK,,30.0,YR,A,F,Y,,,20181217.0,,CN,BR,BR,2018,Q4,Young Adult
157420081,15742008,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,,,,,10.0,MG,,,2018,Q4,Sepsis,,2018,Q4,1,I,20181013.0,20181015.0,20181219,20181219,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-096858,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,79.5,KG,20181219.0,,OT,ES,ES,2018,Q4,Elderly
157420081,15742008,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,U,,,,,10.0,MG,,,2018,Q4,Urinary tract infection,,2018,Q4,1,I,20181013.0,20181015.0,20181219,20181219,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-096858,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,79.5,KG,20181219.0,,OT,ES,ES,2018,Q4,Elderly
157580721,15758072,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"20 MILLIGRAM, ONCE A DAY",,,U,U,,,,20.0,MG,TABLET,QD,2018,Q4,Hypercholesterolaemia,,2018,Q4,1,I,201801.0,20181210.0,20181225,20181225,EXP,,DE-AUROBINDO-AUR-APL-2018-062254,AUROBINDO,,48.0,YR,,M,Y,86.0,KG,20181225.0,,MD,DE,DE,2018,Q4,Adult
157580721,15758072,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"20 MILLIGRAM, ONCE A DAY",,,U,U,,,,20.0,MG,TABLET,QD,2018,Q4,Renal impairment,,2018,Q4,1,I,201801.0,20181210.0,20181225,20181225,EXP,,DE-AUROBINDO-AUR-APL-2018-062254,AUROBINDO,,48.0,YR,,M,Y,86.0,KG,20181225.0,,MD,DE,DE,2018,Q4,Adult
157580721,15758072,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"20 MILLIGRAM, ONCE A DAY",,,U,U,,,,20.0,MG,TABLET,QD,2018,Q4,Type 2 diabetes mellitus,,2018,Q4,1,I,201801.0,20181210.0,20181225,20181225,EXP,,DE-AUROBINDO-AUR-APL-2018-062254,AUROBINDO,,48.0,YR,,M,Y,86.0,KG,20181225.0,,MD,DE,DE,2018,Q4,Adult
157580721,15758072,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,U,U,,,,10.0,MG,TABLET,QD,2018,Q4,Hypercholesterolaemia,,2018,Q4,1,I,201801.0,20181210.0,20181225,20181225,EXP,,DE-AUROBINDO-AUR-APL-2018-062254,AUROBINDO,,48.0,YR,,M,Y,86.0,KG,20181225.0,,MD,DE,DE,2018,Q4,Adult
157580721,15758072,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,U,U,,,,10.0,MG,TABLET,QD,2018,Q4,Renal impairment,,2018,Q4,1,I,201801.0,20181210.0,20181225,20181225,EXP,,DE-AUROBINDO-AUR-APL-2018-062254,AUROBINDO,,48.0,YR,,M,Y,86.0,KG,20181225.0,,MD,DE,DE,2018,Q4,Adult
157580721,15758072,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,U,U,,,,10.0,MG,TABLET,QD,2018,Q4,Type 2 diabetes mellitus,,2018,Q4,1,I,201801.0,20181210.0,20181225,20181225,EXP,,DE-AUROBINDO-AUR-APL-2018-062254,AUROBINDO,,48.0,YR,,M,Y,86.0,KG,20181225.0,,MD,DE,DE,2018,Q4,Adult
157648941,15764894,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2018,Q4,Diabetic ketoacidosis,,2018,Q4,1,I,20181203.0,20181218.0,20181227,20181227,EXP,,GB-ASTRAZENECA-2018SF67900,ASTRAZENECA,,84.0,YR,,F,Y,,,20181227.0,,PH,GB,GB,2018,Q4,Elderly
157689651,15768965,2,SS,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,D,,,,,,,,,2018,Q4,Medication error,,2018,Q4,1,I,,20181214.0,20181228,20181228,EXP,,US-AUROBINDO-AUR-APL-2018-062128,AUROBINDO,,61.0,YR,,M,Y,,,20181228.0,,MD,US,US,2018,Q4,Adult
157738141,15773814,9,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q4,Confusional state,,2018,Q4,1,I,20181115.0,20181220.0,20181229,20181229,EXP,GB-MHRA-EYC 00191112,GB-TEVA-2018-GB-992469,TEVA,,64.0,YR,,F,Y,110.0,KG,20181229.0,,CN,GB,GB,2018,Q4,Adult
157738141,15773814,9,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q4,Depression,,2018,Q4,1,I,20181115.0,20181220.0,20181229,20181229,EXP,GB-MHRA-EYC 00191112,GB-TEVA-2018-GB-992469,TEVA,,64.0,YR,,F,Y,110.0,KG,20181229.0,,CN,GB,GB,2018,Q4,Adult
157738141,15773814,9,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q4,Dyspnoea,,2018,Q4,1,I,20181115.0,20181220.0,20181229,20181229,EXP,GB-MHRA-EYC 00191112,GB-TEVA-2018-GB-992469,TEVA,,64.0,YR,,F,Y,110.0,KG,20181229.0,,CN,GB,GB,2018,Q4,Adult
157738141,15773814,9,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q4,Headache,,2018,Q4,1,I,20181115.0,20181220.0,20181229,20181229,EXP,GB-MHRA-EYC 00191112,GB-TEVA-2018-GB-992469,TEVA,,64.0,YR,,F,Y,110.0,KG,20181229.0,,CN,GB,GB,2018,Q4,Adult
157738141,15773814,9,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q4,Nausea,,2018,Q4,1,I,20181115.0,20181220.0,20181229,20181229,EXP,GB-MHRA-EYC 00191112,GB-TEVA-2018-GB-992469,TEVA,,64.0,YR,,F,Y,110.0,KG,20181229.0,,CN,GB,GB,2018,Q4,Adult
157738141,15773814,9,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q4,Pruritus,,2018,Q4,1,I,20181115.0,20181220.0,20181229,20181229,EXP,GB-MHRA-EYC 00191112,GB-TEVA-2018-GB-992469,TEVA,,64.0,YR,,F,Y,110.0,KG,20181229.0,,CN,GB,GB,2018,Q4,Adult
157738141,15773814,9,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2018,Q4,Visual impairment,,2018,Q4,1,I,20181115.0,20181220.0,20181229,20181229,EXP,GB-MHRA-EYC 00191112,GB-TEVA-2018-GB-992469,TEVA,,64.0,YR,,F,Y,110.0,KG,20181229.0,,CN,GB,GB,2018,Q4,Adult
84597452,8459745,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2018,Q4,Chills,,2018,Q4,2,F,,20180925.0,20120314,20181004,PER,,US-ASTRAZENECA-2011SE48968,ASTRAZENECA,,60.0,YR,,F,Y,,,20181004.0,,CN,US,US,2018,Q4,Adult
84597452,8459745,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2018,Q4,Product dose omission,,2018,Q4,2,F,,20180925.0,20120314,20181004,PER,,US-ASTRAZENECA-2011SE48968,ASTRAZENECA,,60.0,YR,,F,Y,,,20181004.0,,CN,US,US,2018,Q4,Adult
84597452,8459745,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2018,Q4,Pyrexia,,2018,Q4,2,F,,20180925.0,20120314,20181004,PER,,US-ASTRAZENECA-2011SE48968,ASTRAZENECA,,60.0,YR,,F,Y,,,20181004.0,,CN,US,US,2018,Q4,Adult
84597452,8459745,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2018,Q4,Streptococcal infection,,2018,Q4,2,F,,20180925.0,20120314,20181004,PER,,US-ASTRAZENECA-2011SE48968,ASTRAZENECA,,60.0,YR,,F,Y,,,20181004.0,,CN,US,US,2018,Q4,Adult
